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Preface 
The work presented in this doctoral thesis summarises the research that I have been involved 
in since 2009 with regard to the regulation and risk assessment of nanomaterials (NMs), 
specifically in regard to: 1) mapping current uses of nanomaterials in Europe, 2) 
understanding the limitations of existing legislation and, finally, 3) addressing the restraints of 
risk assessment and alternatives to risk assessment when it comes to nanomaterials.  
The thesis itself focuses on extracting key research observations and findings from 
within each of these three areas and integrating them into a proposal for a new regulatory 
framework for the registration, evaluation and authorisation of nanomaterials. This proposed 
framework is termed Registration, Evaluation, Authorisation, Categorisation and Tools to 
Evaluate Nanomaterials – Opportunities and Weaknesses (REACT NOW). The need for a 
new framework for the regulation of nanomaterials might not seem self-evident, and the view 
that it is urgently needed might be somewhat controversial.  
Schopenhauer once said that “All truth passes through three stages. First, it is ridiculed. 
Second, it is violently opposed. Third, it is accepted as being self-evident.” If the ideas 
presented in this doctoral thesis seem ridiculous or are violently opposed, then I hope that it is 
just because they – and REACT NOW – are about to be accepted as self-evident in the near 
future. 
The elements of REACT NOW have been developed over time and are inspired by the 
Danish and European research projects in which I have been involved, the foremost being 
“EnvNano – Environmental Effects and Risk Evaluation of Engineered Nanoparticles,” led by 
Principal Investigator Professor Anders Baun and funded by the European Research Council, 
“SUN – Sustainable Nanotechnologies,” led by Principal Coordinator Professor Antonio 
Marcomini and funded by the EU FP7 Research Programme, and, finally, “Better Regulation 
of Chemicals,” led by the Danish Ecological Council and funded by the Villum Foundation.  
Further encouragement has come from the national and international public authority 
service and consultancy with which I have been engaged. This includes the Reach 
Implementation Project on Nanomaterials (RIP-oN 1) on Substance Identification of 
Nanomaterials, where I represented the European Environmental Bureau, and RIP-oN 2 and 3 
on the development of specific advice on the implementation of REACH for nanomaterials, 
led by the Institute of Occupational Medicine. It furthermore includes reviews of 
environmental legislation for the regulatory control of nanomaterials, commissioned by the 
European Commission and led by Milieu Ltd. in 2011 and Ricardo Energy & Environment in 
2016, reviews of the scientific state of the art when it comes to environmental effect and 
exposure, as requested by the Danish Environmental Protection Agency and led by COWI 
Denmark, and, finally, assisting in preparing a meeting report on human health, scientific 
evidence and the risk governance of nanomaterials for the World Health Organisation, 
Regional Office for Europe. Additional motivation and further indications of the need for 
REACT NOW has revealed itself to me through the effort that I have put in to fulfilling my 
role as a scientific and technical advisor for the European Environmental Bureau in the 
Nanomaterials Working Group, established by the European Chemicals Agency, as well as in 
the Partner Expert Groups (PEGs) on registration, QSARs and Grouping and End-point 
specific guidance.  
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The work presented in this doctoral thesis is based on 28 peer-reviewed papers 
published in the period 2009-2017 and is based on the research that I performed at the 
Department of Environmental Engineering, Technical University of Denmark and during my 
external stay at the European Environmental Agency as a guest researcher from November 
2011-April 2012.  
Althea Gibson once said that “No matter what accomplishments you make, somebody 
helped you.” And this is also true for the work presented in this thesis; there are a lot of 
people that I would like to thank. First of all, I wish to thank Professor Anders Baun and all 
the co-authors with whom I have had the pleasure of working with. Second, I would like to 
thank the members of the Nanorisk group and the Environmental Chemistry section at DTU 
Environment. And third, I would like to thank Torben Dolin for graphical assistance and 
Mette Topp Hansen for secretarial support. Finally, I would like to thank my parents and my 
brother for their relentless encouragement and Maria and our children for their unconditional 
support.  
     
                       Copenhagen, August 2017  
 
         Steffen Foss Hansen 
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Executive summary 
Nanotechnology and nanomaterials (NMs) have become an integrated part of our lives in the 
past decade, whether we realise it or not, and we have entered a phase where the early hype 
about the benefits of this mind-blowing technology is over.  
Concerns have been raised throughout this period about the adverse impacts of NMs, 
and although these have previously been very loud, they are now slowly quieting down. This 
is not because we have resolved the challenges related to assessing and managing the risks of 
NMs but rather because we seem to have caught a sense of “nanorisk-immunity” where we 
gradually have become more and more indifferent to hearing about the potential risks of NMs.  
Instead of implementing a regulatory framework tailored to NMs, the European 
Commission has initiated multiple reviews of state-of-the-scientific literature in regard to 
environmental, health and safety, and seems to be discussing the same risk assessment and 
regulatory challenges over and over. If history in regard to emerging risks and hazards can be 
used as a guide, we can now expect 15-20 years of univocal environmental, health and safety 
research that will not provide definitive answers but only dropwise glimpse into the true 
nature of the risks of NMs.  
This thesis summarises the state of research and regulatory affairs within the field of 
nanomaterial regulation and risk assessment. Specifically, the focus is on areas of research 
with which I have been involved since 2009 in regard to: 1) mapping current uses of NMs in 
Europe, 2) understanding the limitations of existing legislation and, finally, 3) addressing the 
restraints of risk assessment and alternatives to risk assessment when it comes to NMs.  
In order to obtain an overview of consumer products in Europe that are claimed to 
contain NMs or are claimed to be based on nanotechnology, we established an online 
inventory, The Nanodatabase (www.nanodb.dk), back in 2012 and started systematically to 
collect information about the proclaimed nanoproducts name, producers “nanoclaim”, country 
of origin, used NMs, location of the NM in the product, most likely exposure route among 
other. The Nanodatabase originally contained a little more than 1,200 products and now has 
information about more than 3,000 products. Through our research, we found that most of the 
products fall into the category of “Health and Fitness” and “Home and Garden”. The most 
used NMs are silver and titanium dioxide, but it is not possible to identify the NMs used for 
almost 60% of the products in the database.  
The safety evaluation tool, NanoRiskCat, was developed and integrated into The 
Nanodatabase with the purpose of communicating what is known about the hazard and 
exposure potential of consumer products containing NMs. In its simplest form, the final 
NanoRiskCat evaluation of a specific nanomaterial in a given application can be 
communicated in the form of a short title describing the use of the NM and a colour code 
whereby the first three coloured bullets (׀) refer to the potential exposure of professional 
end-users, consumers and the environment – in that sequence – and the last two coloured 
bullets refer to the hazard potential for humans and the environment. The colours assigned to 
the exposure and hazard potential are green (), yellow (), red () and grey (), 
corresponding to high, medium, low and unknown, respectively. A data analysis of the 
products in The Nanodatabase shows that for most product categories, the dominant route of 
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exposure is dermal, and that the NanoRiskCat exposure potential as well as human and 
environmental hazard potential of most products is either “high ()” or “unknown ()”.  
In order to address the potential risks of NMs and take the unique properties of NMs 
into account, a number of EU regulations and directives have been amended in recent years 
such as, for instance, the biocidal product regulation. However, the research presented in this 
thesis identifies three major weaknesses to the current regulation, namely how to define 
“nanomaterials”, threshold values and information requirements not tailored to the nanoscale 
and how to overcome the obstacles of chemical risk assessment applied to NMs.  
The outcome of this research has led me to conclude that the fact that NMs are covered 
by the scope of existing legislation is not enough to ensure the protection of human health and 
the environment. We therefore need a new regulatory framework tailored for NMs and their 
applications. A proposal of such a framework termed “Registration, Evaluation, 
Authorisation, Categorisation and Tools to Evaluate Nanomaterials – Opportunities and 
Weaknesses (REACT NOW)” is proposed and presented herein.  
The thesis consists of nine chapters. An introduction is provided in chapter 1. In chapter 
2, what is known about the current uses of NMs is presented in detail, and it is established 
that there is a general lack of data and access to data on, for example, production volumes and 
uses of NMs which hampers qualitative and quantitative occupational, consumer and 
environmental exposure assessment of NMs – and this in turn impedes the completion of any 
kind of risk assessment. The latter has repetitively led to questions being raised by politicians, 
NGOs, academics and members of the public about whether current regulatory frameworks 
are up to the job, as many of them rely heavily on, for instance, the completion of meaningful 
risk assessments.  
Chapter 3 is devoted to an analysis of the revisions that have been made to existing 
regulatory frameworks, such as REACH, BPR and food legislation, whereas Chapter 4 is 
allocated to an evaluation of proposed revisions made by a number of EU member states and 
REACH competent authorities such as German UBA, BfR and BAuA and the Swedish 
KEMI, as well as the NGOs CIEL, ClientEarth and BUND. It is concluded that the revisions 
that have been implemented for existing EU legislation and the proposed revisions by UBA, 
BfR and BAuA, KEMI and CIEL, ClientEarth and BUND collectively provide a lot of 
opportunities. However, a number of weaknesses have also been identified and these are 
elaborated on and discussed in Chapter 5, as they continue to dog the effective regulation of 
NMs and still need to be addressed.  
In recognition of the challenges that traditional chemical risk assessments entail, and 
outstanding scientific research questions that still need to be resolved, no less than 50 
alternative decision-support tools, or supplements to traditional risk assessments, have been 
explored and proposed in recent years. These are analysed in Chapter 6, in order to identify 
tools that could potentially be used to support a new regulatory framework tailored 
specifically for NMs and their applications throughout the life cycle. This evaluation is based 
on a series of recent scientific publications which provide substantial reviews of these 
alternative tools applied in regard to risk governance, worker protection, consumer exposure, 
environmental assessment, waste, etc. This led to the realisation that we need a tool that is 
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both regulatory-relevant and can be applied despite the lack of data and lack of access to 
information.  
Safety evaluation plays a key role in REACT NOW and the safety evaluation tool 
NanoRiskCat developed by Hansen et al. (2014, 2017c) is presented in detail in chapter 7. A 
strength of NanoRiskCat is that it has been applied to more than 2,000 products claimed to 
include NMs or to be based on nanotechnology. The outcome of this is presented in this 
thesis. Finally, in Chapter 8, REACT NOW is introduced and key components of the 
framework are outlined.  
As part of REACT NOW, I recommend that manufacturers and importers of NMs 
should be required to register their NM(s) prior to commercialisation and independent of 
production and import volumes.  
For NM(s) already being sold, manufacturers and importers should be required to 
register and fulfil the REACT NOW requirements within a certain time period e.g. six months 
of the adoption of the framework. NMs are defined according to SCENIHR’s definition and 
not the one recommended by the EC. Primary particle size distribution, shape (including 
aspect ratio), specific surface area and surface treatment are considered “identifiers” and not 
the “characterisers” as suggested by UBA, BfR and BAuA (2013). In practice, this means that 
any variation in size, shape, surface area and surface-treated NM that is commercialised in the 
EU has to be identified, named, registered and safety-evaluated separately, before it is placed 
into a separate registration dossier.  
The European Chemicals Agency is identified as the European authority that should be 
responsible for the management and carrying out the technical and administrative aspects of 
REACT NOW, however the burden of proof of safety should be placed on industry to ensure 
that data are generated in good time. In order to ensure the protection of health and the 
environment, I recommend that the registrant should be required to explain a relevant 
product’s functional use, provide justification for its use and carry out an effectiveness 
evaluation prior to the commercialisation of any nanomaterial.  
Following the requirements of REACT NOW, all uses of NMs have to be evaluated 
according to NanoRiskCat. The health and environmental hazard information required as part 
of the information requirements focuses on enabling the application of NanoRiskCat. In 
regard to human health it includes High Aspect Ratio Nanoparticles (HARN), bulk CLP 
classification, acutely toxicity, genotoxicity and mutagenicity, carcinogenicity and respiratory 
toxicity. For the environment, it includes bulk CLP classification, aquatic toxicity, freshwater 
tests for degradation, bioaccumulation and a scientific review in regard to dispersive or long-
range transport, ecosystem effects and novelty. It is important to note that NanoRiskCat uses 
a tiered approach and that the registrant only has to submit enough information to enable the 
categorisation of the health and environmental hazard potential of the specific NM into high 
(), medium (), low () or unknown ().  
Depending on the outcome of the NanoRiskCat evaluation, manufacturers and 
importers of NMs and producers of NM products might have to seek authorisation, which can 
only be given for specific uses of NMs and nanoproducts that are deemed necessary, efficient 
and have a functional use.  
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For NMs that have undergone a NanoRiskCat evaluation and have 1) a red professional 
end-user and/or a consumer exposure profile combined with a red human health hazard 
profile and/or 2) a red environmental exposure profile combined with a red environmental 
hazard profile, the registrant is required to complete an “Alternatives Assessment” and the 
agency responsible for REACT NOW is required to seek opinion on safe use from the 
European scientific committee of relevance. In such cases, authorisation should be granted, 
but only if the specific use under consideration is deemed safe and necessary.  
Uses of NMs deemed not to be safe by the scientific committees e.g. dispersive uses of 
HARN, indoor consumer uses of spray products with NMs associated with respiratory 
toxicity, should not be granted authorisation and should not be given permission to be 
marketed in Europe. For all other combinations of exposure and hazard profiles, i.e. 
NanoRiskCat categories 2-4, the agency responsible for REACT NOW can ask for an opinion 
from the scientific committees of relevance on a case-by-case basis.  
As a general rule, authorisation should only be given for specific professional end-user 
and consumer applications of NMs and nanoproducts, if they have a green human health 
hazard profile combined with a green professional end-user exposure profile and a consumer 
exposure profile, respectively. The same goes for uses that are expected to lead to 
environmental exposure that should only be granted authorisation if the NM in question has a 
green environmental hazard profile.  
Should the agency or the scientific committees have questions about the safety of a 
given NM and its specific use, the agency can make a request for additional information, to be 
generated within 3 years, within which time conditional authorisation can be granted.  
For combinations of yellow exposure and hazard profiles, conditional authorisation is 
possible for a time-limited period during which time the agency should request the generation 
of additional information by the registrant. In order to assist industry and especially Small and 
Medium-sized Enterprises in the process of implementing REACT NOW, technical and non-
technical assistance is needed and should be provided by the European Commission Joint 
Research Centre and the European Chemicals Agency.  
REACT NOW is the first attempt to present a comprehensive and transparent decision-
making framework tailored to regulate the use of NMs, but as no framework is without either 
potential or limitations, the opportunities and weaknesses related to the implementation of 
REACT NOW are pinpointed. Strengths include that NanoRiskCat can be used despite lack 
of data and information, whereas the lack of clear-cut definitions of “necessity” and 
“effectiveness” could be considered a weakness along with the arguably crude exposure 
assessment in NanoRiskCat.  
In the appendix, the 28 peer reviewed journal papers on which this thesis is based are 
included. It is worth pointing out that most of the topics briefly discussed and presented in 
Chapters 2-8 are detailed in the journal papers and that this thesis is written to present 
REACT NOW and to give the reader an overview of the original achievements of the work. 
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Danish summary 
Uanset om vi er klar over det eller ej, er nanoteknologi og nanomaterialer i det seneste årti 
blevet en integreret del af vores liv. Vi er gået ind i en fase, hvor den tidlige hype om 
fordelene ved denne – mildt sagt forbløffende – teknologi er forbi.  
Siden nanoteknologiens spæde begyndelse er der blevet rejst tvivl om de eventuelle 
negative miljø- og sundhedseffekter af nanomaterialer. Men som tiden er gået, er der blevet 
mere og mere stille omkring disse. Det er ikke, fordi vi har løst udfordringerne i forbindelse 
med risikovurdering og håndtering af nanomaterialer, men snarere fordi vi synes at være 
fanget af en følelse af “nanorisiko-immunitet”, hvor vi efterhånden er blevet mere og mere 
immune overfor nyheder om de potentielle risici ved nanomaterialer.  
I stedet for at implementere et nyt regelsæt skræddersyet til nanomaterialer, synes 
Europa-Kommissionen at foretrække at igangsætte diverse udredninger af den videnskabelige 
litteratur med hensyn til miljø og sundhed samt at diskutere de samme risikovurderings- og 
lovgivningsmæssige udfordringer igen og igen. Hvis erfaringerne fra tidligere tiders 
håndtering af nye risici og teknologier kan benyttes som en rettesnor, kan vi nu forvente 15-
20 års miljø- og sundhedsforskning, der ikke vil give endegyldige svar på, hvorvidt 
nanomaterialer er farlige, og som kun dråbevist vil vise glimt af den sande natur af risikoen 
ved anvendelsen af nanomaterialer.  
Denne afhandling sammenfatter vores nuværende viden indenfor risikovurdering og 
regulering af nanomaterialer. Konkret er fokus på de tre forskningsområder, som jeg har 
været involveret i siden 2009 med hensyn til: 1) at kortlægge af nuværende anvendelser af 
nanomaterialer i Europa, 2) at forstå begrænsningerne i den eksisterende lovgivning, og 
endelig 3) at adressere begrænsningerne som risikovurdering – og alternativer til 
risikovurdering – har, når det kommer til nanomaterialer.  
For at få et overblik over forbrugerprodukter i Europa som enten hævdes at indeholde 
nanomaterialer, eller som hævdes at være baseret på nanoteknologi, etablerede vi i 2012 en 
online database, Nanodatabasen (www.nanodb.dk) og begyndte systematisk at indsamle 
information om påståede nanoprodukters navn, producentens “nanopåstand”, oprindelsesland, 
anvendt nanomateriale, lokalitet af det anvendte nanomateriale i produktet og mest 
sandsynlige eksponeringsrute blandt anden. Nanodatabasen indeholdt oprindeligt lidt mere 
end 1.200 produkter og indeholder nu information om mere end 3.000 forskellige produkter. 
Igennem vores forskning har vi fundet ud af, at de fleste produkter falder indenfor 
kategorierne “Health and Fitness” and “Home and Garden”. De mest anvendte nanomaterialer 
er sølv og titaniumdioxid, men det er vigtigt at påpege, at det ikke er muligt at identificere 
identiteten af det anvendte nanomateriale i næsten 60% af produkterne i databasen.  
Evalueringsværktøjet, NanoRiskCat, blev udviklet og integreret i Nanodatabasen med 
det formål at kommunikere, hvad man ved om fare- og eksponeringspotentialet af produkter, 
som indeholder nanomaterialer. Det endelige resultat af NanoRiskCat evalueringen af et 
specifikt nanomateriale til en given anvendelse kan i sin simpleste form fremlægges i form af 
en kort titel, som beskriver anvendelse af nanomaterialet og en farvekode, hvor de første tre 
farvede bullets (׀) refererer til den potentielle eksponering for henholdsvis 
professionelle slutbrugere, forbrugere og miljøet – i den rækkefølge – og de sidste to bullets 
refererer til farepotentialet for mennesker og miljøet. Farverne, som kan allokeres til 
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eksponerings- og farepotentialet, er henholdsvis grøn (), gul (), rød () and grå (), svarende 
til henholdsvis høj, medium, lav og ukendt. En dataanalyse af produkterne i Nanodatabasen 
viser, at dermal eksponering er den mest sandsynlige eksponeringsvej, og at NanoRiskCat 
eksponeringspotentialet såvel som menneske- og miljøfarepotentialet for de fleste produkter 
er enten “høj ()” eller “ukendt ()”.  
En række EU forordninger og direktiver så som, bl.a. biocidforordningen, er blevet 
ændret i de seneste år for at tage højde for de potentielle risici forbundet med nanomaterialer 
og for at tage højde for nanomaterialers unikke egenskaber. Dog viser den forskning, der 
præsenteres i denne afhandling, at der er tre store svagheder forbundet med den nuværende 
regulering, såsom: 1) hvordan man definerer “nanomaterialer”, 2) tærskelværdier og 
oplysningskrav, som ikke er skræddersyet til nanomaterialer og 3) de massive videnskabelige 
udfordringer, der er ved at anvende traditionel kemisk risikovurdering som metode på 
nanomaterialer i praksis. 
Resultatet af denne forskning har fået mig til at konkludere, at det, at nanomaterialer er 
omfattet af eksisterende lovgivning, rent juridisk ikke i sig selv er nok til at sikre beskyttelsen 
af miljøet og menneskers sundhed. Vi har derfor brug for en ny lovgivning, som er 
skræddersyet til nanomaterialer og deres anvendelser. I den sidste del af afhandlingen foreslås 
en sådan lovgivning kaldet Registration, Evaluation, Authorisation, Categorisation and Tools 
to Evaluate Nanomaterials – Opportunities and Weaknesses (REACT NOW). Afhandlingen 
består af ni kapitler.  
En kort introduktion gives i kapitel 1. I kapitel 2 præsenteres vores viden om de 
nuværende anvendelser af nanomaterialer. Det fastslås, at der er en generel mangel på data og 
adgang til data om, blandt andet vedrørende produktionsmængder og anvendelser af 
nanomaterialer. Den manglende viden hæmmer enhver form for kvalitativ og kvantitativ 
eksponeringsvurdering af nanomaterialer, hvilket igen hindrer enhver form for kemisk 
risikovurdering.  
En række politikere, forskere, NGO’er og medlemmer af offentligheden har sat 
spørgsmålstegn ved, om den nuværende regulering er god nok. Blandt andet fordi mange af 
de mest relevante EU-forordninger og direktiver er stærkt afhængige af vores evne til at 
færdiggøre meningsfulde videnskabelige risikovurderinger.  
Kapitel 3 er helliget en analyse af de ændringer, der er foretaget i den eksisterende 
lovgivning inden for kemikalie-, biocidholdige produkt- og fødevarelovgivningen. I kapitel 4 
præsenteres en analyse og vurdering af de yderligere juridiske og tekniske revisioner, som er 
blevet foreslået af en række EU-landes REACH-kompetente myndigheder som de tyske 
UBA, BfR og BAuA og den svenske KEMI, samt NGO’erne CIEL, ClientEarth og BUND. 
Det konkluderes, at de ændringer, der er blevet gennemført i den eksisterende EU-lovgivning 
og de foreslåede yderligere ændringer, kollektivt indeholder en masse muligheder. Dog blev 
der ligeledes identificeret en række svagheder, og disse bliver uddybet og diskuteret i kapitel 
5, da de fortsat obstruerer en effektiv regulering af nanomaterialer.  
I erkendelse af de udfordringer, som anvendelsen af kemisk risikovurdering indebærer 
og de udestående videnskabelige usikkerheder, er mere end 50 alternative beslutningsmetoder 
eller supplement til kemisk risikovurdering blevet udarbejdet og foreslået i de senere år. Disse 
analyseres i kapitel 6 for at identificere metoder, der kan anvendes til at understøtte en 
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lovgivning, som er skræddersyet specielt til nanomaterialer og deres anvendelser. Denne 
evaluering er baseret på en række af de seneste videnskabelige publikationer, som systematisk 
gennemgår, hvorledes disse alternative metoder kan anvendes i forbindelse med 
risikohåndtering, beskyttelse af arbejdstagerne, forbrugernes eksponering, miljøvurdering, 
affald, osv. Dette fører til den erkendelse, at vi har brug for en evalueringsmetode, der er både 
lovgivningsmæssig relevant, og som kan anvendes på trods af manglende data og manglende 
adgang til information.  
I kapitel 7 præsenteres evalueringsmetoden NanoRiskCat. En stor styrke i NanoRiskCat 
er, at metoden er blevet anvendt på mere end 2.000 produkter, som enten hævdes at indeholde 
nanomaterialer, eller som hævdes at være baseret på nanoteknologi.  
Endelig introduceres REACT NOW i kapitel 8. Centrale elementer i den foreslåede 
lovgivning skitseres. Som en del af REACT NOW anbefales det, at producenter og importører 
af nanomaterialer bliver forpligtiget til at registrere deres nanomaterialer forud for 
kommercialisering og uafhængig af mængden, der produceres og/eller importeres.  
For nanomaterialer, som allerede er på markedet, bør det kræves, at producenter og 
importører opfylder betingelserne i REACT NOW inden for en tidsperiode som for eksempel 
seks måneder. Nanomaterialer defineres i REACT NOW i henhold til Europa-Kommissionens 
videnskabelige komite, SCENIHR’s forslag og ikke i henhold til den definition, som 
anbefales af Europa-Kommissionen. Primær partikelstørrelsesfordeling, form, specifikt 
overfladeareal og overfladebehandling betragtes som identifikatorer og ikke som 
karakteristika, som foreslået af UBA, BfR og BAuA (2013). I praksis betyder det, at enhver 
variation i primær partikelstørrelsesfordeling, form, specifikt overfladeareal og 
overfladebehandling skal identificeres, navngives, registreres og evalueres separat.  
Det Europæiske Kemikalieagentur identificeres som værende den Europæiske 
myndighed, som bør være ansvarlig for forvaltningen og gennemførelsen af de tekniske og 
administrative aspekter af REACT NOW, mens bevisbyrden for at vise, at nanomaterialer er 
sikre, pålægges producenterne og importørerne af disse for at sikre, at relevant information og 
data genereres i tide.  
For at sikre beskyttelsen af sundheden og miljøet anbefales det, at registranten er 
forpligtet til at forklare det pågældende produkts funktion, begrunde dets nødvendighed og 
gennemføre en effektivitetsevaluering forud for en kommercialisering. I forlængelse af disse 
krav skal alle nanomaterialer evalueres ved hjælp af NanoRiskCat.  
De oplysninger vedrørende nanomaterialers fare for sundhed og miljø, som der stilles 
krav om, at producenterne og/eller importørerne indleverer, er fokuseret på at gøre det muligt 
at anvende NanoRiskCat. Det vil sige, at fokus er på, om nanomaterialet er et såkaldt “High 
Aspect Ratio Nanoparticles” (HARN), den nuværende klassificering og mærkning af ikke-
nanoformen af materialet, dets akutte toksicitet, genotoksicitet og mutagenicitet, 
carcinogenicitet samt dets respiratoriske toksicitet.  
Vedrørende miljøet drejer det sig hovedsaglig om den nuværende klassificering og 
mærkning af ikke-nanoformen af materialet, dets akvatiske toksicitet, ferskvands test for 
nedbrydning og bioakkumulering. Dertil kommer en videnskabelig gennemgang med hensyn 
til udbredelse og langtrækkende transport, økosystemets effekter og nyhedsværdi.  
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Det er vigtigt at bemærke, at NanoRiskCat bruger en trinvis fremgangsmåde. 
Registranten behøver kun at indsende nok information til, at der kan foretages en 
kategorisering af farepotentialet for miljø- og sundhed af det specifikke nanomateriale i dets 
specifikke anvendelse. Der anvendes 4 farvekategorier, nemlig 1) rød for, at farepotentialet er 
højt; 2) gul for, at farepotentialet er medium; 3) grøn for, at farepotentialet er lavt og endelig 
4) grå for, at farepotentialet er ukendt.  
Afhængigt af resultatet af NanoRiskCat evalueringen kan det være, at producenter og 
importører af nanomaterialer samt producenter af nanoprodukter skal søge om tilladelse til 
produktion og anvendelse. Generelt bør der – som hovedregel – kun gives tilladelse til 
specifikke anvendelser af nanomaterialer og nanoprodukter, når anvendelsen skønnes 
nødvendig, effektiv og funktionel. Som en konsekvens af NanoRiskCat evalueringen kan 
registranten efterfølgende blive forpligtiget til at gennemføre en vurdering af tilgængelige 
alternativer. Dette gør sig gældende for anvendelser af nanomaterialer, som resulterer i en 
NanoRiskCat evaluering med 1) et rødt eksponeringspotentiale for professionelle slutbrugere 
og/eller et rødt eksponeringspotentiale for forbrugere kombineret med et rødt potentiale for 
menneskers sundhed og/eller 2) en rød miljøeksponering kombineret med en rød miljøfare. I 
disse tilfælde skal der indhentes en udtalelse fra de relevante videnskabelige komiteer i 
Europa-Kommissionen om, hvorvidt nanomaterialet og dets anvendelse er sikker.  
Brug og tilladelse til produktion, import og anvendelse bør kun gives, hvis den 
specifikke anvendelse skønnes at være nødvendig og sikker. Anvendelse af nanomaterialer, 
som de videnskabelige komitéer ikke anser for at være sikre, bør der ikke gives tilladelse til at 
markedsføre i Europa. Dette gælder fx udbredt anvendelse af HARN og indendørs 
forbrugeranvendelse af sprayprodukter med nanomaterialer forbundet med respiratorisk 
toksicitet. For alle andre kombinationer af eksponerings- og fareprofiler, dvs. NanoRiskCat 
kategorierne 2-4, kan agenturet anmode om en udtalelse fra de relevante videnskabelige 
komiteer i Europa-Kommissionen fra sag til sag.  
Som en generel regel bør der kun gives tilladelse til specifikke anvendelser af 
nanomaterialer og nanoprodukter, hvis de har et grønt fare potentiale for menneskers sundhed 
kombineret med et grønt professionelt slutbruger- og forbrugereksponeringspotentiale. Det 
samme gælder for anvendelser, der forventes at føre til miljømæssig eksponering. Her bør der 
kun gives tilladelse, hvis det pågældende nanomateriale har et grønt miljøfare potentiale. 
Skulle de videnskabelige komitéer have spørgsmål til sikkerheden af et nanomateriale og dets 
specifikke anvendelse, kan agenturet anmode producenter/importøren om yderligere 
oplysninger. Disse skal genereres inden for 3 år, som er den periode, der kan udstedes en 
betinget godkendelse for. For kombinationer af gule eksponerings- og farepotentialer er 
betingede godkendelser mulige for en tidsbegrænset periode. I dette tidsrum skal agenturet 
anmode registranten om at generere yderligere specifikke oplysninger.  
For at hjælpe industrien og navnlig små og mellemstore virksomheder med at 
implementere REACT NOW er der behov for teknisk- og ikke-teknisk bistand. Den skal 
leveres af den Europæiske Kommissions Joint Research Centre og det Europæiske Kemikalie 
Agentur.  
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REACT NOW er det første forsøg på at præsentere en omfattende lovgivning, der er 
skræddersyet til nanomaterialer og disses anvendelser.  
Al lovgivning har styrker og svagheder. Det gælder også REACT NOW. Disse handler 
blandt andet om, at NanoRiskCat kan bruges på trods af mangel på data og information; om, 
hvordan man definerer “nødvendighed” og “effektivitet”; og om, at vurderingen af 
eksponeringspotentialet i NanoRiskCat velsagtens er noget simpel.  
Denne afhandling er baseret på 28 peer review artikler, som er inkluderet i appendiks til 
afhandlingen. Det er værd at pege på, at de fleste af de emner, der kort bliver diskuteret og 
præsenteret i kapitel 2-8, er beskrevet i de 28 artikler. Denne afhandling er skrevet for at 
præsentere REACT NOW og for at give læseren et overblik over de videnskabelige resultater, 
som er opnået. 
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1. Introduction 
Nanomaterials (NMs) are increasingly used in production methods and in consumer products 
(European Commission 2012a, b, Hansen et al. 2016), however, major knowledge gaps still 
remain regarding the health and environmental risks posed by NMs (Wiesner et al. 2009, 
WHO 2013, Lynch 2015). Concerns have furthermore been raised about the potential lack of 
regulation, the lack of knowledge regarding the safety of nanomaterials and the lack of 
funding of research into environmental, health and safety (EHS) issues compared to 
investment into the research and technological development of nanotechnology (CIEL, 
ClientEarth and BUND 2012, WHO 2013, Schwirn et al. 2014, Hansen and Gee 2014).  
We have recently seen a number of incidences of and reports on the adverse health 
effects of nanomaterials in laboratories and production sites around the world. Although 
nanomaterials may or may not have been involved directly in the adverse effects observed, 
the mere fact that these incidents are occurring is a cause of concern in the first place (Hansen 
2016).  
The strategy implemented by the European Commission, in order to address these 
concerns and research needs, has involved funding environmental, health and safety research 
and adopting a so-called “incremental” approach to implementing a minimum number of 
revisions to existing regulation relevant to the application of nanomaterials, e.g. food, 
cosmetics and chemicals (European Commission 2004a, CEC 2008a). The implementation of 
the incremental approach seems to have developed into a series of stopgap measures and has 
previously been questioned by Franco et al. (2007), Hansen and Baun (2012a) and 
Vogelezang-Stoute (2014), as it does not address the heart of the challenges we face related to 
risk assessment, risk management and the regulation of nanomaterials. 
As noted by representatives from the European Commission at a 2014 OECD Expert 
Meeting on Categorisation of Manufactured Nanomaterials, the lack of specific risk 
management tools for assessing NM, means that case-by-case assessment is needed. Case-by-
case assessment on the other hand is becoming increasingly difficult due to the sheer number 
of existing nanomaterials and new ones constantly being created. NMs are furthermore also 
difficult to regulate due to a lack of information, their complexity, and a regulatory 
framework tailored for chemicals rather than manufactured materials (Laursen 2014 cited in 
OECD 2016a). 
In order to address these fundamental problems, the aim of this doctoral thesis is to 
develop the main components of a new suggested regulatory framework termed “Registration, 
Evaluation, Authorisation, Categorisation and Tools to Evaluate Nanomaterials – 
Opportunities and Weaknesses” (“REACT NOW”). Although some NGOs and European 
member state authorities have also developed suggestions along these lines, none has so far 
put forward or developed a framework tailored to manufactured nanomaterials that covers 
their full life cycle i.e. production, use, waste and environmental release.  
This doctoral thesis consists of four main parts. The first part focuses on what is known 
about the current production, use and release of nanomaterials throughout the life cycle of 
nanomaterials (Chapter 2). The second part explores the benefits and limitations of existing 
regulation in the light of the revisions that have been implemented recently in various areas of 
regulation, e.g. REACH, biocides, food, water, waste (Chapter 3) and provides a discussion 
on the proposed suggestions made by NGOs and European member states (Chapter 4).  
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The third part identifies and discusses issues that have generally plagued the regulation 
of nanomaterials in the EU in general and risk assessment specifically (Chapter 5), including 
suggested alternatives to risk assessment when it comes to NMs (Chapter 6) and specifically, 
the safety evaluation tool, NanoRiskCat developed by Hansen et al. (2014, 2017c) (chapter 7). 
The fourth and final part of the thesis focuses on introducing REACT NOW in regard to 
its core elements, namely registration, evaluation, authorisation, categorisation and safety 
evaluation. As no framework is without both potential and limitations, opportunities and 
weaknesses related to the implementation of REACT NOW will also be discussed in Chapter 
8. Finally, conclusions and recommendations will be presented in chapter 9. 
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copper) and information about the category of cosmetics (e.g. face mask, nail varnish, sun 
protection products), exposure route (e.g. dermal) and whether the cosmetics is a rinse-off or 
leave on product (European Commission 2017). Brand name, nanomaterial function, particle 
size distribution, nanomaterial surface chemistry is among the information not included in the 
catalogue (Oziel 2017). Recently, the European Commission decided against the 
establishment of an EU-wide nanomaterial register, as it was not perceived as an appropriate 
way to provide information to consumers on nanomaterials, and because full coverage of all 
nanomaterials and mixtures would be difficult to achieve (Paun 2015). Conversely, the 
Belgian, Danish and French governments have proposed and established their own 
nanomaterial/product inventories, but any information collected so far has only been made 
available publically in an overview and summary format and has generally been considered 
not to “…add much more to what it could be already known by an informed audience” 
(BIRPO and RPA 2014).  
Collectively, all of the above-mentioned inventories have a number of limitations. First 
of all, they are not continuously updated, meaning that months or even years may pass before 
the provided information is checked and revised. Secondly, the inventories contain a large 
number of “dead” products, i.e. products that are no longer on the market. Thirdly, some of 
them are not available to the public, thereby preventing consumers from easy access to 
information regarding the products they buy. None of the inventories provides analysis tools 
that would enable researchers and others to do their own independent analysis of the data and 
information. And finally, the inventories do not contain any health and safety information. A 
comparative analysis of the different databases and inventories is provided in Table 1. 
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Table 1: Overview of the scope, update frequency, sources, limitations and strengths of different databases and inventories (From Hansen et al. 2016). 
Name Est. Scope Update 
frequency 
Sources Limitations Strengths Reference 
The 
Nanodatabase 
2012 1) Products claimed 
to contain NMs or be 
based on NT 
2) Products available 
to European 
consumers 
Daily 1) Online search 
2) Reporting by 
users 
 
1) Based on claims 
2) Specifically focused 
on EU 
1) Updated daily 
2) Possible for users to  
do their own analysis 
3) Includes hazard potential 
evaluation (NanoRiskCat) 
4) Publically available 
Hansen et al. 2016, 
Aschberger et al. 2014 
CPI 2006 1) Products claimed 
to contain NMs or be 
based on NT 
2) Products available 
globally 
Annually  1) Online search 
2) Reporting by 
users 
 
1) Based on claims 
2) Only updated 
periodically 
3) Tends to have focus 
on the American market 
1) Evaluation of claims  
in regard to credibility 
2) Publically available 
CPI 2015, Wijnhoven 
et al. 2010, Vance et 
al. 2015 
ANEC/BEUC 2010 
 
1) Products claimed 
to contain nanosilver 
2) Products available 
to European 
consumers 
Unclear 1) Online search 
2) Reporting by 
users 
 
Not updated since 2013 1) Publically available ANEC/BEUC 2015, 
Wijnhoven et al. 2010 
CSF 
Nanotechnology 
in Food 
2015 1) Food products 
claimed to contain 
NMs 
Unclear Other nanodatabases 
e.g. The 
Nanodatabase 
1) Based on other 
databases  
1) Publically available CSF 2015  
 
BUND 
Nanoproduktdat
enbank 
2010 1) Products claimed 
to contain NMs or be 
based on NT 
2) Products available 
in Germany 
Unclear 1) Online search 
2) Reporting by 
users 
 
1) Only available in 
German 
2) Tends to have focus 
on the German market 
1) Publically available BUND 2010, 2015, 
Wijnhoven et al. 2010 
French NM 
compulsory 
reporting 
scheme 
2013 Substance 
manufactured at the 
nanoscale  
 
Annually Producers,	im‐
porters	or	
distributers	of	at	
least	100	g/year	
1) Limited information 
made publically 
available e.g. chemical 
name and uses of NMs 
1) Reporting mandatory  
by manufacturers 
 
Paun 2013b, BIPRO 
and RPA 2014 
Belgian NM 
registry 
2016 Substance 
manufactured on the 
nanoscale  
 
 
Annually Producers of at least 
100 g/year  
 
1) Not publically 
available 
2) Exemptions include 
e.g. cosmetic products, 
biocides, treated 
products 
 
1) Reporting mandatory  
by manufacturers 
Paun 2013a, BIPRO 
and RPA 2014, 
Chemical Watch 
2014a 
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Danish 
nanoproduct 
registry 
2014 Nanoproducts 
available in 
Denmark 
Annually Producers	and	
importers	to	report	
products	
containing	or	
releasing	
nanomaterials 
1) Exemptions include 
food contact materials, 
cosmetics, mixtures, 
printed products, textiles 
containing NMs in 
colours or dyes; paints, 
wood preservatives, 
glues and fillers, that 
contain nanoscale 
pigments used solely as 
colorants, rubber 
products that contain 
nano carbon black or 
silicon dioxide and 
products containing a) 
unintentionally produced 
NMs, b) “fixed” NMs 
2) Information about 
concentration of the 
nanomaterial in the 
product, particle size 
distribution and specific 
surface area is voluntary 
3)	Not	publically	
available 
1) Reporting mandatory  
by manufacturers 
Paun and Chynoweth 
2014, BIPRO and RPA 
2014 
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In order to address these limitations, The Nanodatabase (www.nanodb.dk) was established 
in 2012 by DTU Environment, the Danish Consumer Council and the Danish Ecological 
Council. The Nanodatabase is an online inventory of products claimed by manufacturers or 
others in Europe (e.g. retailers, product reviews) to contain nanomaterials. Along with a 
description of the product, The Nanodatabase provides available exposure/hazard 
information. Moreover, to broaden its usefulness, The Nanodatabase is equipped with 
different analytical tools, thereby allowing the user to sort and extract data in different ways 
(Hansen et al. 2016).  
 
2.2 The Nanodatabase and use of nanomaterials in consumer products in the EU 
The following is based on information available in The Nanodatabase. In this part of the 
thesis, data that has been published by Hansen et al. (2016) and Mackevica et al. (2016a) are 
presented. Up-to-date information can be found at www.nanodb.dk. 
 
2.2.1 Development of nanoproduct commercialisation 
The number of products contained in The Nanodatabase has increased steadily over time: 
1,212 products were originally in the database from the outset in 2012, and this number had 
risen to more than 2,200 by 2015 (see Figure 2). At the beginning of 2017, more than 3,000 
products can be found in The Nanodatabase. This increase in the number of products is 
primarily the result of increased nanoproduct marketing, as nanomaterials are employed in 
new applications. A total of 59 products have been retracted from the market and 16 products 
have lost their “nanoclaim” since 2012.  
 
 
Figure 2: Number of products listed in The Nanodatabase in the period January 2012 to August 2015 and in the 
Consumer Product Inventory (CPI) in the period 2005-2015 (Hansen et al. 2016). 
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2.2.2 Distribution of nanoproducts in product categories and subcategories 
Most of the products listed in The Nanodatabase belong to the product category “Health and 
Fitness” (55%), followed by “Home and Garden” (21%) and “Automotive” (12%) (see Figure 
3). 
 
 
Figure 3: Distribution of products in categories in The Nanodatabase and the CPI 
 
In The Nanodatabase, individual product categories include a number of subcategories, for 
instance personal care, clothing and cleaning (see Figure 4). In some cases, for example in the 
“Health and Fitness” category, products fall into several different subcategories, suggesting a 
broad range of applications of nanotechnologies in a specific field (see Figure 4a). In other 
cases, such as “Home and Garden”, nanomaterial utilisation is restricted to fewer or single 
subcategories, thereby indicating potential for the further development and utilisation of 
nanotechnologies in this area (see Figure 4b). 
 
 
Figure 4: Distribution of a) “Health and Fitness” products in subcategories; b) “Home and Garden” products in 
subcategories. 
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2.2.3 Nanomaterials reported to be used 
Figure 5 shows the identity of nanomaterials that are claimed to be used across the various 
product categories in The Nanodatabase.  
 
 
Figure 5: Identity of nanomaterials claimed to be used in different product categories. Products where the used 
nanomaterial is “unknown” are excluded. Please note that individual products may have more than one type of 
nanomaterial (From Hansen et al. 2016). 
 
The analysis shows that silver is the most prominently used nanomaterial across all product 
categories (see Figure 5). Other nanomaterials are specifically relevant to specific product 
categories: carbon nanotubes and bamboo charcoal in “Health and Fitness”; titanium dioxide 
in “Health and Fitness” and “Home and Garden”; gold in “Appliances”, “Health and Fitness” 
and “Home and Garden”; titanium in “Automotive”, “Health and Fitness” and “Home and 
Garden” and phosphate in “Appliances”. It should also be noted that for a large number of 
products it was not possible to identify and/or report the type of nanomaterial employed, due 
to the lack of information provided by the manufacturer. This was especially the case for the 
product categories “Automotive”, “Electronics and Computers” and “Home and Garden”, 
where 89%, 79% and 80% of the products, respectively, could not be associated with a 
specific nanomaterial type. The share of unknown nanomaterial was 15%, 17%, 35% and 
47% for “Appliances”, “Goods for Children”, “Food and Beverages” and “Health and 
Fitness”, respectively. The Nanodatabase (and CPI, the BUND Nanoproduktdatenbank and 
other public inventories) only contains products in which the manufacturer or others claim 
comprise nanomaterials, though nanomaterials are also used in consumer products where the 
manufacturer does not disclose this information publically. In 2012, the European 
Commission (2012b) published a so-called Staff Working Paper (SWP) to accompany the 
Second Regulatory Review on Nanomaterials. From this SWP, it is clear that a wide range of 
nanomaterials is used in products and processes that could potentially be relevant to 
consumers. For instance, silica is well known to be used widely in the food industry (e.g. for 
clarifying wine, beer and fruit juice), but according to the data collected in The Nanodatabase, 
its use is not declared in any of the more than 90 products listed in the “Food and Beverages” 
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category as of 2016 (Hansen et al. 2016). There are two products with nanosilica in this 
category, but both of them are reported by third parties to contain nanoparticles. Similarly, 
carbon black and carbon nanotubes are used widely in the automotive industry but do not 
appear under that category in the database.  
The lack of reporting the identity of nanomaterials is a major limitation to any effort to 
obtain an overview of what kind are actually being used in products available to European 
consumers, as well as to any kind of subsequent exposure and hazard evaluation. Knowing the 
identity of the nanomaterial or chemical substance is the starting point for any exposure 
assessment, hazard evaluation or risk assessment. It is noteworthy that even for the category 
“Cosmetics”, in which products containing nanomaterials must be labelled with the term 
“[nano]” as part of the list of ingredients according to the European Cosmetics Directive, the 
identity of the nanomaterial is not reported for almost 50% of the items found in The 
Nanodatabase (Hansen et al. 2016).  
 
2.2.4 Biocidal Products and treated articles 
A number of NMs are utilised as biocides, due to their antimicrobial or antifungal 
properties, but little is known about to what extent biocidal products containing NMs are 
available on the market. The current list of approved substances, under the Biocidal Product 
Regulation (BPR), and those substances being examined under the Review Programme, 
gives a good indication as to what kinds of nanomaterials might be used in biocidal products 
in the EU (Mackevica et al. 2016a). This list currently contains a number of materials which 
are commercially available in nanoform, namely basic copper carbonate, boric oxide, copper 
(II) oxide and copper hydroxide (Nanowerk 2016). It is unknown whether the nanoforms of 
these materials are sold as biocidal ingredients in Europe, although some are clearly being 
marketed as such, such as the “biocidal copper carbonate nanoparticles” sold by the German 
company nanoSaar (Hansen and Brinch 2014, Mackevica et al. 2016a). So far, only 
synthetic amorphous silicon dioxide (SAS) has been approved as an active substance in the 
BPR as a product type (PT) 18 (insecticide). Silicon dioxide (as a nanomaterial formed by 
aggregates and agglomerates) and silver adsorbed on silicon dioxide (HeiQ AGS-20) are 
currently under review for PT 18 and PT 9 categorisations, respectively (ECHA 2016a, b). 
Considering the list of existing active substances that are currently under review, it is clear 
that at least some of them might also be available in the nanoform, for instance silver, 
copper, dicopper oxide and silicon dioxide. See Table 2 for substances currently being 
examined under the review programme which might be available in the nanoform, and the 
product types in which they have been notified for use. 
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Figure 8: Potential route of exposure for individual product categories. Please note that individual products may 
have more than one route of exposure (From Hansen et al. 2016). 
 
There are a lot of products in The Nanodatabase for which the identity of the nanomaterial is 
not reported. For nanoproducts in the database for which nanomaterials are reported, silver is 
the most prominent type when it comes to dermal exposure (see Figures 6 and 7), followed by 
titanium dioxide and bamboo charcoal. For inhalation, silver is also the most prevalent 
followed by titanium, titanium dioxide and gold. Finally, a total 34 products can lead to the 
oral exposure of nanosilver, whereas 17 and four products lead to oral exposure of 
nanotitanium dioxide and nanocalcium, respectively (see Figures 9 and 10).  
 
 
Figure 9: Potential routes of exposure with respect to individual nanomaterials a) including unknown and b) 
excluding products where the used nanomaterial is “unknown” (From Hansen et al. 2016). 
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Figure 10: Identity of nanomaterials reported according to their potential route of exposure: a) including 
products for which the nanomaterial used is unknown and b) excluding products for which the used nanomaterial 
is unknown (From Hansen et al. 2016). 
 
When considering the body parts that might be exposed during use of the nanoproducts in The 
Nanodatabase, it is clear that the palm only, the face and scalp (chin, cheeks, hair) and the 
upper torso (hips, back, trunk, chest, loins) are the areas of the body that might be most 
exposed (see figure 11) (The Nanodatabase 2017). 
 
 
Figure 11: Number of products in The Nanodatabase distributed across human body parts 
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distribution of particulate fractions. Mackevica et al. (2016c) found that the total mass and the 
median size of released particulate Ag were generally highest in 3% acetic acid for three out 
of four food container brands. The total content of silver in the containers varied from 13 to 
42 l g/g. Similar to Hauri and Niece (2011), Mackevica et al. (2016c) found that the highest 
migration was observed in the 3% acetic acid food simulant for all four brands of containers, 
with total silver release up to 3.1 ng/cm2 after 10 days at 40C (see Table 3). 
 
Table 3: Dissolved and particulate Ag leached into food simulants, measured by spICP-MS (From Mackevica 
et al. 2016c). 
Product Release medium Dissolved 
Ag (µg/L) 
Particulate Ag 
(106 particles/L) 
Particulate 
Ag (ng/L) 
Median 
size (nm) 
Fresher Longer™ 
Miracle Food 
Storage™ bags 
MilliQ - 37.6 13.9 30.3 
10% Ethanol - 2.8 0.5 23.9 
3% Acetic acid 6.79 - - - 
The Original 
Always Fresh 
Containers™ 
MilliQ 0.57 18.3 10.5 41.1 
10% Ethanol 0.66 9.5 7.1 35.5 
3% Acetic acid 10.71 2.0 27.5 89.6 
Kinetic Go 
Green™ Premium 
MilliQ - 2.7 0.1 17.4 
10% Ethanol 0.13 7.4 2.5 26.9 
3% Acetic acid 3.18 4.2 27.8 67.2 
Special Nanosilver 
Mother's milk pack 
MilliQ 0.03 5.5 4.5 29.8 
10% Ethanol - 5.8 1.4 25.5 
3% Acetic acid 7.51 1.9 18.3 63.8 
 
Although the body of literature on the release of nanomaterials from consumer products is 
growing, little of the information provided in currently available studies is of relevance to 
REACH, because, for instance, less than half of the studies report their findings in a format 
that can be used for exposure assessment. Furthermore, most do not include any 
characterisation of the released particles (Mackevica and Hansen 2016). Although inhalation, 
dermal and oral exposure estimates can be derived using REACH guidelines on how to 
complete consumer exposure assessments, it is clear that the equations are not developed to 
take into consideration the unique properties of nanomaterials, and further research is needed 
in order to develop more relevant consumer exposure models of nanomaterials and 
nanoproducts, and to develop more generalised methods for representing nanomaterial release 
from different product groups in relevant environmental conditions (Larsen et al. 2015, 
Mackevica 2016, Mackevica and Hansen 2016).  
 
2.5 The environmental release of NMs 
Historically, the environmental concentration of chemical substances has been found to 
increase with their use in society, and we can therefore expect increasing future 
environmental concentrations of NMs in surface waters, air, groundwater and soils 
(Ganzleben and Hansen 2012a).  
The environmental release of NMs may occur at different stages during the life cycle of 
a material e.g. production, use and end-of-life, and can occur via multiple pathways and from 
multiple sources especially given the diversity of NMs produced and commercialised as well 
as the diversity of nanoproducts. Potential point sources of NM emissions include spills 
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during production and transport, industrial emissions into the air, water and soil, emissions 
into the air from construction sites and incineration plants, effluents released into surface 
waters from urban wastewater treatment plants, landfill leachates into soil and groundwater 
and direct releases of NM into soils and groundwater for remediation purposes. Diffuse 
sources include NM release from products during use and re-use, NM leaching into 
groundwater and then into surface waters from landfills, the run-off from agricultural land of 
pesticides that contain NM and from sewage sludge and spilt lubricants that are washed off 
roads into stormwater discharges (Baun et al. 2009, Ganzleben and Hansen 2012 a, b).  
Available data on point source emissions remain very limited, while a reliable estimate 
of diffuse source emissions from nanoproducts is currently hampered by the lack of 
information and lack of access to information about: volumes of NMs on the market; volume 
fractions incorporation into products; market penetration and use patterns and emissions of 
NM from products throughout the life cycle (Ganzleben and Hansen 2012 a, b). Once in the 
environment, the behaviour of NM will depend on its physicochemical properties (and 
nanoforms thereof), and on the environment into which they are released. The fact that NMs 
behave differently to dissolved chemicals limits the applicability of existing exposure models 
(Ganzleben and Hansen 2012b, Gottschalk et al. 2015). Insights into the environmental fate 
and pathways of NMs has increased in the last decade to the extent that aquatic reactions of 
NM, such as dissolution and aggregation, can be modelled in complex media, especially in 
the case of data-rich ENM materials such as Ag (e.g. Quik et al. 2011, Dale et al. 2013). The 
first attempts to group different NMs in regard to environmental fate and behavioural 
properties have been made, such as by Hartmann et al. (2014) (see Table 4).  
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Table 4: Relative importance of transformation processes for modelling the environmental fate of 
uncoated, non-functionalised forms of selected NMs (From Hartmann et al. 2014).  
 Process Importance of the environmental process in fate modelling 
       Low                                         Medium                                                        High 
(P
ho
to
) 
ch
em
ic
al
 
Photochemical nZVI, CB ZnO, CuO Ag, CeO2      TiO2, CNT   
Redox TiO2, 
CNT, 
CeO2, CB 
ZnO, CuO    Ag, nZVI 
Dissolution TiO2, 
CNT, 
nZVI, CB 
CeO2   CuO Ag, ZnO 
Ph
ys
ic
al
 
Aggregation / 
Agglomeration 
    Ag, ZnO TiO2, CNT, 
CuO, nZVI,     
CeO2, CB, 
Sedimentation     Ag, ZnO TiO2, CNT, 
CuO, nZVI, 
CeO2, CB 
In
te
ra
ct
io
ns
 
w
ith
 su
rf
ac
es
/ 
su
bs
ta
nc
es
 NOM adsorption 
    Ag, TiO2, 
ZnO, CuO, 
nZVI,CeO2 
CNT, CB 
Sorption onto 
other surfaces/ 
retention in soil
   Ag, ZnO, CuO TiO2, CeO2 CNT, nZVI, 
CB 
Bi
ol
og
ic
al
ly
 
m
ed
ia
ed
 
Biodegradation Ag, TiO2, 
ZnO, CuO, 
nZVI, 
CeO2, CB 
CNT     
Bio-
modification 
 Ag, TiO2, 
ZnO, CuO, 
nZVI, CeO2, 
CB 
CNT    
 
Attempts have also been made to model the environmental fate and pathways of NMs (see 
Ganzleben and Hansen (2012a) and Gottschalk et al. (2015) for a review), suggesting a 
number of data characteristics relevant to environmental exposure data for NM, including: 
 Mass concentrations in the range of μg/L – pg/L and changes in concentrations over 
time; 
 Particle size and shape and range of particle distribution, i.e. identifying and 
measuring the size fractions of different nanoforms; 
 Available surface area; 
 Distinguishing between NM and naturally occurring nanomaterials and  
 Data on the degree of aggregation and dissolution, i.e. ongoing fate and behaviour 
(Ganzleben and Hansen 2012a). 
However, there are quite a few gaps in our knowledge when it comes to the environmental 
fate and behaviour of nanomaterials and a number of processes have to be studied further, 
including chemical/photochemical transformation processes, dissolution/precipitation/ 
speciation processes, agglomeration/aggregation processes, biological transformation 
processes, sedimentation, adsorption and desorption processes and, above all, appropriate NM 
characterisation and measuring methods for NM in environmentally relevant media 
(Hartmann et al. 2014). 
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2.6 Solid waste flows from nano-enabled consumer products 
The increasing use of NMs in society, and specifically in consumer products, means that NMs 
will eventually find their way into various forms of waste treatment processes (incineration, 
wastewater treatment plants, etc.) not originally designed to treat such materials (Heggelund 
et al. 2016, OECD 2016d). Very few experimental studies have investigated the fate and 
behaviour of pristine nanomaterials in simulated landfill conditions (e.g. Bolyard et al. 2013) 
and during incineration (Walser et al. 2012).  
In order to gain a better understanding of the end-of-life waste treatment of nano-
enabled consumer products, Heggelund et al. (2016) used The Nanodatabase to provide an 
overview of NMs flowing into and throughout waste systems in Europe, including in 
Denmark and the United Kingdom. First, the available nano-enabled products were 
categorised into waste material fractions. Then the types of NMs present in waste material 
fractions were estimated, followed by an estimation of the region-specific waste management 
of individual waste material fractions. Finally, the information obtained was combined to 
determine the distribution of NMs routed to specific waste treatment options (Heggelund et al. 
2016). The largest of a total of nine different waste fractions identified by Heggelund et al. 
(2016) was found to be “Plastic, packaging”, “Textile” and “Electronics”, with 847, 390 and 
306 products, respectively, out of a total of 2,312 products in The Nanodatabase. The most 
abundant NM across all waste fractions was found to be silver, but otherwise the second-most 
abundant NM was found to vary between different waste fractions (see Figure 13). Plastic 
packaging waste comprised the largest variety of NMs, namely 20 different NMs, which 
might be caused by the fact that this waste material fraction is generated from many different 
sources (product categories) such as the automotive, food & beverage and home & garden 
sectors.  
 
Figure 13: Distribution of ENM in the different waste material fractions according to data from nanodb.dk. The 
Y-axis represents the number of products containing a certain ENM (nanodb.dk). Please note that the products 
have been grouped according to which primary nanotechnology substance they contain, e.g. “Titanium” includes 
both titanium and titanium dioxide, and “carbon based” includes CNTs, carbon black, fullerenes and graphite 
(From Heggelund et al. 2016). 
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By combining information on the distribution of NM types in waste fractions with 
information on how the individual waste fractions are treated within the European Union 
(EU), Denmark (DK) and the United Kingdom (UK), Heggelund et al. (2016) estimated the 
relative distribution of nanoproducts to waste treatment technologies and found that more than 
50% of nanoproducts are likely to end up in recycling processes for all three regions within 
the nine waste fractions identified (see Figure 14). Europe and the UK offer quite comparable 
incineration and landfilling treatment options, routing 19% and 13% to incineration and 26% 
and 29% to landfilling, respectively. Denmark, on the other hand, to a large extent, combines 
incineration with energy recovery, which results in 38% of nanoproducts ending up in waste 
incineration plants and only 8% in landfills. 
 
Figure 14: Relative distribution (%) of end-of-life nanoproducts into waste treatment options in the three 
analysed scenarios: Europe (EU), Denmark (DK) and the United Kingdom (UK) (From Heggelund et al. 2016). 
 
By combining the distribution of NM types in waste fractions (Figure 13) and the relative 
distribution of EOL nanoproducts into waste treatment options in the EU, Denmark and the 
UK (Figure 14), Heggelund et al. (2016) finally derived the distribution of nanomaterials for 
the four different waste management options: incineration, recycling, landfilling and 
composting/anaerobic digestion (see Figure 15). 
From Figure 15, one can see that 31% of EOL nano-enabled consumer products in 
Europe entering a waste incineration plant will contain nanosilver and that anaerobic 
digestion/compost is expected to be relevant for a few nanoproducts only. The distribution of 
NMs in the different waste management systems was found to be similar for Europe, e.g. the 
numbers of items containing silver and titanium NM were more or less the same, regardless of 
the management scenario. Some interesting regional differences were furthermore observed; 
the proportions of titanium- and carbon-based NMs were found to be higher in the UK landfill 
scenario, because greater amounts of plastic waste (both packaging and other plastic) are 
disposed of in landfills in the UK compared to Denmark, whereas bamboo charcoal and 
nanogold are expected to be present in Danish landfills, due to the larger amounts of textile 
waste. 
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Figure 15: Distribution of nanomaterials for the four different waste management options: incineration, 
recycling, landfilling and composting/anaerobic digestion. The figure illustrates the percentage of products 
entering a waste treatment option that will contain a certain ENM. Note: the area of the pie is proportional to the 
number of products entering individual treatments, thus reflecting the size of the bars in Figure 14 (From 
Heggelund et al. 2016). 
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In order to assess the environmental exposure of nanoparticles from solid waste, Boldrin et al. 
(2014) proposed a five-step framework (see Figure 16) and applied it to three different 
examples: nanosilver in polyester textiles, nano-scale titaniumdioxide in sunscreen lotion and 
carbon nanotubes in tennis racquets. Boldrin et al. (2014) found that considerable amounts of 
these nanoproducts entered waste management systems, based on data available in 2011 
(globally 23.7  103 Mg of polyester textiles, 715–1,430 Mg of sunscreen lotion and 313–825 
Mg tennis racquets). On a global scale, this would result in 0.8–5.6 Mg of nanosilver, 14–143 
Mg of nanoTiO2 and 0.5–1.2 Mg of CNTs being released annually into the environment, 
based on potential waste management practices and exposure routes (Boldrin et al. 2014). 
 
 
Figure 16: Proposed framework for an environmental exposure assessment of nanoparticles in solid waste. The 
framework includes steps 1–5. When combined with results from an effect assessment, the results of the 
exposure assessment may be used as an input into the environmental risk assessment of nanoparticle emissions 
from waste (lower dotted box, outside the scope of the present study). 
 
Boldrin et al. (2014) observed that the main challenges in relation to further research into 
nanomaterials and waste were: 1) the transformation of nanomaterials within waste treatment 
technologies, 2) release mechanisms in conditions relevant for waste disposal, 3) exposure 
assessments performed at the local level and within a precise context, (4) the characterisation 
of nanowaste and the development of appropriate analytical methods and (5) a definition of 
appropriate regulatory limit values and nanowaste data reporting. 
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3. Existing legislation – opportunities and weaknesses  
Numbers of EU regulations and directives have been amended in recent years, namely 
REACH, BPR, food, cosmetics and eco-labelling. A range of advisory reports have also been 
published to support this legislation, the most important of which are provided by Aitken et 
al. (2011), Hankin et al. (2011), Christensen et al. (2012), Rauscher et al. (2015), SCENIHR 
(2005, 2007, 2009), EFSA (2009, 2011) and ECHA (2012a-c, 2016). Figure 17 presents a 
timeline of the implementation of key EU regulations, directives as well as the publication of 
key advisory reports and technical guidance.	
In the following an analysis of REACH, the BPR and the relevant food legislation will 
be presented. The analysis focuses on regulations that have been revised in order to meet the 
specific challenges that nanomaterials present. REACH, BPR and relevant food legislation 
will be analysed in depth in this chapter, but all amended regulations and directives have been 
subject to an analysis of their opportunities and weaknesses and are included in Table 5. 
Opportunities are considered to be aspects that improve the current situation, should they 
materialise and be implemented successfully; nonetheless, given that many of the 
opportunities place a burden on industry, EC or EU member states, this cannot always be 
taken for granted. Weaknesses are understood as elements that we already know are vague, 
difficult to fulfil or require the impossible, given the current state of knowledge. For details 
on legislation that has been amended, see Hansen and Baun (2012a), Gellert et al. (2015) and 
Broomfield et al. (2016). For a review of relevant regulations and directives that have yet to 
be amended, and their limitations when it comes to nanomaterials, see Ganzleben et al. 
(2011), Hansen and Baun (2012a), Gellert et al. (2015) and Broomfield et al. (2016). 
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Table 5: Overview of regulations and directives that have been amended in the EU in regard to nanomaterials and their opportunities and weaknesses 
Legislation Opportunities Weaknesses References 
 
Cosmetics 
 
Scope 
Substance/mixtures 
intended to be placed in 
contact with external parts 
of the human body, teeth, 
etc. with the purpose of 
cleaning or perfuming them, 
changing their appearance, 
protecting them, keeping 
them in good condition or 
correcting body odour 
Pre- and post-market notifications 
 For cosmetics, already on the market, 
manufacturers have to inform the European 
Commission about the presence, identity and form 
of nanomaterials and exposure conditions  
 Six months prior to the commercialisation of 
cosmetic products not yet placed on the market, 
manufacturers have to submit a notification to the 
EC including, among others, information about 
size, quantitative annual estimates of marketed 
NMs and the toxicological profile  
Pre-market safety assessment 
 Prior to placing a cosmetic product on the market, 
manufacturers have to ensure that a safety 
assessment has been performed 
 The SCCS is provided to give guidance on test 
methodologies which take into account specific 
characteristics of nanomaterials 
Labelling 
 The presence of nanomaterials in products has to be 
indicated clearly in the list of ingredients via the 
name of the nanomaterial followed by the word 
“nano” in brackets 
Scientific opinion on safety  
 On the EC’s request the Scientific Committee on 
Consumer Safety (SCCS) is to give its opinion 
within six months on the safety of a nanomaterial 
for use in the relevant cosmetic product categories 
Authorities reporting  
 The EC has to make a publicly available catalogue 
of all nanomaterials used in marketed cosmetic 
products, indicating, for example, cosmetic product 
categories and exposure conditions 
Definition  
 Unclear NM definition in regard to terms such 
as “insoluble”, “bio-persistent” and 
“intentionally manufactured”  
Pre- and post-market notifications 
 Pre-market notification only required if the 
cosmetic product has not already been placed on 
the market before 11 January 2013 
Pre-market safety assessment 
 Pre-market safety assessment is challenging 
especially when it comes to establishing the 
toxicological profile of substances and possible 
impacts on the toxicological profile due to 
particle size  
 
 
 
Bowman et al. 2009, Hansen and 
Baun 2012b, Vogelezang-Stoute 
2014, Gellert et al. 2015, 
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 The EC has to prepare an annual status report 
outlining, for instance, the present and future use of 
nanomaterials in cosmetic products, the number of 
notifications and any progress made regarding 
nano-specific safety assessment methods 
 
WFD 
 
Scope 
Priority substances in the 
field of water policy  
 
Risk screening 
 
Revised methodology for COMMPS scheme now 
able to identify NMs as priority substances 
Definition 
 No specific reference is provided to NMs but 
rather to particle size 
Risk screening  
 Lack of monitoring data on nanomaterials in EU 
surface waters hampers the applicability of the 
revised methodology for the COMMPS scheme 
 No nanomaterials were included in any 
international agreements or EU legislation on 
hazardous substances 
Risk assessment 
 Virtually impossible to conduct risk 
assessments and determine whether any 
nanomaterials give rise to an equivalent 
concern as PTB substances (i.e. persistent, 
toxic and able to bio-accumulate) 
 The establishment of environmental quality 
standards (EQS) for priority substances is 
hampered by uncertainties related to the use of 
mass-based thresholds for establishing EQS 
 Questionable whether the principles for 
deriving EQSs for chemicals can be transferred 
directly to NPs 
Enforcement 
 Lack of appropriate end-of-pipe measures to 
control discharges of nanomaterial pollutants 
from point sources 
 Impossible to categorise NMs as specific 
pollutants of river basins because of the 
absence of appropriate monitoring techniques 
 
Baun et al. 2009, Ganzleben et al. 
2011, Ganzleben and Hansen 
2012b, Gellert et al. 2015, 
Broomfield et al. 2016 
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Table 5 continued: Overview of regulations and directives that have been amended in the EU in regard to nanomaterials… 
Legislation Opportunities Weaknesses References 
 
REACH 
 
Scope 
Manufacturing/import of 
chemicals including 
nanomaterials 
 Definition 
Unclear substance definition when it comes to 
NMs  
Registration 
 Size not listed as information necessary to 
enable each substance to be identified 
 The 1 ton/year threshold would hardly be 
reached for many nanoparticles 
 Registration is not required when the 
concentration of a substance in the final 
product is lower than 0.1% w/w 
Information requirements  
No specific registration or information 
requirements for nanomaterials 
Risk assessment 
 Four elements of risk assessment not tailored 
for NM  
 Unclear whether wholesale hazard information 
is appropriate for nanoforms 
OECD TGs not developed for dispersed NM but 
for soluble chemicals instead 
 
CIEL, ClientEarth and BUND 
2012, Hansen and Baun 2012b, 
Hansen 2013, UBA, BfR and 
BAuA 2013, Schwirn et al. 2014, 
Gellert et al. 2015, Syberg and 
Hansen 2016 
 
 
Food legislation 
 
Scope 
Information for consumers, 
food additives and novel 
foods 
Risk assessment 
 Scientific appropriateness and technical 
adaptations/ adjustments of the performed test have 
to be provided for NMs 
 Obligation of the applicant to take the latest EFSA 
guidance documents into account when submitting 
a technical dossier on food additives 
 Technical dossier on food additives should include 
all available data relevant for risk assessment  
 Data required for risk assessment of food additives: 
particle size distribution,  physicochemical  
characteristics and NM toxicology 
Definition 
 Unclear what constitutes “significant changes 
to the production process or starting materials” 
of a food additive and what it means that food 
additives are produced “through 
nanotechnology” 
 Definition of “novel foods” excludes NMs 
marketed before 15 May 1997  
 Definition of NM different from other non-
food regulations, thereby creating 
inconsistency across legislative areas and 
meaning that a NM could be a NM according 
to one regulation and not according to another  
 
Hansen and Baun 2012b, 
Vogelezang-Stoute 2014, Gellert 
et al. 2015 
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 Verification has to be provided that the proposed 
use does not mislead the consumer and that there is 
a reasonable functional and technological need that 
cannot be achieved by other means  
 The applicant has to provide a description of the 
analytical methods, thus allowing the identification 
and quantification of the additive or its residues in 
food 
Scientific opinion on safety  
 On the EC’s request, the European Food Safety 
Authority (EFSA) is to give its opinion within six 
months on whether a novel food may pose a safety 
risk to human health, by considering possible 
effects on vulnerable groups of the population and 
verifying that the most up-to-date test methods are 
used to assess safety where a novel food consists of 
engineered nanomaterials 
 EFSA shall, upon request, provide an opinion on 
food additives that should include, among others, 
an overall risk assessment highlighting 
uncertainties and limitations, where relevant 
Authorisation 
 The use of nanomaterials requires prior 
authorisation 
 A reasonable technological need for food additives 
has to be present that cannot be achieved by other 
economically and technologically practicable 
means 
 Use of food additive must not mislead consumers  
 Use of a food additive must have advantages and 
benefits for consumers 
Labelling 
Specific labelling requirements which do not mislead 
the consumer 
 
 
 Hard to operationalise terms in the definition, 
such as physico-chemical properties that are 
different due to SSA and/or different from bulk 
Risk assessment 
 Unclear how applicants are to provide 
“Scientific evidence demonstrating that the 
novel food does not pose a safety risk to human 
health” in light of the uncertainties identified 
and noted by EFSA (2009, 2011) 
Authorisation  
 Unclear how “reasonable technological need” 
is to be determined for food additives, 
considering other economically and 
technologically practicable means  
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Table 5 continued: Overview of regulations and directives that have been amended in the EU in regard to nanomaterials… 
Legislation Opportunities Weaknesses References 
 
EU Ecolabel Regulation 
 
Scope  
Products and services which 
have a lower environmental 
impact than other products 
in the same group 
Life cycle considerations 
 
Criteria must be determined on a scientific basis, by 
considering the whole life cycle of products 
Information requirements 
 It is necessary that applicants list all ingoing 
substances by mentioning ingoing quantity, the 
function of the substance and the form it takes in 
the final product formulation  
 Information provided by applicants must relate to 
the forms or physical states of the substance or 
mixtures as used in the final product 
Evaluation 
 Consideration of uncertain consequences 
associated with the widespread use of nanosilver 
in hygiene products 
Restriction  
Nanoforms of hazardous substances intentionally 
added to three product categories, i.e. all-purpose 
cleaners have to be excluded for any concentration 
Definition and information requirements  
Inconsistencies across different EU ecolabel criteria 
decisions in regard to information requirements on 
nanoforms and NM definition and whether reference is 
made to forms and physical state of substances, or no 
reference is made at all 
Restriction  
Relies on CLP categorisation of hazardous substances 
which might not be adequate for NMs 
 
Broomfield et al. 
(2016) 
 
Biocides 
 
Scope 
Production and import of 
nanomaterials and treated 
products 
Risk assessment 
 Specific risk assessment must be performed 
separately for the nanomaterial 
 Scientific appropriateness and technical 
adaptations/ adjustments of the performed test 
have to be provided when it comes to 
nanomaterials 
 
Registration  
Hard to operationalise EC recommendations on NM 
definition 
Risk assessment 
 Four elements of risk assessment not tailored for NM  
 OECD TG not developed for dispersed NM but for 
soluble chemicals instead 
Authorisation 
Approval of an active bulk substance does not 
automatically cover a corresponding NM form 
Labelling 
Label required providing information of the names of all 
nanomaterials in the product and information on any 
specific, related risks  
Gellert et al. 2015, 
Hansen 2015, Brinch et 
al. 2016, Mackevica et 
al. 2016a 
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Medicines and medical 
devices 
 
Scope 
Medicinal products for 
human and veterinary use, 
medical devices, active 
implantable medical devices 
and in vitro diagnostic 
medical devices  
 
Designed to reduce risks 
In the proposal on medical devices, in order to 
amend, among others, the Directive 2001/83/EC 
concerning medicinal products for human use, 
devices shall be designed and manufactured in such 
a way as to reduce to a minimum, risks linked to the 
size and the properties of the particles used 
Authorisation 
Explicit prior authorisation of devices that 
incorporates or consists of a nanomaterial  
Safety assessment 
Pre-market safety assessment should ensure that the 
benefits outweigh any identified risks or adverse 
side-effects  
Labelling  
Requires label to indicate that the device 
incorporates or consists of a nanomaterial, unless 
the nanomaterial is encapsulated or bound so that it 
cannot be released into the patient or user’s body 
Definition 
 Most directives do not mention or define NMs 
 Unclear whether “novel nanomedicine” is to be defined 
as a medicinal product or as a medical device 
 Definition of NM in the proposal on medical devices, in 
order to amend, among others, the Directive 
2001/83/EC concerning medicinal products for human 
use, is hard to operationalise, as it follows EC 
recommendations on NM definition 
Information requirements  
 No specific registration or information requirements for 
nanomaterials 
Risk assessment 
Risk assessment, safety and quality requirements may not 
be suitable to address various aspects relating to 
nanomedicine and novel applications of nanotechnology 
Baun and Hansen 2008, 
Hansen and Baun 
2012b 
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3.1 Registration, Evaluation and Authorisation of CHemicals (REACH) 
In mid-2007, Regulation (EC) No 1907/2006 of the European Parliament and of the Council 
of the European Union, known as “Registration, Evaluation and Authorisation of Chemicals” 
(REACH), came into force (EP and the Council 2006). Although not originally intended to 
address nanomaterials, REACH has evolved into one of the key pieces of European 
legislation in this regard (CEC 2008a, European Commission 2012a, Azoulay 2012, Hansen 
and Baun 2012b, Hansen 2013). In short, REACH consists of four elements: 
1. Registration, i.e. data collection on chemical use and toxicity; 
2. Evaluation, i.e. examination by governments of the need for the additional testing 
and regulation of chemicals;  
3. Authorisation of chemicals, i.e. requirements for firms to seek permission to use 
chemicals of high concern and 
4. Restrictions or a complete ban on certain chemicals that cannot be used safely. 
As something of a new approach, the responsibility for providing data and information in the 
registration and authorisation phases of REACH shifted onto manufacturers and importers. 
The registration process would happen gradually, and by 30 November 2010 manufacturers 
and importers had to register substances produced or imported in quantities of more than 1000 
tons per year. The same applied to substances produced in quantities of more than 100 tons 
and which had been classified as very toxic to aquatic organisms, as well as substances 
produced in amounts more than 1 ton that had been classified as Category 1 or 2 carcinogens, 
mutagens or reproductive toxicants. By 1 June 2013, producers or importers of substances in 
quantities of more than 100 tons had to register, and by 1 June 2018, the registration of 
substances produced in quantities of more than 10 tons will have to be completed (EP and the 
Council 2006). Only seven nanomaterials were listed during the first two registration periods 
(Jones 2013).  
Carbon and graphite were taken off the list of substances exempted from registration 
under REACH in 2008, in order to ensure that nanomaterials such as C60 and carbon 
nanotubes would fall under the scope of REACH, if produced in sufficient tonnage per year, 
per producer or importer (Hansen 2010).  
Although a number of substances, e.g. nanosilver and various forms of carbon 
nanotubes, have been registered as nanomaterials under REACH, the regulation does not 
specifically mention the word “nanomaterials”, and size is not listed as information necessary 
to make it clear that each substance should be identified (CIEL, ClientEarth and BUND 
2012). Furthermore, there are no specific registration or information requirements for 
nanomaterials (EP and the Council 2006), which might help explain why so few 
nanomaterials have been registered under REACH to date (Azoulay 2012, Hansen 2013). 
After the first round of REACH registration in 2010, only three dossiers were registered, 
meaning that “nanomaterial” was selected as the substance’s form in IUCLID5.2 (Jones 
2013), whereas a total of seven substance registrations and 18 CLP notifications had been 
made voluntarily as of February 2012 (Christensen et al. 2012). In response to the very few 
registrations of NMs, the European Commission asked the European Commission Joint 
Research Centre (JRC) and the European Chemicals Agency (ECHA) to assess how 
nanomaterials had been addressed in REACH registrations and CLP notifications by assessing 
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the adequacy of available information in the REACH registration dossiers from the first round 
of REACH registrations. One of the key challenges associated with assessing the selected 
dossiers was found to be the ambiguity of the scope of the registration dossier and the lack of 
clarity about the registrants’ intentions regarding which nanomaterials/nanoforms fall under 
the scope of the registration. This included ambiguity that cascaded through the dossiers, as it 
not only applies to the identity/characterisation of the registered substance, but also to the 
provided information on the exact form/particle size of the tested material for many physico-
chemical and hazard end-points (Christensen et al. 2012, Hansen 2013). For instance, only a 
few dossiers distinguish between “bulk” and “nano”, and differences in characteristics 
between nanoforms of the same substance were not addressed at all. Test data provided for 
physico-chemical, human health and environmental end-points were furthermore found, 
generally, not to describe the test material in great detail, and any description of sample 
preparation varied or was lacking (Christensen et al. 2012). As noted by Christensen et al. 
(2012), “The impact of this ambiguity on the assessment of dossiers containing 
nanomaterials/nanomaterials cannot be overstated.” 
Although there is no tonnage-related exemption under REACH regarding authorisation, 
restriction or classification and labelling requirements, a second limitation is that substances 
manufactured or imported in volumes of less than 1 ton/year do not need to be registered. 
Hence producers or importers are not required to provide toxicological data or assess any kind 
of environmental exposure. As noted by Chaundry et al. (2006), Franco et al. (2007) and 
Azoulay (2012), this threshold would hardly be reached for many nanoparticles. Chaundry et 
al. (2006) estimated that the majority of applications are likely to fall outside the scope of 
REACH on the basis of the low tonnage currently used in gram-to-kilogram quantities – 
something which was later confirmed when the German REACH competent authority failed 
to collect nanomaterial exposure data from German companies and attributed this to having 
asked for information on activities related to production, use and processing involving 
nanomaterials in quantities of more than 10 kg/year (BAuA 2008, CIEL, ClientEarth and 
BUND 2012). As a consequence, ECHA has asked the European Commission for 
clarification on whether the registration requirements for substances on the EU market in low 
amounts could be changed, as very toxic chemicals are often sold in small amounts (Chemical 
Watch 2014b, Hansen and Baun 2015). 
Furthermore, the usually low concentration of nanomaterials in the final product could 
potentially exclude some from the REACH legislation, since no registration is required when 
concentrations of a substance in the final product are lower than 0.1% w/w. However, a 
general lack of access to information about product formulation and nanoparticle 
concentrations hampers the determination of substance concentrations by weight (Franco et 
al. 2007, Hansen and Baun 2012b). A great deal of effort has been put into revising the 
technical guidance provided by ECHA. In 2010, the EC established the first of three so-called 
“REACH Implementation Projects on Nanomaterials” (RIP-oNs). The outcome of RIP-oN1 
was the identification of two possible options, namely to address nanomaterials either as 
“well-defined substances” or as “substances of defined chemical composition and additional 
identifiers” (European Commission Joint Research Centre 2011).  
Based on RIP-oN2, on information requirements, and RIP-oN3, on chemical safety 
assessments, ECHA updated some of its guidance back in 2012, especially in regard to 
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sample preparation, exposure quantifications, measurement, dose metrics, etc. (Chemical 
Watch 2012, Hankin et al. 2011, Hansen and Baun 2015). Further updates to the guidance are 
currently being discussed and are out for consultation in so-called “partner-expert groups”, 
based on draft guidance documents concerning nanomaterials developed by ECHA (ECHA 
2016c).  
Recommendations from RIP-oN2 address a range of issues, including physiochemical 
properties, toxicological and ecotoxicological end-points, which would require a modification 
to the REACH annexes (Hansen 2013). However, for such modifications, once adopted, to be 
implemented, nanomaterials must first be identified systematically (Azoulay 2012). Since 
2013, there has been a lot of discussion about whether and how to update the REACH 
Annexes. The European Commission has put forward six different options ranging from 
maintaining the current situation under REACH and adopting no new policy actions (option 
1) through focusing on enhancing the competitiveness and innovation of companies by 
reducing the economic burden of REACH compliance (option 5) and by introducing changes 
to certain REACH Annex provisions to clarify what companies are expected to do. These 
include revised or additional end-points for nanomaterials and additional emphasis on the 
generation of targeted information on risk regarding the influence of particle- and 
nanomaterial-specific properties (option 6) (European Commission 2013b). It generally seems 
that industry branch organisations prefer option 5, whereas NGOs prefer option 6 (Hansen 
and Baun 2015). What the modifications to the REACH Annexes will eventually look like, 
and when they will be implemented, is unclear at this moment in time, but they have been 
under scrutiny by the EC’s Regulatory Scrutiny Board since February, 2016 and are planned 
for early 2017 (European Commission 2016, Roberts 2016, Bergeson and Hutton 2016). 
 
3.2 Biocidal Products Regulation (BPR)  
Chemicals with claimed antibacterial properties, such as nanosilver, are regulated as “biocidal 
active substances” or as “biocidal products” in the EU under the EU Biocidal Products 
Regulation (BPR) (EP and the Council 2012a). A key feature of the BPR is the specific 
provisions regarding nanomaterials (Hansen and Brinch 2014). In the BPR, nanomaterials are 
defined as “a natural or manufactured material containing particles, in an unbound state or as 
an aggregate or as an agglomerate and where, for 50% or more of the particles in the number 
size distribution, one or more external dimensions is in the size range 1 nm-100 nm” (EP and 
the Council 2012a). This definition is in most aspects in line with the European Commission’s 
recommended definition, although “incidentally created NPs” have been omitted from the 
BPR definition of NMs as well as the possible replacement of the 50% threshold by a lower 
one (Hansen and Brinch 2014).  
Besides being the first piece of legislation to adopt the definition of NMs 
recommended by the European Commission, the BPR is also the first to specify that approval 
of an active substance does not cover a corresponding NM form, except where this is 
mentioned explicitly. Furthermore, in order to gain authorisation for a biocidal product 
containing nanomaterials, a specific risk assessment must be performed separately for the 
nanomaterial in question, and it is not possible to apply for a simplified authorisation if the 
biocidal product contains nanomaterials (EP and the Council 2012a). These requirements 
were implemented to address concerns about the safety of nanomaterials, and as a result the 
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BPR provides the most ambitious piece of nano-specific legislation yet to be implemented by 
European legislators. Prior to being allowed to commercialise their active substance or 
biocidal product, a manufacturer has to submit a dossier to the European Chemicals Agency 
that fulfils specific information requirements outlined in the Annexes of the BPR (EP and the 
Council 2012a). These requirements include information on the physio-chemical properties of 
the chemical/nanomaterial in question, for what type of products the active substance is to be 
used, expected exposure patterns as well as toxicological and ecotoxicological information. 
This information has to be obtained by following the methods specified in the Test Methods 
Regulations (EP and the Council 2009b), which again are equivalent to OECD guidelines for 
the testing of chemicals. It is noteworthy that the BPR requires that an explanation has to be 
provided on the scientific appropriateness of the test when it comes to nanomaterials and, 
where applicable, on the technical adaptations/adjustments that have been made in order to 
respond to the specific characteristics of these materials. The BPR furthermore specifies that 
it is possible to use other scientifically suitable methods if a test method is considered 
inadequate or not included in the BPR. Justification for the appropriateness of these 
alternative methods, however, is required (EP and the Council 2012a), and fulfilling these 
BPR requirements can be quite challenging, as analysed and reported by Brinch et al. (2016) 
who explored how nano-specific testing requirements in the BPR might be fulfilled in the 
case of copper oxide nanoparticles. They found that while useful information and data are 
available in the open literature (see Figure 18), most of the studies do not take into 
consideration the OECD’s nano-specific test guidelines (see Figure 19). About a third of all 
the studies report on four or less of the parameters suggested by the OECD, and the studies 
that report most, report on seven to nine of these factors. This makes it difficult for companies 
as well as regulators to fulfill the BPR information requirements for nanomaterials, for 
instance due to the lack of best practices regarding stock suspension preparation and 
characterisation, exposure suspensions preparation and conducting ecotoxicological tests 
(Brinch et al. 2016). 
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Figure 18: Number of studies potentially fulfilling the Biocidal Product Regulation (BPR) information 
requirements for ecotoxicity tests (From Brinch et al. 2016). 
 
 
Figure 19: Number of ecotoxicity studies on copper oxide nanoparticles considering the reporting and 
characterization parameters recommended in the Organisation for Economic Co-operation and Development 
(OECD) guidance document (OECD 2012). 
 
Synthetic amorphous silicon dioxide (SAS) is the only NM that has been approved as an 
active substance to date, and it is approved as such under product type (PT) 18 (insecticides). 
According to the assessment report, SAS is a NM according to the NM definition in the BPR, 
as it consists of primary particles sized < 25 nm, whereas the active substance will be an 
aggregate of primary particles sized 1-6 μm. Therefore, the hazard and risk of the individual 
silicon dioxide NPs were not evaluated in the dossier, as aggregates are considered to be the 
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smallest stable particles under normal handling and use conditions (France 2014).  
Silicon dioxide nanoforms formed by aggregates, agglomerates and silver adsorbed on 
silicon dioxide (HeiQ AGS-20) are currently under review for PT 18 and PT 9 (fibre, leather, 
rubber and polymerised material preservatives), respectively (ECHA 2016a, b). HeiQ AGS-
20 consists of stable 1-50 μm particle aggregates containing primary particles on the 
nanoscale, and in an opinion piece, the Biocidal Products Committee (BPC) (2014) has 
explained that AGS-20 is to be regarded as a biocidal active substance. In the opinion, the 
BPC (2014) refers to the approval of SAS and states that it could be outlined that AGS-20 is a 
stable aggregate with primary particles in the nanoscale, with additional specification of 
particle size and volume specific surface area (BPC 2014). The latter indicates that the SAS 
evaluation could create a precedence when it comes to approving nanomaterials (Mackevica 
et al. 2016a). The use of nanosilver as a biocidal active ingredient under the EU’s biocidal 
product regulations review programme is currently being assessed by the Swedish Chemicals 
Agency (KEMI), which is known as “the competent authority.” KEMI, at the time of writing, 
is on public record stating that their work is progressing slowly and that it is not possible for 
them to say whether there are sufficient data to carry out a risk assessment on silver 
nanoforms, as the data which have been submitted by industry follow the usual data 
requirements for bulk substances (Chemical Watch 2011, Mackevica et al. 2016a). 
Other assessment reports mention specifically that they do not cover the nanoform of 
that active substance and that the nanoforms of these substances are not included in the 
reports. For instance, for basic copper carbonate, the assessment states that “the applicant is 
not currently placing nanoforms of basic copper carbonate on the market. Therefore, the 
submitted dossier and the finalised assessment report do not cover potential nanoforms of this 
copper compound, should such forms exist” (Standing Committee on Biocidal Products 
2011). 
Besides active substances and biocidal products, the BPR also contains provisions that 
apply to products which incorporate a biocidal product or have been treated with one. 
Products can only be treated with active substances which have been approved in the EU for 
that specific purpose. Moreover, treated products have to be labelled with a label providing 
information on the names of all nanomaterials contained in the product, followed by the word 
“nano” in brackets e.g. “Ag“. The label furthermore has to include information on any 
specific related risks of the nanomaterial. 
It is not clear which products commercially available in the EU have been treated with 
nanomaterials or incorporate a biocidal form. It is, however, well known that, for instance, 
nanosilver and nano-copper are used in consumer products because of their antibacterial 
properties (Brinch et al. 2016, Mackevica et al. 2016b, c). In a study of biocidal products and 
treated articles in The Nanodatabase, Mackevica et al. (2016a) found that for about 50% of all 
nanosilver-containing products, the producers make antibacterial or antifungal claims, which 
means that the products are likely to fall under the provisions of the BPR. However, 
Mackevica et al. (2016a) also reported that it was not possible to “determine whether 
nanomaterials were actually present in the products with claims about “nano” by looking at 
the labels of the products, and it was not possible to evaluate whether the products claiming to 
have biocidal properties are actually effective as antimicrobials.” 
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3.3 Food legislation and nanomaterials 
Until recently, none of the EU regulations applicable to agriculture, food or food packaging 
considered or mentioned nanoscale products or materials, but in 2011 the regulation on the 
provision of food information to consumers made it clear that “all ingredients present in the 
form of engineered nanomaterials shall be clearly indicated in the list of ingredients (EP and 
the Council 2011b). The names of such ingredients shall be followed by the word “nano” in 
brackets.” This approach is similar to the one adopted in regard to cosmetics, but whereas 
nanomaterials were defined as “an insoluble or bio-persistent and intentionally manufactured 
material with one or more external dimensions, or an internal structure, on the scale from 1 
to 100 nm” (EP and the Council 2009a) in the cosmetics regulations, “engineered 
nanomaterial” was defined in the regulations as “[…] any intentionally produced material that 
has one or more dimensions of the order of 100 nm or less or that is composed of discrete 
functional parts, either internally or at the surface, many of which have one or more 
dimensions of the order of 100 nm or less, including structures, agglomerates or aggregates, 
which may have a size above the order of 100 nm but retain properties that are characteristic 
of the nanoscale. Properties that are characteristic of the nanoscale include: (i) those related 
to the large specific surface area of the materials considered; and/or (ii) specific physico-
chemical properties that are different from those of the non-nanoform of the same material” 
(EP and the Council 2011b). The regulation provides no further clarification as to what these 
properties might be, or how they are to be determined and by whom. This definition is 
markedly different from the one in the cosmetics regulation and the one proposed by the 
European Commission that has been adopted in, for instance, the BPR (EP and the Council 
2012a). 
In late 2015, the new European Regulation on Novel Foods was adopted and entered 
into force (EP and the Council 2015). In the regulation, the term “Novel Foods” is defined as 
“any food that was not used for human consumption to a significant degree within the Union 
before 15 May 1997” and which can be categorised as, among others, “food with a new or 
intentionally modified molecular structure, where that structure was not used as, or in, a food 
within the Union before 15 May 1997” or “food consisting of engineered nanomaterials 
defined in a manner similar to the regulation on the provision of food information to 
consumers” (EP and the Council 2011b). 
During the legislative procedure, the definition of NMs was discussed, and the 
Committee on the Environment, Public Health and Food Safety of the European Parliament 
suggested amending the proposed definition by the EC and having a 10% nanoparticle 
threshold for a food ingredient to qualify as “nano”, as recommended by EFSA’s Scientific 
Committee Unit (EFSA 2012) (citing concerns about uncertainties over safety), instead of the 
Commission’s proposed 50% (European Parliament 2014). The justification for adopting the 
EC NM definition and avoiding the definition in Reg. 1169/2011 was that the latter dealt with 
labelling and was not appropriate for risk assessment, which was the subject of the Novel 
Food Regulation, and that if the “50% threshold was applied even for risk assessment 
purposes, there would be the serious risk that some nano-ingredients will not be captured by 
the definition, and would therefore not be subject to risk assessment” (Committee on the 
Environment, Public Health and Food Safety 2014). Ultimately, the European Parliament 
decided to adopt the same definition of NM as in the regulation on the provision of food 
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information to consumers (see EP and the Council 2011b), because, for consistency and 
coherence purposes, it is important to ensure a single definition of an engineered nanomaterial 
in the area of food law (EP and the Council 2015).  
The Novel Food Regulation makes it clear that the use of nanomaterials requires prior 
authorisation. As part of the authorisation procedures for a novel food, the applicant has to 
provide, among others, a description and detailed composition of the novel food, scientific 
evidence demonstrating that it does not pose a safety risk to human health and a proposal for 
the conditions of intended use and for specific labelling requirements which do not mislead 
the consumer (EP and the Council 2015). As part of the scientific evidence on safety risk, the 
applicant has to provide an explanation for the scientific appropriateness of any test methods 
used and, where applicable, for the technical adaptations or adjustments that have to be made 
in order to respond to the specific characteristics of a nanomaterial (EP and the Council 
2015). Upon request by the European Commission, the European Food Safety Authority 
(EFSA) shall give its opinion on whether or not a novel food may pose a safety risk to human 
health, by considering possible effects on vulnerable groups of the population and verifying 
that the most up-to-date test methods are used to assess safety where a novel food consists of 
engineered nanomaterials.  
It is important to note that although the regulation that entered into force ended in 2015, 
many of its provisions will only become applicable from 1 January 2018, including the ones 
on nanomaterials.  
Besides the regulation on the provision of food information to consumers, and the novel 
food regulation, the regulation on food additives mentions “nanotechnology” and requires that 
when there are significant changes to the production process or the starting materials of a food 
additive, a new entry in the Community list of food additives approved for use in foods, or a 
change in the specifications, has to be made before it can be placed on the market despite the 
fact that it might already be included in a Community list (EP and the Council 2008a). This 
means that food additives produced via nanotechnology resulting in a change in particle size 
shall be considered as different additives and may only be authorised if, among others, a) they 
do not pose a safety concern to the health of the consumer at the level of use proposed on the 
basis of the available scientific evidence, b) there is a reasonable technological need that 
cannot be achieved by other economically and technologically practicable means, c) its use 
does not mislead the consumer and d) it has advantages and benefits for the consumer in 
regard to, for example, preserving nutritional quality, meeting special dietary needs, 
enhancing the quality or stability of a food or aiding in the manufacture, processing, 
preparation, treatment, packing, transport or storage thereof (EP and the Council 2008a).  
The procedures for approving food additives in regard to deadlines for various stages of 
the process, the role of the parties involved and the principles that apply are laid down by 
Regulation No 1331/2008 on establishing a common authorisation procedure for food 
additives, food enzymes and food flavourings (EP and the Council 2008b), whereas 
procedures surrounding the content, drafting and presentation of applications, information 
requirements and risk assessment, for instance, are laid down in Commission Regulation No 
234/2011 (Commission 2011). Regulation No 234/2011 provides general provisions on data 
required for risk assessment as well as specific data required for risk assessment and the risk 
management of food additives.  
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General provisions include the obligation of the applicant to take into account the latest 
guidance documents adopted or endorsed by EFSA when drafting and submitting the 
technical dossier, and that this dossier should include all the available data relevant to the 
purpose of the risk assessment (i.e. fully published papers of all references cited, or full copies 
of the original unpublished studies). Literature search strategies should also be documented in 
the application regarding any assumptions made, keywords used, databases used, time period 
covered, limitation criteria and outcomes of the literature search. Toxicological studies used 
for risk assessment should be conducted in facilities which follow the OECD Principles of 
Good Laboratory Practice (GLP), and studies not conducted according to standard protocols, 
data interpretation and justification on their appropriateness for risk assessment should also be 
provided. The burden is on the applicant to provide an overall conclusion in regard to the 
safety of the proposed uses of the substance and evaluate the potential risks in the context of 
known or likely human exposure.  
Specific provisions and data required for the risk assessment of food additives that are 
relevant when it comes to nanomaterials include information on a) particle size, particle size 
distribution and other physicochemical characteristics, b) stability, reaction and fate in foods 
to which the additive is added, c) proposed normal and maximum use levels, d) a dietary 
exposure assessment and e) information on toxicokinetics, subchronic toxicity, genotoxicity, 
chronic toxicity/carcinogenicity and reproductive and developmental toxicity. When it comes 
to data required for the risk management of food additives, the applicant has to provide in the 
technical dossier information verifying that the proposed use does not mislead the consumer 
and that there is a reasonable functional and technological need that cannot be achieved by 
other economically and technologically practicable means, including investigations into the 
efficacy of the food additive for the intended effect at the use level proposed, advantages and 
benefits for the consumer and analytical methods allowing the identification and 
quantification of the additive or its residues in food. 
Once the Commission has received an application, it shall, where necessary, request 
EFSA to verify the suitability of the data for risk assessment within 30 days, and prepare, if 
appropriate, an opinion. This opinion should include, among others, an assessment of 
biological and toxicological data, a dietary exposure assessment and an overall risk 
assessment establishing – if possible and relevant – a health-based guidance value, 
highlighting uncertainties and limitations, where relevant (Commission 2011). 
EFSA (2009) has already provided a scientific opinion on the potential risks arising 
from nanoscience and nanotechnologies on food and feed safety, noting a range of specific 
uncertainties when it comes to the risk assessment of nanotechnologies and their possible 
applications. These specific uncertainties relate to, for instance, the limited knowledge of 
(likely) exposure to possible applications and products, difficulties in characterising, detecting 
and measuring NMs in food/feed and limited information on optimal toxicokinetics and 
toxicological testing methods. Despite these uncertainties, EFSA (2009) considers the usual 
risk assessment paradigm (hazard identification, hazard characterisation, exposure assessment 
and risk characterisation) as applicable to NMs, and it sees current toxicity testing approaches 
as being a suitable starting point for the case-by-case risk assessment of NMs, concluding that 
nanotechnology aspects shall be considered when risk assessment guidance documents in the 
food and feed area are reviewed. Furthermore, they recommend that nanomaterial risk 
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assessment in the food and feed areas should consider the specific properties of nanomaterials 
in addition to those common to equivalent non-nanoforms (EFSA 2009).  
Following a request made by the European Commission, EFSA (2011) prepared a 
practical guidance for assessing the application of nanomaterials in food and feed application, 
including guidance covering risk assessments for food and feed applications relating to food 
additives, enzymes, flavourings, food contact materials, novel foods, feed additives and 
pesticides. Most notably, EFSA provided guidance on the physico-chemical characterisation 
requirements for and testing approaches to identifying and characterising hazards arising from 
nano-properties. Since physico-chemical parameters may change in various environments, the 
former should be determined ideally as manufactured (pristine state), as delivered for use in 
food/feed products, as present in the food/feed matrix, as used in toxicity testing and as 
present in biological fluids and tissues. The latter should include information from in vitro 
genotoxicity, absorption, distribution, metabolism and excretion and repeated dose 90-day 
oral toxicity studies in rodents, if the ENM persists in the food/feed matrix and in 
gastrointestinal fluids. Importantly, the guidance allows for reduced information to be 
provided if data verify and indicate no migration from food contact or when complete 
degradation/dissolution is demonstrated with no absorption of engineered nanomaterials as 
such (EFSA 2011).  
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4. Proposed new regulatory frameworks and their opportunities and 
weaknesses  
A number of NGOs, EU member states and REACH competent authorities have 
independently proposed a series of REACH revisions that go beyond simply revising the 
REACH Annexes as the EC has currently suggested (CIEL, ClientEarth and BUND 2013, 
KEMI 2013, UBA, BfR and BAuA 2013). In the following these proposals will be presented, 
while an overview of their opportunities and weaknesses can be found in Table 6.  
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Table 6: Overview of proposed new regulatory frameworks in regard to their scope, opportunities and weaknesses 
Legislative proposal Opportunities Weaknesses Reference 
 
German Dossier-in-
Dossier proposal 
 
Scope 
NMs 
Information requirements 
Very detailed when it comes to what 
information requirements should be 
triggered when, e.g., requiring REACH 
(eco)toxicological information at a 
lower tonnage level 
Substance identification 
Size is termed a characteriser, but for pragmatic reasons only and out of 
concern that considering size as an identifier and considering surface-
treated NMs as a substance on its own will lead to the splitting into 
numerous new substances 
Definition 
 The definition of NM in the proposal is hard to operationalise, as it 
follows EC recommendations on NM definition 
 The term “Most relevant form” is vague and not defined  
Registration 
Unclear how the registrant is to justify which of the surface-treated 
nanoforms could be considered together in one registration. Criteria for 
this issue have yet to be developed 
Information requirements 
Not clear what it means that two forms of “a substance differ significantly” 
and when a difference is “relevant” and hence when information has to be 
provided for different forms of a substance in a dossier and when 
additional testing might be necessary  
Evaluation  
Unclear how all the required information and data will be used to evaluate 
different nanoforms and feed into the authorisation process  
Authorisation 
Unclear under which circumstances authorisation could be granted 
Restriction 
It is unclear what would trigger restrictions of the whole NM, bulk or 
selected NM forms or respirable granular and fibrous particles and what 
these restrictions could be  
Risk assessment 
 Four elements of risk assessment not tailored for NM  
Obtaining (eco)toxicological information at a lower REACH tonnage level 
does not overcome that OECD TGs have not been developed for dispersed 
NM and that received information might not be relevant for NMs 
 
Schröder 2012, UBA, 
BfR and BAuA 2013, 
Schwirn et al. 2014 
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Table 6 continued: Overview of proposed new regulatory frameworks in regard to their scope, opportunities and weaknesses 
Legislative proposal Opportunities Weaknesses Reference 
 
CIEL, ClientEarth 
and BUND’s “nano 
patch”  
 
Scope 
NMs and any use of 
them 
Registration 
 Clear registration dates are to be 
staggered over a period of three years 
following the entry into force of the 
regulation on the basis of production 
volumes of 10 kg, 100 kg and 1000 
kg 
 A separate dossier required for NM 
forms if produced in quantities of 
more than 10 kg per year  
Notification 
Obligation to notify ECHA about 
products on the market that contain 
nanomaterials 
Labelling 
Require suffix “nano” to all products 
that have list of ingredients  
Register of nanomaterials 
A register of NMs will be established 
containing information on the 
quantities produced, distributed or 
imported if a minimum of 1 kg of a 
NM is produced, imported or 
distributed 
CLP 
Suggest that CLP Article 40 applies to 
NMs and whether the lack of 
classification in some hazard classes is 
due to lack of data, inconclusive data 
or data which are conclusive although 
insufficient for classification 
Definition 
 The definition of NM in the proposal is hard to operationalise, as it 
follows EC recommendations on NM definition 
Information requirements 
 Information to be submitted as part of the Chemical Safety Assessment 
(CSA) is to be volume dependent and set out in Annex 2 of the 
regulation, but the details of Annex 2 are not specified further in the 
proposal and it is not clear how information requirements are volume-
dependent  
Evaluation 
 It is stated that priority should be given to substances that have wide 
dispersive use, and substances registered above 1 tonne, but it is not 
clear how NMs are to be evaluated  
Authorisation 
Unclear under what circumstances authorisation could be granted 
Restriction 
Unclear in what circumstances restrictions should be implemented 
Risk assessment  
 Four elements of risk assessment not tailored to NMs 
 Not clear how the hazards and risks deriving from nanomaterials, 
including tailored test guidelines, can be documented as part of the CSA 
 
CIEL, ClientEarth and 
BUND 2012 
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Sweden’s Kemi 
nanomaterials 
regulation 
 
Scope 
NMs, NMs in 
mixtures and NMs in 
articles 
Registration  
 NMs are regarded as substances in 
their own right 
 Registration is required if more than 
10 kg is manufactured or imported 
per year, calculated on the basis of 
average production or import volumes 
for the three preceding calendar years 
Information requirements 
 Information requirements laid out in 
REACH Annexes VII + VIII + IX 
and X are to be applied to 10 kg, 100 
kg, 1 tonne and 10 tonnes, 
respectively 
 Exposure information should be 
included in dossiers for nanomaterials 
produced between 10- 100 kg  
 Chemical safety report is to be 
included in the registration when in 
quantities of 100 kg or more per year, 
per registrant 
Down-stream users 
 The obligation to prepare a Chemical 
Safety Assessment applies to 
downstream users as well, if they use 
a nanomaterial or mixture containing 
nanomaterials in a total quantity of 
less than 10 kg per year 
Notification 
A notification has to be provided by 
producers or importers of articles 
containing nanomaterials if the NM is 
present in quantities of more than 10 kg 
per producer or importer per year 
Definition 
NMs are defined according to Commission Recommendation of 18 
October 2011 on the definition of nanomaterials (2011/696/EU) 
Information requirements 
 Not clear how “special consideration to the specificities of 
nanomaterials, e.g. sample preparation and dosimetry” can be taken 
 As Annex I to this regulation has yet to be inserted, it is not clear what 
information has to be included in the “study summaries” and “robust 
study summaries”  
 
 
KEMI 2013 
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4.1 German Dossier-in-Dossier proposal from 2012 
4.1.1 Revisions needed, size as a characteriser, relevant forms and surface-treated 
NMs 
Several German federal institutions and agencies, including the Federal Environment Agency 
(UBA), Federal Institute of Risk Assessment (BfR) and the Federal Institute for Occupational 
Safety and Health (BAuA), have been engaged in a process with the aim of developing a 
proposal with regard to the regulation of nanomaterials within REACH. The process has been 
underway for at least two years, and its results have been presented at the Competent 
Authority for REACH and CLP (CARACAL) Subgroup (CASG) Nano 8 meeting (Schröder 
2012) and published in UBA, BfR and BAuA (2013) and Schwirn et al. (2014).  
While noting that the European Commission’s proposal on a definition of nanomaterials 
has yet to be implemented in REACH, and that there are no legal obligations to provide nano-
specific data, the proposal takes outset in three notions about nanomaterials and REACH. The 
first notion is that chemical legislation needs to be revised on the grounds of the precautionary 
principle, due to uncertainties related to evaluating the risks of nanomaterials (UBA, BfR and 
BAuA 2013, Schwirn et al. 2014). The second notion is that nanomaterials fall under the 
definition of a chemical substance as defined under REACH and are covered by REACH 
(Schröder 2012, Schwirn et al. 2014). The third notion is that the bulk and the nanoform types 
of a given material should be covered in one REACH registration dossier, as both have the 
same chemical composition and are chemically identical despite the fact that size changes 
lead to changes in the properties of a substance (Schröder 2012, Schwirn et al. 2014).  
The latter implies that particle size is seen as a “characteriser” used to distinguish forms 
of the same REACH substance within the same REACH registration dossier and not as an 
“identifier” i.e. something that uniquely defines and identifies a nanomaterial. In practice, this 
means that all information on one substance is kept in one REACH dossier, within which 
different information requirements could/should apply to bulk and NM and additional testing 
might be necessary if the properties of two forms of a substance “differ significantly” 
(Schröder 2012, UBA, BfR and BAuA 2013, Schwirn et al. 2014), thereby leading to the 
“dossier-in-dossier” proposal. The German “dossier-in-dossier” proposal does not specify 
what or how it is to be determined whether two forms of a substance differ significantly, but it 
does note that morphological properties (e.g. size, crystalline structure, shape, rigidity), water 
solubility and surface characteristics (e.g. surface charge, hydrophobia, photocatalytic 
properties, functional groups, agglomeration, volume-specific surface area) are the most 
important parameters which distinguish nanoforms from bulk forms, and between different 
nanoforms (UBA, BfR and BAuA 2013), and that a difference between nanoforms should be 
considered as “relevant” if it is likely that it would lead to a change in the hazard profile 
(Schwirn et al. 2014). It is noted throughout the German proposal that criteria for determining 
“relevance” still have to be developed, but it could be, for instance, quantitatively the most 
significant form, functionally the most important form or the form of probably the greatest 
toxicological relevance (UBA, BfR and BAuA 2013). 
It is pointed out that surface treatment may influence and govern the risk profile of NMs 
to a crucial degree, while surface-treated NMs are regarded as a special nanoform of the 
treated source material and are to be included in the registration of the source material (UBA, 
BfR and BAuA 2013). It is not viewed as being feasible to consider surface-treated NMs as 
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substances in their own right, as basically any conceivable combination of different 
substances A and B would be possible with surface treatment, thereby leading to the problem 
of the extreme splitting of similar materials into various substances on their own, and that 
tonnage bands which trigger a registration obligation would not be reached as a consequence 
(UBA, BfR and BAuA 2013).  
That is why the German proposal is to apply the substance identity approach, with the 
80 wt.% criterion meaning that if the surface-treated nanomaterial consists of at least 80 wt.% 
of the core material, it is to be regarded as a separate nanoform of the core material. On the 
other hand, it has to be defined as a new substance if the surface-treated nanomaterial consists 
of less than 80 wt.% of the core material. This means that the registrant has to demonstrate 
that the different nanoforms can be jointly considered, or have to be separately considered, for 
further test performances and fulfilment of the REACH requirements (UBA, BfR and BAuA 
2013, Schwirn et al. 2014). 
UBA, BfR and BAuA (2013) furthermore argue that it is challenging to “… develop 
clear criteria which would allow defining and checking under which conditions surface 
treatment results in a new substance and how the different surface treatments can be defined 
in relation to one another.” It is, however, not clear why this is specifically the case for the 
option of regarding surface-treated NMs as substances in their own right and not, for instance, 
the option that the Germans propose, namely to apply the 80/20 rule. It is well-known that “at 
present, there is no standardized method for determining the degree of surface treatment,” as 
noted by the UBA, BfR and BAuA (2013).  
 
4.1.2 Tonnage threshold 
Revisions are also found to be necessary with regard to current tonnage thresholds and 
information requirements, in order to make REACH concepts legally binding in relation to 
NMs (Schröder 2012). The German proposal requires the adoption of REACH articles as well 
its annexes. Tonnage thresholds are suggested to be lowered to 100 kg/a, without any 
argumentation being made for why this should happen. For NMs produced in quantities ≥ 100 
kg/a (aggregated tonnage), reduced registration requirements for all different nanoforms 
should apply and be limited to: substance identity, characterisation of the material(s)/form(s), 
a description of its use(s) and all other available data (Schröder 2012, UBA, BfR and BAuA 
2013, Schwirn et al. 2014).  
For NMs produced in quantities ≥ 1 t/a (aggregated tonnage), full registration should 
furthermore include one or more chemical safety reports considering every form collectively 
or separately, depending on the choice of the registrant, and which fulfils the nano-specific 
information requirements for the specific tonnage band to be laid down in a new and yet to be 
established Annex XVIII (Schröder 2012, UBA, BfR and BAuA 2013, Schwirn et al. 2014). 
If different nanoforms of one substance are manufactured, data requirements depend on 
the individual tonnages that are manufactured as well as the aggregated tonnage. If the 
aggregated tonnage is 200 t/a and nanoforms 1, 2, 3 and 4 are manufactured in quantities of 
150 t/a, 10 t/a, 1 t/a and 39 t/a, the data requirements should correspond to ≥ 100 t/a, ≥ 10 t/a, 
≥ 1 t/a and ≥ 39 t/a, respectively. 
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If the aggregated tonnage is 200 t/a and no nanoform is in the tonnage band of the 
aggregated tonnage, e.g. nanoforms 1, 2, 3 and 4 are manufactured in quantities of 60 t/a, 70 
t/a, 1 t/a and 69 t/a, the data requirements corresponding to ≥ 100 t/a would have to be 
fulfilled for the “most relevant nanoform,” e.g. nanoform 3, despite the fact that only 1 t/a is 
manufactured in. Data requirements for nanoforms 1, 2 and 4 will then correspond to the data 
requirements for ≥ 10 t/a (Schröder 2012, UBA, BfR and BAuA 2013).  
Although quite important, the German proposal does not define the term “most relevant 
form” further, and other elements therein seem in some regard to contradict the presence and 
possibility of identifying such a form. For instance, the UBA, BfR and BAuA (2013) 
appendix states that “To date it is not possible either to make sound assumptions with respect 
to the selection of the probably most critical material on the effect side or to make predictions 
of the environmental fate and exposure,” and that “To date no reliable information is available 
to which variations are acceptable for individual parameters. In many cases it will remain a 
case by case decision. It is desirable to develop appropriate screening tests, where applicable, 
to gain experience on comparability.” In light of these statements, how can one therefore 
determine “the most relevant form,” given that it is not possible to make sound assumptions 
and no reliable information is available? 
 
4.1.3 Information requirements and waiving 
The German proposal argues that nano-specific information requirements are needed and 
suggest that a new Annex XVIII should be “oriented on existing Annexes but with some 
amendments/additions,” including the comprehensive characterisation of nanoforms as part of 
substance registration in regard to morphological parameters (e.g. size, shape and crystal 
structure), surface properties (e.g. charge, surface reactivity, functional group, dispersibility) 
and solubility in different media (Schröder 2012, Schwirn et al. 2014). 
Amendments furthermore include moving some toxicological testing requirements to 
lower tonnages, e.g. genotoxicity already at 1 t/a and requiring 28-day, 90-day and chronic 
and carcinogenicity studies to be conducted by inhalation as administration route (Schröder 
2012, UBA, BfR and BAuA 2013). 
For ecotoxicology, the German proposal suggests that many of the REACH information 
requirements are moved to a lower tonnage level for nanomaterials, meaning that REACH 
Annexes VII and VIII would already apply from 1 t/a. Annex IX and the chronic sediment 
test from Annex X would apply from 10 t/a, and Annex X would apply from 100 t/a, except 
for the chronic plant test and the reproduction test for birds, which remain at 1000 t/a 
(Schröder 2012, UBA, BfR and BAuA 2013). Furthermore, it is suggested that chronic tests 
be required instead of acute examinations at lover tonnage levels and that information 
requirements must cover sediment and soil organisms (Schwirn et al. 2014). Finally, a fish-
feeding study is to be given preference over the BCF test in the case of bioaccumulation, as 
the BCF often fails to provide a realistic picture of the accumulation behaviour of NMs 
(UBA, BfR and BAuA 2013). 
According to the German proposal, information requirements have to be fulfilled 
separately for the individual forms, if substance nanoforms differ in a relevant way (UBA, 
BfR and BAuA 2013, Schwirn et al. 2014). What is “relevant” is again not specifically 
defined, as noted above.  
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Sub-chronic and chronic toxicity studies are considered to be essential, and waiving due 
to low water solubility is not considered appropriate, albeit waiving is possible on a case by 
case basis with reference to data from bulk form(s) and other nanoforms with the same 
chemical substance identity or with reference to read-across from a bulk/nanoform to a 
nanoform with different chemical substance properties. It may also be possible to waive tests 
in individual cases if the bulk material is classified in the highest category and this 
classification is also applied to the NMs, though criteria and guidance for waive tests still 
need to be developed (Schröder 2012, UBA, BfR and BAuA 2013).  
While noting that surface characteristics probably play a greater role for NMs than the 
volume characteristics of the materials, the German proposal requires that the registrant 
demonstrates that the different surface-treated nanoforms can be jointly considered or have to 
be separately considered for further test performances and REACH requirements. The precise 
procedure for how to obtain a precise delimitation needs further clarification (UBA, BfR and 
BAuA 2013, Schwirn et al. 2014).  
 
4.1.4 Substance evaluation, authorisation and restriction 
The German proposal provides limited information on how the substance evaluation is to be 
performed and what the criteria might be for authorisation and restriction. Nonetheless, it 
does state that substance evaluation, authorisations and restrictions could be implemented for 
the whole NM, selected forms of the NM or only for the bulk form of the substance or 
respirable granular and fibrous particles. 
 
4.2 CIEL, ClientEarth and BUND’s “nano patch” from 2012 
In 2012, CIEL, ClientEarth and BUND published an initial concept note called “Draft 
proposal for Regulation of the European Parliament and of the Council on the marketing and 
use of nanomaterials amending Regulation 1907/2006,” outlining the basic idea of a 
horizontal piece of legislation covering nanomaterials. The proposal was the result of several 
years of work on the issue of nanomaterials, in which CIEL, ClientEarth and BUND (2012) 
suggest that the best way to address shortcomings in the regulation of nanomaterials is to have 
a separate horizontal instrument that is based on a set of general principles which apply to all 
nanomaterials on the market across all relevant fields (chemicals, products and environmental 
protection legislation).  
As REACH is the cornerstone for assessing and regulating chemical substances in the 
EU, CIEL, ClientEarth and BUND furthermore suggest that REACH is amended through a 
“nano patch,” so that it also becomes the cornerstone for filling regulatory gaps on 
nanomaterials and nanotechnologies as well as sectoral chemicals legislation, thereby making 
the latter “nano-fit” (CIEL, ClientEarth and BUND 2012).  
 
4.2.1 Policy issues that require attention  
The notion that there is a need for a separate horizontal instrument as well as REACH 
amendments is based on a number of policy issues identified by CIEL, ClientEarth and 
BUND as needing attention and which, overall, mean that workers’ protection measures may 
prove to be neither adequate nor sufficient, due to the lack of information on nanomaterials 
(CIEL, ClientEarth and BUND 2012). 
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The first problem is that there is no commonly agreed definition of NM that applies to 
all regulatory frameworks relevant to nanomaterials and that the assessment of the nanoforms 
of a given substance is not required to be separate from the bulk form of the substance. 
According to CIEL, ClientEarth and BUND, the result of this issue is that manufacturers, 
users and importers of nanomaterials are free to refer to data from the bulk form of a 
substance when documenting hazards and risks. As a consequence, information will not be 
tailored to the specific properties that the nanomaterial might have in terms of toxicity and 
ecotoxicity, which again makes it hard to define and implement appropriate risk management 
measures. 
The second problem is that the nanoforms of existing substances would be treated as 
phase-in substances under REACH. As a result, no toxicological and ecotoxicological 
information will be provided on the nanoforms, as only physiochemical data for phase-in 
substances has to be submitted, unless the parent substance is likely to be a CMR or a PBT, or 
if it falls into a hazard class of the CLP for substances with dispersive and diffuse uses. The 
same goes for exposure information as well as the availability of information further down the 
supply chain.  
Third, the current volume thresholds do not account for NMs usually produced in much 
smaller quantities than their bulk counterparts.  
Fourth, the lack of finalised and recognised testing guidelines which are fit enough to 
test properly for potential nanomaterial hazards constitutes a serious issue, and even in the 
case where the testing guidelines will not need to be adapted, the test will need to be carried 
out on the specific nanoform to yield adequate information (CIEL, ClientEarth and BUND 
2012).  
Finally, fifth, it is not possible to obtain a complete overview of which nanomaterials 
are on the EU market, due to the lack of registration and notification requirements when it 
comes to the use of NMs. This might delay regulatory action, e.g. a recall of affected 
products, if a NM is found to pose a health or an environmental risk, and the lack of market 
transparency also affects consumers, who are unable to make informed choices about 
purchasing nanoproducts (CIEL, ClientEarth and BUND 2012). 
 
4.2.2 Legal elements of the “nano patch” 
The proposal by CIEL, ClientEarth and BUND (2012) consists of one part comprising general 
provisions applicable to all nanomaterials in the EU and one part that focuses on amending 
existing regulatory instruments such as REACH and the Cosmetics Products Regulation. 
The proposal aims at regulating nanomaterials and shall apply to any usage thereof. 
Nanomaterials are defined according to the European Commission’s Recommendation 
2011/696/EU, and a central tenet of the proposal by CIEL, ClientEarth and BUND (2012) is 
that the Commission’s proposal is adopted in all legislation that might be relevant, and that 
the existing definitions of NMs are amended in the Cosmetics Products Regulation and the 
regulation on food information to consumers. 
According to the proposal, all nanomaterials imported into or placed on the market in 
the EU have to be registered under REACH, along with a separate dossier for bulk materials 
if produced in more than 10 kg per year. Additionally, ECHA must be notified about products 
on the market that contain nanomaterials. The 10 kg weight was chosen as it was initially 
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proposed in the REACH negotiation and was the threshold for the notification of new 
substances in place under the previous directive on classification, packaging and labelling 
(CIEL, ClientEarth and BUND (2012). The registration dates are to be staggered over a 
period of three years following the entry into force of the regulation on the basis of production 
volumes of 10 kg, 100 kg and 1000 kg. Nanomaterials that have been assessed separately 
from their bulk form under other EU legislation, e.g. food contact materials and biocides, are 
exempted from registration. 
A Chemical Safety Assessment, according to REACH, has to be completed for all 
registered nanomaterials, and the information submitted is to be volume-dependent and set 
out in Annex 2 of the regulation. The information requirements to be submitted aim to 
document the hazards and risks deriving from nanomaterials, including tailored test 
guidelines, while the technical and scientific tasks related to the notification and registration 
are to be carried out by ECHA; besides that, the specifics of Annex 2 are not quantified 
further in the proposal (CIEL, ClientEarth and BUND 2012).  
 
4.2.3 Evaluation 
When it comes to evaluation, CIEL, ClientEarth and BUND (2012) call for ECHA to perform 
compliance checks for all registered nano-substances, giving priority to substances that have 
wide dispersive use and those registered above 1 tonne. All registered nanomaterials are 
furthermore to be included in the CoRAP within two years of registration. 
 
4.2.4 Report, notify, classification and labelling 
According to the proposal made by CIEL, ClientEarth and BUND (2012), manufacturers and 
importers are required to notify ECHA of information required under Article 40 of the CLP 
Regulation, including, among others, the classification of the substance and an indication of 
whether the lack of classification in some hazard classes is due to lack of data, inconclusive 
data or data which are conclusive but insufficient for classification. 
Furthermore, CIEL, ClientEarth and BUND (2012) propose that the requirement to add 
the suffix “nano” to the name of the ingredient should be expanded from food, cosmetics and 
biocidal products to all products that are required to have labels detailing ingredients, e.g. 
detergents, aerosols, sprays and paints (CIEL, ClientEarth and BUND 2012). 
In order to achieve a better understanding of the uses of nanomaterials, and to allow 
their traceability throughout the supply chain, operators are finally obliged to report quantities 
of substances and their uses in the nanoform through which they are produced, distributed or 
imported into the EU, if a minimum of 1 kilogram of a nanomaterial is produced, imported or 
distributed. This information is to be put into a register of nanomaterials (CIEL, ClientEarth 
and BUND 2012). 
 
4.3 Swedish draft proposal on regulation of nanomaterials from 2013 
In 2013, the Swedish Chemical Agency (KEMI) presented its preliminary ideas on the future 
regulation of NMs, laying down rules for manufacturing and marketing of nanomaterials, 
NMs in mixtures and NM in articles. In the Swedish proposal, NMs are defined according to 
Commission Recommendation of 18 October 2011 on the definition of nanomaterial and 
regarded as substances in their own right.  
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4.3.1 Registration of Nanomaterials  
Manufacturers or importers of a nanomaterial, either on its own or in one or more mixture(s) 
in quantities of 10 kg or more per year, are required to register. Quantities per year shall be 
calculated on the basis of the average production or import volumes for the three preceding 
calendar years. Pre-registration is also required for “phase-in nanomaterials,” defined in the 
Swedish proposal as a nanomaterial that was placed on the market on the date for entry into 
force of this regulation. Similarly, producers or importers of articles containing nanomaterials 
have to notify ECHA if the nanomaterial is present in those articles in quantities totalling over 
10 kg per producer or importer per year.  
 
4.3.2 Information requirements 
As part of the registration process, various information requirements have to be fulfilled. The 
information specified in REACH Annex VII is to apply for nanomaterials manufactured or 
imported in quantities of 10 kg or more per year, per manufacturer or importer, whereas 
REACH Annexes VII and VIII apply to 100 kg or more, REACH Annexes VII + VIII and IX 
to 1 tonne or more and finally REACH Annexes VII + VIII + IX and X to NMs manufactured 
or imported in quantities of 10 tonnes or more. It is important to note that tests on 
nanomaterials should be carried out with special consideration given to the specificities of 
nanomaterials, e.g. sample preparation and dosimetry, according to the proposal made by 
KEMI. 
Exposure information is to be included in the technical dossier for nanomaterials 
produced in quantities of 10 to 100 kg, whereas a chemical safety report is to be included in 
the registration when in quantities of 100 kg or more per year, per registrant. The obligation 
to prepare a chemical safety assessment applies to downstream users as well, if they use a 
nanomaterial or mixture containing nanomaterials in a total quantity of less than 10 kg per 
year. 
The REACH requirement to provide so-called “study summaries” and “robust study 
summaries” (see REACH Articles 10 (a) (vi) and (vii)) shall also apply to NMs in the 
proposal made by KEMI (2013), but it should furthermore include the information derived 
from the application of Annex I to this regulation. However, Annex I to this regulation has yet 
to be inserted.  
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5. Issues plaguing EU regulations of nanomaterials 
As pointed out in Table 5 and 6, a number of issues are, and have been, plaguing the EU 
regulation of nanomaterials for some time now despite recent revisions to certain existing 
legislation. These include: 1) how to define nanomaterials, 2) whether nanomaterials should 
be considered as different from their bulk counterparts and 3) how to deal with the profound 
limitations of risk assessment when it comes to nanomaterials. Collectively, they raise the 
question about whether to continue adapting existing legislation or whether it might be better 
to develop a new regulatory framework tailored for nanomaterials. 
 
5.1 Definitions of nanomaterials in the EU 
Many different definitions of nanotechnology and nanomaterials exist in the literature. One of 
the most cited definitions is the one applied by the US National Nanotechnology Initiative, 
which defines nanotechnology as follows: “Nanotechnology is the understanding and control 
of matter at dimensions of roughly 1 to 100 nanometers, where unique phenomena enable 
novel applications. (…). At this level, the physical, chemical, and biological properties of 
materials differ in fundamental and valuable ways from the properties of individual atoms and 
molecules or bulk matter” (Nanoscale Science Engineering and Technology Subcommittee 
2004). 
At the moment, terms such as nanotechnology, nanomaterials and nanoparticles are 
understood in a variety of ways (Hansen 2010, Arts et al. 2014, Roebben et al. 2014, Boholm 
and Arvidsson 2016). It is clear from the many proposed definitions that NMs and/or NPs 
need to be in the nanometre range and have properties different from bulk materials; 
nonetheless, terms such as “roughly 1 to 100 nanometers”, “dimension between 
approximately 1 and 100 nanometers” and “differ in fundamental and valuable ways from 
bulk matter” are in many cases too vague to provide a clear legal foundation (Hansen 2010).  
A clear definition of nanomaterials is vital, as it will eventually help define the scope of 
any subsequent regulation, and determine which nanomaterials and applications are covered, 
which producers have to comply with the regulations and then and what they will have to 
comply with successfully (Hansen 2010, Roebben et al. 2014, Boholm and Arvidsson 2016).  
Back in 2009, the European Parliament made a resolution calling for the “introduction 
of a comprehensive science-based definition of nanomaterials in Community legislation as 
part of nano-specific amendments to relevant horizontal and sectoral legislation” (European 
Parliament 2009), but it is evident from Table 5 that different definitions of nanomaterials 
have subsequently been implemented in the different pieces of EU legislation that have been 
amended.  
In 2011, the EC adopted a definition of a nanomaterial as: “A natural, incidental or 
manufactured material containing particles, in an unbound state or as an aggregate or as an 
agglomerate and where, for 50 % or more of the particles in the number size distribution, one 
or more external dimensions is in the size range 1 nm - 100 nm. In specific cases and where 
warranted by concerns for the environment, health, safety or competitiveness the number size 
distribution threshold of 50 % may be replaced by a threshold between 1 and 50 %” 
(European Commission 2011c). Fullerenes, graphene flakes and single wall carbon nanotubes 
with one or more external dimensions below 1 nm should furthermore be considered as 
nanomaterials by default (European Commission 2011c). 
                                             
68 
REACH and Ecolabelling legislation do not define nanomaterials, but in the case of 
REACH the EC definition is used in guidelines relating to legal provisions that address 
nanomaterials (Rausher et al. 2015). The BPR only adopts parts of the definition of 
nanomaterials recommended by the European Commission, omitting “incidentally” created 
NPs (Brinch et al. 2016, Mackevica et al. 2016a), whereas a nanomaterial is defined as “an 
insoluble or bio-persistent and intentionally manufactured material with one or more external 
dimensions, or an internal structure, on the scale from 1 to 100 nm” under the Cosmetic 
Regulation (EP and the Council 2009a), while food legislation again has a NM definition 
completely different from other non-food regulations. Only the regulation on medical devices 
follows EC recommendations on NM definitions, which thereby creates general inconsistency 
across legislative areas and means that a NM could be a NM according to one regulation and 
not according to another. 
The EC definition furthermore has a number of limitations or implementation 
challenges that are important to keep in mind.  
First of all, it equates nanomaterials with nanoparticles, not making the important 
distinction between the two. Nanomaterials include not only nanoparticles, but also materials 
with nanostructures on the surface as well as bulk materials with nanostructures (Hansen et al. 
2007, Roebben et al. 2014, Rauscher et al. 2015).  
Second, generally agreed methods and technical standards on how to measure particle 
size distribution are not yet available, and we especially lack methods that can be used to 
characterise agglomerates and aggregates and non-spherical particles. In the REACH 
registration dossiers analysed by Christensen et al. (2012), the methods used for measuring 
the particle size distributions of nanomaterials were found to be inappropriate, as they do not 
detect particles in the 1-100 nm range and do not distinguish between primary particles, 
aggregates and agglomerates. It is well known that particle size is linked strongly to the 
manufacturing process. Hence, in order to enable robust assessments, a combination of 
methods have to be applied supported by a description of sample preparation and information 
about the nanomaterial production process (Christensen et al. 2012, Linsinger et al. 2012, 
Rauscher et al. 2014, 2015).  
Third, the current definition refers to natural, incidental and manufactured materials and 
thereby applies to all materials regardless of their origin, meaning that nanoparticles 
stemming from volcanoes and forest fires fall under the definition (Rauscher et al. 2015). 
According to Arts et al. (2014) and Roebben et al. (2014), the EC definition of NMs is the 
only one that does include natural and accidentally occurring nanoparticles, whereas all other 
definitions are restricted to intentionally produced, manufactured or engineered NMs. This is 
counterintuitive, especially considering that the purpose of nanotechnology is to design, 
control and manufacture technologies and materials at the nanoscale and has little to do with 
the random combustion processes that go on during forest fires and volcanic eruptions.  
Arguably hard or impossible to define, the definition also does not consider or attempt 
to make a distinction between nanomaterials that have “unique properties” and materials that 
have no novel properties whatsoever (Lövestam et al. 2010, Roebben et al. 2014), which 
seems to be in stark contradiction to the whole concept and historical foundation of 
nanotechnology, where terms such as “unique properties” and “new phenomena” are often 
used in association with nanotechnology and nanomaterials (Nanoscale Science Engineering 
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and Technology Subcommittee 2004, European Commission 2004b).  
Finally, although there might not be a scientific threshold applying to when a material is 
to be considered “nano” (Arts et al. 2014, Roebben et al. 2014), the 50% threshold seems set 
arbitrarily high. The EC definition was inspired by SCENIHR, who, after considering the 
“essential scientific elements of a working definition for the term “nanomaterial” for 
regulatory purposes” proposed that a “material is considered to be a nanomaterial, and nano-
specific risk assessment has to be performed when >0.15% (or a specified percentage) of the 
number size distribution is <100 nm”. The 0.15% was recommended by SCENIHR, as it 
represents the mean size plus/minus three times the standard deviation and would mean that 
any material would be a nanomaterial when >0.15% of the material, based on number 
concentration, has a size below 100 nm (SCENIHR 2010). Although SCENIHR does state 
that the values could be 0.15% “or any specified percentage”, there seems to be good distance 
between the 0.15% and the 50% that the EC ended up recommending in their proposal for a 
definition. 
From the actual operationalisation of the EC NM definition in the BPR, these 
limitations or implementation challenges have already shown themselves in regard to the 
assessment and approval of Synthetic Amourphous Silica (SAS). The Assessment Report 
prepared by France clearly states that the approval covers SAS as a nanomaterial in the form 
of stable 1-6μm aggregates with primary particles of < 25 nm. However, when it comes to 
assessing the hazard and risk, it was the aggregates – and not the nanoparticles – that were 
subject to the evaluation. The reason given in the Assessment Report is that the aggregate 
comprises of strongly bound or fused particles that are the smallest stable particles found in 
normal handling and use conditions. Exposure to nanoscale primary particles is therefore not 
expected during the specific intended biocidal use. Although it might be reasonable to include 
handling and use considerations when it comes to defining NMs and whether NM aggregates 
have to be subject to nano-specific testing requirements under the BPR, it does seem to 
somewhat contradict the intention of the EC definition of NM and the BPR. The EC 
definition of NMs, as also adopted in the BPR, is quite clear on the notion that aggregates and 
agglomerates of primary particles are to be considered as NMs, and the BPR is quite specific 
on the fact that a nano-specific risk assessment is required and arguments have to be made in 
regard to the nano-relevance of the test performed that provides the basis of the assessment. 
Hence, it seems contradictory to argue that no hazard or risk assessment has be done, due to 
the smallest stable particles being 1-6μm (Hansen and Brinch 2014). 
Similarly, under REACH, some potential practical issues have arisen as some 
registrants specifically refer to their substance as a “nanomaterial” in physical and chemical 
properties reported in the registration, but subsequently they conclude that the substance is 
not a NM in the same section of the dossier and report that the size distribution of a sample’s 
particles, counted under TEM, do not conform with the European Commission definition of 
nanomaterials, as only 39 ± 2.8% of all particles in the measured test material were found to 
be between 1 nm and 100 nm (Broomfield et al. 2016). It seems that we might have a problem 
with the NM definition when everyone – and even REACH registrants – speaks of a given 
material as a “nanomaterial” in their daily operations, but not when it comes to regulation, as 
it does not fall under the EC definition of a NM because only  40% - and not >50% of the 
particles were found to be 1-100 nm.  
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From the drafting and recasting of existing food regulation, it is evident that there have 
also been significant discussions by experts on how to define nanomaterials in the food area. 
In the food field, EFSA initially endorsed a definition similar to that of SCENIHR, 
considering NMs as “… any material that is deliberately created such that it is composed of 
discrete functional parts, either internally or at the surface, many of which will have one or 
more dimensions of the order of 100 nm or less” (EFSA 2009). The elements “deliberately” 
and “of the order to 100 nm or less” were initially considered as sufficiently valid parameters 
in identifying NMs, but the later EFSA’s Scientific Committee Unit (EFSA 2012) 
recommended adopting the EC definition of a 10% nanoparticle threshold for a food 
ingredient to qualify as a “nanomaterial” instead of a 50% threshold, citing concerns about 
uncertainties as to safety. In the end, the European Parliament	 ended up using the same 
definition as in other areas of food law, in order to ensure uniformity across EU food 
legislation (EP and the Council 2011b), though it left terms such as “intentionally produced 
material”, “dimensions of the order of 100 nm or less”, “discrete functional parts” and 
“specific physico-chemical properties that are different from those of the non-nanoform of the 
same material” open to interpretation. 
Work has been underway in order to evaluate the EC definition, and the JRC have 
developed a series of scientific-technical reports to assist the EC in taking into account any 
experience gained during the use of the EC definition (Rauscher et al. 2015). In its final 
report, the JRC (Rauscher et al. 2015) argued that terms such as “particle,” “size” and 
“external dimension” should be defined more rigorously, in order to leave less room for 
interpretation. Among others, the JRC (Rauscher et al. 2015) additionally pointed out that 
although variable thresholds may allow regulators to address specific concerns in certain 
application areas, they may also confuse customers and lead to an inconsistent classification 
(as nanomaterial or not) of the same material based on the field of application (Rauscher et al. 
2015, Roebben et al. 2014).  
Updates to the definition were expected in mid-2016 (Roberts 2016), but there is no 
telling when the proposed updated definition will be implemented in existing legislation, and 
at least until then the many sometimes conflicting definitions of NM in the EU legislation will 
create additional confusion and complicate efforts to develop a sensible, effective policy 
(Hansen 2010). 
 
5.2 Should nanomaterials be considered as different from their bulk counterparts? 
The European Commission has long argued that nanomaterials in general fall under the scope 
of existing legislation (CEC 2008a, European Commission 2012a, b), which again has raised 
the question of “whether a nano-equivalent of a substance with different physicochemical and 
(eco) toxicological properties from the bulk substance would be considered as the same or as 
new substances under existing regulation of, for instance, chemicals” (Chaundry et al. 2006 
Azoulay 2012).  
Whether nanomaterials are considered to be equivalent to or different from the bulk 
material will have a major impact on the requirements put on manufacturers prior to placing 
products on the market. For instance, if a nanomaterial is considered to be the same as a 
registered bulk material, the appropriateness of the hazard information data should be open to 
discussion. On the other hand, if the nanomaterial is considered a different substance, hazard 
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information would, for example, have to be generated for the registration dossier under 
REACH, if it is produced in quantities of more than 1 ton/year (Chaudhry et al. 2006, Führ et 
al. 2006, Azoulay 2012, Hansen and Baun 2012b). 
The BPR makes it very clear that the approval of an active substance does not cover a 
corresponding NM form, except where this is mentioned explicitly; for instance, the Novel 
Food Regulation makes it clear that the use of nanomaterials requires prior authorisation. 
The European Commission has argued that nanomaterials are covered by the definition 
of chemical substances under REACH, which defines a substance as a “chemical element and 
its compounds in the natural state or obtained by any manufacturing process, including any 
additive necessary to preserve its stability and any impurity deriving from the process used, 
but excluding any solvent which may be separated without affecting the stability of the 
substance or changing its composition” (EP and the Council 2006, art. 3). According to the 
EC, any registration dossier on an existing chemical substance, already placed on the market 
as a bulk substance, will have to be updated to include specific properties of the nanoform of 
that substance when the nanoform is introduced onto the market (CEC 2008a, Hansen 2010). 
Furthermore, REACH competent authorities “have clarified that the REACH provisions apply 
to nanomaterials and that registrants should attempt to apply the existing guidance in their 
registrations” (CEC 2008a, Christensen et al. 2012). 
Despite the EC’s and REACH competent authorities’ attempts to provide clarification, 
information and especially hazard information on nanomaterials, there is still a profound lack 
of information in the REACH dossiers. This means that it is not always clear which form was 
tested and whether the claim made by the registrant that the nanoform has the same 
toxicological properties as the bulk form is valid (UBA, BfR and Baua 2013, Depallens cited 
in Buxton 2016). Industry is not legally obliged to provide this information, as it is not part of 
the standard information requirements in REACH Annexes VI-XI, as noted repetitively by 
UBA, BfR and BAuA (2013) and the European Commission in their second regulatory 
review of NMs. Hence, it is not surprising that there is profound ambiguity in the scope of 
many of the registration dossiers and registrants’ intentions regarding which 
nanomaterials/nanoforms fall under the scope of the registration (Christensen et al. 2012). 
According to Christensen et al. (2012) any options for adapting REACH must begin by 
resolving such ambiguities and explicitly requiring registrants to describe the scope of the 
registration dossier, specifying whether different forms are covered and providing 
justification for when data are shared and when they are not shared between different forms. 
Registrants should furthermore explicitly be required to provide more detailed 
characterisations of nanomaterials/nanoforms. In order to clarify REACH requirements for 
nanomaterials in the standard information requirements found in REACH Annexes VI-XI, the 
JRC and ECHA (Christensen et al. 2012) have suggested that the following information 
requirements are explicitly included as a minimum: a) primary particle size distribution with 
an indication of the number fraction of primary particles smaller than 100 nm, b) other 
particle size distributions representing possible agglomerated/aggregated forms during usage 
and following the (environmental) release of substances, c) a description of surface 
functionalisation/treatments, d) shape based on the recommendations of the RIP-oN2 project 
(Hankin et al. 2011) and e) the volume-specific surface area and/or mass-specific surface area 
(Christensen et al. 2012). 
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Despite recommendations made by the JRC and ECHA back in 2012, there are still no 
legal obligations to provide nano-specific data on these end-points in the registration dossiers, 
as they are not part of the standard information requirements. 
In its second regulatory review on NMs in 2012, the European Commission (2012a) 
argued that REACH “sets the best possible framework for the risk management of 
nanomaterials when they occur as substances or mixtures but more specific requirements for 
nanomaterials within the framework have proven necessary”, noting that “there is no 
prescription to undertake specific tests for each different form, or to spell out the way in 
which the different forms have been addressed in the registrations, although the REACH 
dossier structure allows this and the technical advice from ECHA encourages it”. In 2010, the 
hope was that that the publication of the EC recommendation on a NM definition, as well as 
the finalisation of the RIP-oN 1-3 plus REACH competent authorities clarifying that “the 
REACH provisions apply to nanomaterials”, would encourage registrants to attempt to apply 
the existing guidance as part of their registrations (Christensen et al. 2012). This, however, 
has not been the case to date, as only four additional nanomaterials were registered under the 
second REACH registration deadline (Jones 2013). The EC and ECHA are now trying to 
define nanoforms further and to provide additional guidance on the registration of 
nanomaterials as well as testing for human health and environmental end-points and QSARs 
and Grouping before the third and final REACH registration deadline, but the REACH 
Annexes have still to be revised (Hansen and Baun 2015, Hansen et al. 2017a).  
Nanoforms are defined as “a form of a substance that meets the requirements of the EC 
definition and has a specific shape and a specific surface chemistry as additional parameters” 
(ECHA 2016d), while ECHA has specified that when reporting on size as defined in the EC 
recommendation, particle shape and surface chemistry should be seen as minimum criteria for 
the registration of nanoforms. The latter criterion ECHA calls “essentially a wild card”, as any 
combination of treatments may be applied. At the moment, a substance that has one present 
constituent greater than 80% w/w is defined as a mono-constituent, and the identity of the 
substance is based on the identity of the main constituent despite the fact that it may contain 
up to 20% w/w impurities. This is known as the 80/20 rule. A substance that has one or more 
constituents present at > 10 but < 80% (w/w) is defined as a multi-constituent substance. 
Constituents in the range of > 10 but < 80% (w/w) contribute to the substance name, whereas 
constituents present at < 10% are considered as impurities (European Commission Joint 
Research Centre 2011). 
Knowing that much of what makes NMs unique is related to increased specific surface 
area and surface chemistry, and not their mass, concern has been raised that if the 80/20 rule 
was applied to surface-treated nanomaterials, the surface treatment would be considered to be 
an impurity and hence would not contribute to the identity and the name of the substance. 
This would specifically be a concern when the contribution of the surface treatment was less 
than 20% for a mono-constituent NM or less than 10% (w/w) for a multi-constituent NM. 
Surface treatment/surface chemistry was also discussed in detail in the RIP-oN1 project, but 
no consensus could be reached in terms of whether surface treatment/surface chemistry 
should be considered an “identifier” to distinguish a REACH substance from another REACH 
substance or as a “characteriser” used to distinguish forms of the same REACH substance 
within the same REACH registration dossier, or whether surface functionalisation/treatment 
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should trigger the need for a separate registration. However, there was agreement that it was 
relevant for the inherent property data and on the hazard/risk assessment (European 
Commission Joint Research Centre 2011, Christensen et al. 2012). In an analysis of the first 
round of REACH registrations relevant to nanomaterials, Christensen et al. (2012) observed 
that the extent of surface treatment was only indicated in one dossier out of 45 selected for 
further analysis, whereas about half included information indicating that the registered 
substances could be surface-treated.  
When it comes to size, ECHA refrains from going into the scientific and technical 
challenges related to the definition and leaves it to the registrants themselves to determine 
which manufacturing outputs fulfil the “nanomaterial criteria and then determine how to fulfil 
their obligations for all sizes and ultimately report the relevant size ranges in their dossiers 
depending on the information collected/generated” (ECHA 2016d). On the other hand, 
registrants will not be able to demonstrate that they have adequately “addressed their 
obligation to collect/generate a base set of relevant Annex VII-XI data” without this 
information, or that “the hazard profile is meaningful for all forms registered by them” 
(ECHA 2016d). 
On the one hand, this means that it is up to the registrant to determine whether their 
nanoform fulfils nanomaterial criteria, how to fulfil their obligations regarding all sizes and 
report relevant size ranges and whether to report on surface treatment/surface chemistry. On 
the other hand ECHA has stated that without this information, it cannot be ensured that the 
hazard profile is meaningful for all forms registered. Nevertheless, there are no legal 
obligations to provide information on nanoforms in regard to particle size, shape and surface 
chemistry in the registration dossiers, as this information is not part of standard REACH 
information requirements.  
As noted by Christensen et al. (2012), it is basically still up to each registrant to decide, 
e.g. whether the registered material should be considered/described as a NM and whether it 
should be registered on its own or as a nanoform together with other forms of a substance. It 
is furthermore up to the registrant to decide on what nano-specific information to provide on 
the nanoform/nanomaterials, what nano-specific issues to address in the registration dossier, 
how to assess this information and what nano-specific conclusions to draw in the assessments 
in various parts of the dossier (Christensen et al. 2012). As a consequence, we have ended up 
in the situation that many feared, namely that a nanomaterial can basically be considered by 
the registrant to be the same as a registered bulk material, without any regulatory scrutiny. 
Consequently, the appropriateness of the submitted hazard information data is very much 
open to discussion (Chaudhry et al. 2006, Führ et al. 2006, Azoulay 2012, Hansen and Baun 
2012b). 
 
5.3 Risk assessment limitations in regard to nanomaterials 
Current risk assessment procedures with corresponding regulations for nanomaterials have 
been based on procedures extrapolated from chemical risk assessment (mainly of chemical or 
physical agents) (Rocks et al. 2008), which traditionally consists of four steps, namely hazard 
identification, hazard characterisation, exposure assessment and risk quantification (see 
Figure 20). 
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structured carbon black at a concentration up to 10%, as a colourant in cosmetic products, 
does not pose any risk of adverse effects in humans after application to healthy, intact skin. 
SCCP (2015a) stressed that this opinion did not apply to applications that might lead to 
inhalation exposure to carbon black nanoparticles (SCCS 2015a). Similarly, in the opinion of 
2,2'-methylene-bis-(6(2H-benotriazol-2-yl)-4-(l,1,3,3-tetramethylbutyl)phenol) (MBBT), 
SCCP (2015c) argued that the use of nano-structured MBBT as a UV filter in dermally 
applied cosmetic products did not pose a risk of adverse effects in humans after application to 
healthy, intact skin at a concentration up to 10%. However, on the other hand, they noted that 
there are indications of severe inflammatory effects of microfine MBBT in the respiratory 
tract and that caution is warranted against the use of the material in applications that could 
lead to exposure to the consumer’s lungs by inhalation (SCCS 2015c). For silica, hydrated 
silica and silica, surface modified with alkyl silylates (nano form), many inadequacies and 
gaps in the data were identified relating to physicochemical properties, toxicological data and 
exposure assessment. This led SCCS to conclude that “the evidence, both provided in the 
submission and that available in scientific literature, is inadequate and insufficient to allow 
drawing any firm conclusion either for or against the safety of any of the individual SAS 
material, or any of the SAS categories, that are intended for use in cosmetic products” (SCCS 
2015b). Finally, SCCS (2016b) found that the safety of nano-hydroxyapatite materials, when 
used up to a concentration of 10% in oral cosmetic products, cannot be decided on the basis of 
data submitted by applicants or retrieved from a literature search.  
In its statement on the safety assessment of the substance silicon dioxide, silanated for 
use in food contact materials, EFSA (2014) concluded that there was no detectable migration 
of silicon dioxide, silanated to any particle size, from low-density polyethylene film into 
appropriate food simulants and that the substance therefore did not raise safety concerns for 
consumers in the currently authorised conditions of use. For silver and its use as a food 
additive, EFSA, on the other hand, concluded that the available information was insufficient 
to assess the safety of silver and that major knowledge gaps included the chemical 
identification and characterisation thereof, for instance in regard to the quantity of 
nanoparticles and the release of ionic silver as well as similar information on the material 
used in available toxicity studies. This made it impossible for EFSA to establish the relevance 
of the available toxicological studies on the safety evaluation of silver as a food additive 
(EFSA 2016a). For TiO2, EFSA (2016b) found that most of the extensive database on TiO2 
nanomaterials was not considered to be relevant in the evaluation of TiO2 as a food additive, 
as “data provided by interested parties and from the literature” indicate that TiO2 should not 
be considered as a nanomaterial, at least according to the NM definition proposed by the EC, 
as the nano-sized (< 100 nm) fraction was less than 3.2% by mass. 
Under the BPR, only SAS has been subject to substance evaluation, though hazard and 
risk related to the individual particles of silicon dioxide with a nanometric size were not 
assessed in this dossier. The explanation given was that the exposure to nanoscale primary 
particles was not expected during the specific intended biocidal use (France 2014).  
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5.3.2 Hazard identification and effect assessments of nanomaterials 
In general, hazard identification and effect assessments in chemical risk assessment are quite 
extensive tasks that require substantial amounts of data and resources. Hazard identification 
of chemical or physical agents is traditionally based on inherent physical, chemical, biological 
and toxicological properties. End-points usually considered include acute toxicity, repeated 
dose toxicity, irritation, sensitisation potential, mutagenicity, clastogenicity (i.e. the 
propensity to cause a point mutation as compared to disrupting a chromosome), 
carcinogenicity and reproductive toxicity (Rocks et al. 2008). The wide range of end-points, 
along with the diversity of nanomaterials and their properties, makes it an overwhelming 
challenge to conduct in vitro and in vivo evaluations of biological effects (CCA, 2008). 
Preliminary results suggest that in vitro testing may not always accurately predict hazards, 
and large in vivo studies are very sparse and difficult to reproduce. The parts of the ECHA 
guidance on the use of in vitro or alternative testing strategies has not been updated since 
2007 (ECHA 2016f) and the role of alternative testing strategies in risk assessment of 
nanomaterials is still being discussed both when it comes to human health risk assessment 
(Stone et al. 2016) and environmental risk assessment (Hjorth et al. 2017a). 
The possibility of other, possibly unknown end-points can furthermore not be excluded. 
Hazard characterisation involves the establishment of a dose (concentration)-response 
(effects) assessment. Several studies – especially in vitro – e.g. on C60, single- and multi-
walled CNT, and various forms of metal nanoparticles have reported dose-response 
relationships, and based on these some predicted no-effect concentrations have even been 
estimated (Mueller and Nowack, 2008, Park et al. 2008, Kjølholt et al. 2015).  
Interpreting the results reported in the literature, and extrapolating these to the wide 
array of nanomaterials, is difficult at present, since nanomaterials that have been tested differ 
substantially from other nanomaterials with regard to: 1) physical-chemical properties such as 
chemical composition, shape, etc. and 2) end-points tested in relation to duration of exposure 
and methods (e.g. assays) and standards used (Hansen et al. 2007). In addition, based on the 
knowledge taken from studies on nanoparticles detailed in Stone et al. (2010) and Mikkelsen 
et al. (2011), it has been suggested that the biological activity of nanoparticles might not 
always be dose-dependent but is instead dependent on physical and chemical properties not 
routinely considered in toxicity studies (Oberdörster et al. 2005).  
 
5.3.3 Exposure assessments of nanomaterials 
Consumer, occupational and environmental exposure assessments are normally completed 
based on collective consideration of the characteristics of substances, products, processes, 
task/work activities, conditions and risk management measures as well as exposure modelling 
and estimations and exposure measurement, provided they are reliable and representative 
(ECHA 2010). A number of estimation modelling tools are available, all of which have their 
own individual strengths and weaknesses. Information about substance properties, production 
processes and end products, such as molecular weight boiling point/vapour pressure, exposure 
duration and risk management measures, are often needed as input data.  
As with hazard identification and characterisation, exposure data are lacking and no full 
exposure assessment has been published so far for any type of nanomaterial or group of 
nanomaterials. This is partly due to technical difficulties in measuring nanomaterial exposure 
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in the workplace and in regard to consumer exposure, and partly because the biological and 
environmental pathways of nanomaterials are still largely unexplored in detail (NIOSH 2006, 
CCA 2008, Owen and Handy 2007, Gottschalk et al. 2015). However, some efforts have been 
made to estimate, predict or model occupational, consumer and environmental exposures in 
terms of levels of exposure (e.g. Hansen et al. 2008a, Wijnhoven et al. 2009, Gottschalk et al. 
2015, Mackevica and Hansen 2016), while the applicability of current exposure assessment 
methods and guidelines has also been discussed (SCENIHR 2009, OECD 2009a, Ganzleben 
and Hansen 2011). These efforts have been hampered by the lack of information (or access to 
it) e.g. about manufacturing conditions, levels of production, industrial applications and uses 
in both industrial and consumer products (Maynard et al. 2006, Hansen et al. 2008a, 
Ganzleben and Hansen 2012b). 
 
5.3.4 Risk characterization of nanomaterials 
The final risk characterisation or risk evaluation involves critically reflecting on the data 
behind each step of the risk assessment and determining what the overall assessment of the 
risk will be (CCA 2008, WHO 2013). It is clear that with the current state of knowledge each 
of the first three steps in a risk assessment holds general as well as specific limitations and 
challenges. Risk characterisation being at the end of the line, the sum or maybe even the 
power all of these limitations are conveyed in the calculation of risk quotients for 
nanoparticles. 
 
5.3.5 Guidance and test methods relevant to safety assessment of nanomaterials 
Precise, detailed guidance on NM safety assessments is still under discussion, and all current 
initiatives related to developing science-based NM risk assessments can be considered an “on-
going regulatory activities”, as noted by Arts et al. (2014): The European Chemicals Agency 
(ECHA) is in the process of revising nano-related appendices in the existing Technical 
Guidance to accompany the ongoing revisions to the REACH annexes VIII, IX and X on 
information requirements (Schwirn et al. 2014, ECHA 2016c, Hansen and Baun 2015). The 
literature on environmental fate and effects of nanomaterials has expanded vastly since the 
latest version of the nano-related appendices to REACH Technical Guidance in 2012 
(Peijnenburg et al. 2015, Juganson et al. 2015) and numerous European research projects e.g. 
MARINA, NanoValid and NanoReg have made and published overview articles (e.g. 
Bondarenko et al. 2013, Hund-Rinke et al. 2015, Hund-Rinke et al. 2016). In most of these 
projects, however, an incremental approach to revision of the OECD guidelines has been 
applied, assuming that the test methods, developed for soluble chemicals, can be made 
applicable to nanomaterials through methodological adaptation. The properties of 
nanomaterials however clash with the fundamental prerequisite of many of these test 
methods, i.e. that the test substance is water soluble, implying that it distributes in the test 
system by molecular diffusion. Since this has repeatedly been proven not to be the case for 
nanomaterials, it follows that the test methods for soluble chemicals are not suitable for 
nanomaterials (Hansen et al. 2017a). 
In the guidance documents that ECHA provides in order to assist manufacturers and 
importers of chemicals and biocides and biocidal products, and which SCCS (2012b) provide 
on cosmetics and EFSA (2010) on food and feed, several references are made to the OECD 
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TGs for information and guidance on how to complete specific tests. OECD TGs have been 
subject to intense investigation regarding their applicability when it comes to nanomaterials. 
In 2009, the OECD carried out a review of its test guidelines and concluded that “in 
general the OECD guidelines are applicable for investigating the health effects of 
nanomaterials with the important proviso that additional consideration needs to be given to 
the physicochemical characteristics of the material tested”. The OECD also found that basic 
toxicological practices are adequate for the ecotoxicological testing of nanomaterials, but that 
guidance on preparation, delivery, measurement and metrology was currently insufficient 
(OECD 2009a). This finding was subsequently confirmed in 2012, based on a preliminary 
analysis of the OECD sponsorship programme, which ran from 2007-2015 (OECD 2016b, 
Jones 2012) and again after the programme had ended in 2015, when the OECD stated “The 
tests showed that the standard test guidelines used for normal chemical substances are in the 
most part suitable for use on nanomaterials. Changes to the Test Guidelines, to better 
understand the intrinsic properties of nanomaterials, are now providing a clear framework for 
OECD countries to move forward in the examination of nanomaterials” (OECD 2016c). 
However, an independent analysis of the documentation and analyses of the OECD’s 
Sponsorship Testing Programme for Nanomaterials does not support the conclusion that the 
test guidelines used for regular chemical substances are in the most part suitable for use on 
nanomaterials, for instance when it comes to ecotoxicological testing. According to Hansen et 
al. (2017b), most of the studies on physical-chemical characterisation, environmental fate and 
behaviour and ecotoxicological information were not designed to investigate the validity of 
the test guidelines. Most contributors to the sponsorship programme applied existing 
guidelines for chemicals with little, or no, reporting on test performance when used on 
nanomaterials. The few studies in the dossiers that do discuss the validity of the tests and 
explain the modifications that they made to the tests provide substantial points of concern 
about the general applicability of the OECD test guidelines. Furthermore, the analysis by 
Hansen et al. (2017b) indicates that very few studies were carried out for each end-point, 
making it hard to generalise about any single technical guideline being generally applicable. 
Hansen et al. (2017b) concludes that the published dossiers present an incomplete portfolio of 
nanomaterial toxicity evaluations that are difficult to draw substantive conclusions from 
rather than providing a clear framework for OECD member countries to move forward in the 
examination of nanomaterials.  
The BPR requires that an explanation has to be provided on the scientific 
appropriateness of the test when it comes to nanomaterials and, where applicable, on the 
technical adaptations/adjustments that have been made in order to respond to the specific 
characteristics of these materials. In light of the findings of Hansen et al. (2017a, b) and 
Brinch et al. (2016), this must be said to be quite challenging to achieve in reality. A similar 
requirement is present under the Novel Food Regulation (EP and the Council 2015), but many 
of the limitations of risk assessment are applicable not only to chemicals, biocides and 
biocidal products, but also to food, feed and cosmetics, as they rely on the same test methods 
(EFSA 2010, SCCNFP 2002), since REACH, the BPR (CEC 2008b) and many of the test 
methods according to regulation EC 440/2008 are equivalent to the OECD’s TG (Brinch et al. 
2016). As pointed out by EFSA (2011) and SCCS (2012b, 2013), uncertainty in regard to 
physico-chemical characterisation, as well as all elements of risk assessment, are profound 
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and pervasive, including that it is not routinely possible to identify, characterise and detect 
ENM in situ in cosmetics, food or the feed matrix, due to 1) a lack of suitable and validated 
test methods to cover all possible applications, aspects and properties of NMs and 2) 
uncertainties related to the applicability of current standard biological and toxicological 
testing methods to NMs (EFSA 2011, EFSA 2016a, SCCS 2012a, SCCS 2012b, 2013, SCCS 
2014a, SCCS 2014b). 
It is now clear that standards for chemical testing are not appropriate for nanoparticles 
according to Wickson et al. (2014). Development of tests standards and guidelines is a tedious 
process and seems to be a never-ending attempt to balance scientific tensions (Wickson et al. 
2014). Wickson et al. (2014) have identified three so-called “double-binds” that collectively 
led them to warn regulators against requiring data based on standard testing. Double-binds are 
defined as persistent types of dilemmas whereby two choices are in tension and success in one 
inevitably creates problems in the other. The first double-bind identified relates to the notion 
that standardization is long overdue as nanoproducts are already commercially available, 
while any clear pattern in (eco)toxicological testing has yet to emerge on which 
standardization could be based. The second bind insinuates that there is a contradiction 
between pursuing and requiring tests that are performed under real use and environmental 
conditions on the one hand and on the other require that the data is generated using well-
controlled and standardized experimental set-ups that are less realistic and that aim at 
ensuring mutual cross-national acceptance of data for classification. Finally, there is a bind in 
the tendency to create selective ignorance when deciding to pursue knowledge according to 
one particular approach over others (Wickson et al. 2014).  
Overall, as pointed out by Savolainen et al. (2013) in an evaluation of Nanosafety 2015-
2025, “current resources or test methods are not likely to enable safety assessment of the 
numerous novel nanomaterials”, and “we still lack a fundamental understanding of how 
nanomaterials interact with living systems and, thus, we are not yet in a position to assess the 
relevant end-points for nanomaterial toxicity”. Discussing an environmental risk assessment 
of NMs, Klaine et al. (2012) similarly stated that “A consensus view exists that the paucity of 
usable data on the environmental hazard of nanomaterials has created unacceptable 
uncertainty in risk analysis from the regulatory decision-making perspective”. 
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6. Alternatives to Risk Assessment 
In recognition of the above-mentioned challenges that traditional chemical risk assessments 
entail, and because of the outstanding scientific research questions that still need to be 
resolved, a number of alternative decision-support tools or supplements to traditional risk 
assessment have been explored and proposed in recent years. Examples of these include the 
“Control Banding Nanotool,” developed to assess and control the risks behind nanomaterials 
when working in the laboratory (Paik et al. 2008, Zaik et al. 2009), and the more holistic 
“Swiss precautionary matrix,” developed by Höck et al. (2008, 2011, 2013) and the LICARA 
nanoSCAN (van Harmelen et al. 2016). A number of concepts and tools also exist which were 
originally developed to cater for the safe handling of chemicals, such as “Comprehensive 
Environmental Assessment” (Davis 2007), “MultiCriteria Decision Analysis” (Linkov et al. 
2007, Tervonen et al. 2009), Stoffenmanager (van Duuren-Stuurman et al. 2012) and 
GreenScreen (Sass et al. 2016), which have also recently been explored in regard to 
nanomaterials (see Figure 21). Figure 21 provides an overview of 50 alternative decision-
support tools or supplements to traditional risk assessment that have been explored and 
proposed in recent years. The alternative decision-support tools span from focussing solely on 
occupational risks to being very broad in scope encompassing occupational risks, health risks, 
environmental risks, benefits and acceptability. Tools that focus on occupational risks tend to 
be control banding tools that can be applied on nanomaterials/particles, nanoproducts and 
powders, whereas tools that are very broad in scope tend to be risk governance tools that 
focus on nanoparticles. Tools and supplements to traditional risk assessment that have 
elements of risk governance were developed between 2006 and 2010, whereas a large number 
of tools were developed on occupational, health and environmental risks between 2005-2010 
in a range of areas such as control banding, hazard and risk evaluation and life-cycle 
evaluation. After 2009, the development of Control banding tools dominates whereas only a 
few tools have been developed within other areas such as, for instance, risk evaluation and 
risk management since 2010.  
 
6.1 Existing reviews of Alternative Decision-Support Tools  
There have been quite a few reviews of alternative decision-support tools when it comes to 
nanomaterials (Hansen et al. 2011, Grieger et al. 2012, Brouwer et al. 2012, Hristozov et al. 
2012, 2016, Som et al. 2012, Fleury et al. 2013, Arvidsson et al. 2016, Liguori et al. 2016, 
Romero-Franco et al. 2017).  
In 2011, Hansen et al. (2011) evaluated concepts, approaches and frameworks with the 
intention of estimating and controlling the risks inherent in nanomaterials. The tools were 
compared in regard to 1) focus/applicability (e.g. work environment, consumers, 
environment), 2) method (e.g. Qualitative/quantitative), 3) exposure and hazard input 
parameters (e.g. frequency of exposure, level and extent of exposure, 4) scale assessment of 
exposure and hazard level (linear 4-step scale, assignment of severity factor between 0-10), 5) 
risk evaluation (e.g. serious risks to occur soonest, a combination of the severity score and 
probability score into four possible risk levels), 6) risk handling (“hierarchical risk handling” 
based on COSHH principles) as well as 7) opportunities and weaknesses (see Table 7). 
Control banding tools are often included in the reviews of alternative decision-support 
tools despite the fact that many of the reviews’ authors state explicitly that the use of their 
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suggested approach should never replace a comprehensive risk assessment by experts 
(Brouwer 2012, Fleury et al. 2013). Brouwer (2012) compared six control banding 
approaches (see Table 8) and found that they were very similar in their overall approach when 
it comes to combining hazards and exposure into control or risk bands. However, Brouwer 
(2012) also noted that the six approaches differed in regard to structure, applicability domains 
and the assignment of the hazard and exposure bands, which may again affect the consistency 
of the resulting outcome amongst the various control banding tools. Based on his analysis, 
Brouwer (2012) concluded that it is impossible to evaluate the performance of the different 
approaches at present and called for enhanced transparency elucidating the differences that 
users have to take into consideration during the selection of a tool for a specific scenario of 
application. 
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Table 7: Summary of the main characteristic of the different frameworks (Adapted from Hansen et al. 2011). 
Name BSI Nanomaterials 
Handling Guide 
CB Nanotool Swiss Precautionary 
Matrix 
 Nanorisk framework MCM risk-based 
classification system 
Reference BSI (2007) Paik et al. (2008) Höck et al. (2008, 2011, 
2013) 
Genaidy et al. (2009) ED & Dupont (2007) Tervonen et al. 
(2009) 
Focus/  Work environment Work environment Workers, consumers, 
environment 
Work environment Workers, consumers, 
environment 
Human and 
environment 
Scope Nanoparticles Nanoparticles Nanoparticles Nanomanufacturing  Applications  Nanoparticles 
Method Qual. /quan.  Qual. /quan.  Qual. /quan.  Quan.  Qual. /quan.  Qual. /quan.  
Strategy Hazard evaluation  
+ Exposure assessment  
+ Handling risks 
Hazard evaluation 
Exposure assessment + 
recommended risk 
handling  
Hazard evaluation 
+ Exposure assessment  
+ Assessment of risk 
handling need  
Hazard evaluation 
+ Exposure 
assessment  
+ Handling risks 
Describe, evaluate, decide, 
update; life-cycle, hazard-, 
exposure-, risk profiles  
Selection of criteria, 
identifying options, 
ranking and selecting 
optimal option(s) 
Exposure 
assessment 
input 
parameters  
1) Work procedure; 2) 
Who is exposed; 3) 
What is the exposure 
route; 4) When does 
exposure occur; 5) 
Frequency of exposure; 
6) Level and extent of 
exposure; 7) Source of 
exposure potential; 8) 
Protection possibility 
1) Determination of the 
number of employees in 
completing the activity; 2) 
Frequency of the activity; 
3) Time extend of the 
activity; 4) Amount of 
nanomaterial used in each 
cycle of the activity; 5) 
Dustiness index or 
evaluation of mistiness 
1) Type of exposure (air, 
liquid or in a matrix); 2) 
Amount of nanomaterial 
a worker is normally 
exposed to during a day; 
3) How much 
nanomaterial can a 
worker be exposed to in a 
worst case? 
Not specified  
 
 
 
Among others: 1) Number 
and locations of 
manufacturing sites; 2) 
Current and expected 
production; 3) Industrial 
function; 4) Maximum 
concentration used; 5) 
required controls, etc.  
Not applicable 
Scale 
assessment 
of exposure 
level 
Assessment, estimation 
and measurements  
Linear 4-step scale based 
on points given for the five 
exposure parameters/ 
measurements 
Airborne exposure scaled 
by the 2 last parameters; 
normal/ accidental 
conditions 
Logarimic 5-step: 
Frequent, Probable, 
Occasional, Remote, 
Improbable 
Not specified  
 
Not applicable 
Hazard 
evaluation 
input 
parameter 
 
CMAR 
Fibrous 
Insoluble 
Soluble 
Surface chemistry; Particle 
shape; 
Particle diameter; 
Solubility;  
CMAR (nano- and bulk 
materials); 
Dermal toxicity (nano- and 
bulk materials); 
Occupational Exposure 
Level 
Redox activity and/or 
catalytic activity; 
Stability in physiological 
and environmental 
conditions 
Not specified  Short-term tox; skin 
sensitization + pene-tration; 
genetic toxi-city tests; 
biological fate + behavior; 
chro-nic inhalation/Inge-
stion /dermal tox stu-dies; 
developmental, 
reproductive, neuro, genotox 
and EDS- studies 
 
 
Agglomeration and 
aggregation; Reacti-
vity; critical func-
tional groups; particle 
size, and contaminant 
dissociation, size; 
bioavailable and 
bioaccumulation po-
tential and toxic 
potential 
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Scale 
evaluation 
of hazard 
evaluation 
None 1) Assignment of severity 
btw 0-10 p., 2) derivation 
of the overall score btw 0-
100 p., 3) assignment of 
the probability estimation 
(0-100) 
Input parameters are 
scored btw 1-9  
Catastrophic 
(Deaths); Critical 
(Severe injuries); 
Marginal (Minor 
injury); Negligible 
(No illness or injury) 
Not specified  
 
Mean size of particles 
in units of nanome-
ters. Other criteria 
scored from 1 to 5 via 
expert judgment 
Risk 
evaluation 
1) most serious risks to 
health; 2) risks that are 
likely to occur soonest; 
and 3) risks that can be 
dealt with soonest  
Combining severity score 
and probability score into 
four possible risk levels 
(RL)  
Total score of the 
precautionary need V = N 
* (W * E + S) and 
classified as “A” (V= 0-
20) and “B” (V> 20) 
Five risk levels e.g. 
“Very high” or “red” 
based on probability– 
severity values.  
Evaluation of nature, 
magnitude and probability of 
risk types 
Classification into 
extreme, high, 
medium, low, and 
very low risk 
categories 
Risk 
handling 
Hierarchical COSHH 
risk handling  
Control of bands and 
exposure control 
Unspecified Haddon’s system Focusing on minimizing 
exposure 
Unspecified 
Special 
circumstanc
es 
Nanomaterial specific 
maximum exposure 
standards  
Unknown parameters are 
assigned 75 % of the 
maximum score 
Nanoscale  500 nm; 
Unknown parameters 
assigned max high-risk 
score; Actual/ estimated 
daily/ worst case 
inhalation  
For each of the 
intervention 
strategies four 
criteria were applied: 
applicability, benefit, 
cost and feasibility 
Sharing of product info, 
hazard, exposure and risk 
profiles with stakeholders is 
recommended 
Uses an outranking 
model termed 
Stochastic 
multicriteria 
acceptability analysis 
(SMAA-TRI) 
Opportuni-
ties 
Pro-active in the sense 
that risk handling can 
be implemented 
immediately 
High usability, 
Pedagogical color code, 
clear results that limit  
“paralysis by analysis”  
Step-by-step guide is 
clear and easy to apply; 
considers workers, 
consumers, environment 
taking a life-cycle 
perspective  
Scenarios are 
illustrated as activity 
appellations without 
any further 
description of the 
circumstances 
Clear guide on how to 
organize, document, and 
communicate information 
High level of 
transparency in 
selection of criteria 
which enables the 
users to define their 
own criteria 
Weaknesses Relies on having good 
information about the 
hazardous nature of 
materials, the 
effectiveness of control 
approaches and 
convenient and 
accessible ways to 
monitor exposure. This 
information might not 
always be available 
Unclear how severity 
scores and probability 
were assigned e.g. to 
particle shape and 
dustiness and not clear 
why unknown parameters 
are assigned 75 % of the 
maximum score 
Dubious use of default 
values for redox activity 
or catalytic activity; 
Unclear why unknown 
parameters are assigned 
100% of the high-risk 
score; Questionable 
quantitative derivation of 
whether there is a 
precautionary need for 
action; Overall 
classification scores 
seems arbitrary 
Unclear hazard input 
parameters and 
assignment of risk 
codes 
High data requirements 
often not available; unclear 
how to evaluate nature, 
magnitude and probability of 
risk types, as independent 
validation by stakeholders is 
hard to obtain  
Low level of 
transparency in the 
qualitative 
assignment of scores 
between 1 and 5 to 
various 
nanomaterials. 
Unclear how specific 
weight bonds were 
assigned  
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Table 8: Summary of the most important characteristics of the various CB tools (From Brouwer 2012). 
 
 Hazard banding  Exposure banding  Matrix 
 
 
Allocation system  
 
Source domains/type of activities*   
 
Number of bands/levels 
CB too Short 
name Binary Score N
  
 
Synthesis 
 
Powder 
handling 
Application 
Ready-to-use 
products 
 
 
Abrasion 
Emission 
potential 
Exposure 
potential N 
 
CB RL 
Precautionary 
Matrix - + 1
 
(+) (+) (+) (+) + - 1 
 
2 - 
NanoTool - + 4  + + - - + - 4  4 - 
ANSES +  5  (+) + + + + - 4  5 - 
Stoffenmanager 
Nano + - 5
 
+ + + (+) - + 4 
 
- 3 
NanoSafer + + 4  - + - - - + 5   5 
Guidance + - 3  + + + + + - 3  3 - 
*Based on Schneider et al. (2010). 
1 Precautionary matrix does not distinguish separate hazard and exposure bands. 
N Number of bands. 
CB Control band. 
RL Risk Level.  
+ Used/addressed by tool. 
- Not used/addressed by tool. 
(+) only implicitly addressed by tool. 
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In a similar 2016 review of control banding tools, Liguori et al. (2016) reviewed the Control 
Banding Nanotool, IVAM Technical Guidance, Stoffenmanager Nano, ANSES CB Tool, 
NanoSafer and the Precautionary Matrix, in order to evaluate their use-domains, types, extent, 
use and availability of input parameters, their output format and finally their potential use and 
maturity in regard to meeting the minimum requirements for occupational exposure 
assessment under REACH (see Table 9). It was found that the tools varied with regard to 
application domains, inclusion criteria, requested input parameters, exposure assessments, 
derived risk levels and output formats. The tools were furthermore found to be based on 
different concepts and assumptions, which could be explained by the fact that they were 
developed for different purposes. Overall, a direct inter-comparison and combination of the 
different models into a larger holistic framework was found not to be immediately possible, 
and calls were made for the harmonisation of input parameters and output, to allow for the 
establishment of an exposure assessment framework with different levels of information 
requirements (Liguori et al. 2016). 
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Table 9: Key information and application domains of the Control Banding tools considered in this study (Adapted from Liguori et al. 2016). 
Name NM 
Definition 
Target group/scope # of input 
parameters 
# of input parameters used # of control bands “Outcome” 
RM recommendation 
Nano-
relevance 
Haz. 
scaling 
Exp. 
scaling 
Haz. Exp. Risk  
CB Nanotool (6,7) ASTMa (1) 
NM researchers/ 
Risk ass. + man.  45 - 15 5 4 4 4 
Risk Level (RL). 
Recommendations 
IVAM Guidance 
(8) 
Own (2) define- 
tion similar to ECb (3) 
Workers/Occu-
pational hygiene 27 - 2 1 3 3 3 
Control level bands. 
Hierarchic occupational 
hygiene 
Swiss 
Precautionary 
Matrix (9-11) 
ISO/TS 27687c (4) 
Employees, 
consumers + 
environ. / Source id. 
+ risk reduction  
28 7 6 6 n.a. n.a. 2 
Need for action/no 
action 
Stoffen-manager 
Nano (12) 
ISO/TS 27687c, 
SCENIHRd (5) 
Employers and em-
ployees/ Risk prio-
ritization of risks + 
implementation of 
control measures  
47 - 2 26 5 4 3 
Risk priority bands. 
Ranking priority of 
needed actions 
ANSES CB Tool 
(13, 14) ISO/TS 27687
c, ECb 
Small to large 
enterprises/Exposure 
prevention 
10 1 5 3 5 4 5 
Control level (CL). 
Technical solutions for 
exposure prevention  
NanoSafer (15, 16) ISO/TS 27687c, ECb 
SMEs/Precautionary 
risk assessment 
29 5 5 13 4 5 5 
Risk Level (RL). 
Recommendation and 
actions to be taken into 
consideration 
a) ASTM International, 2007; b) European Commission, 2011c; c) ISO, International Organization for Standardization, 2008; d) SCENIHR, Scientific Committee on Emerging and Newly Identified Health Risks, 2010; 
(1) ASTM – definition: As nanotechnology is a rapidly developing field, it will be necessary to continually reassess the terms and definitions contained in this standard, for purposes of revision when necessary. The 
intent of the terms and definitions in this standard is to describe “...materials containing features between approximately 1 and 100 nm and to differentiate those properties different from properties found in either 
molecules or the bulk (interior) of larger, micron-sized systems.”; (2) IVAM – definition: A nanoparticle is a particle with three dimensions in the range of 1 – 100 nm. A fibrous particle does have two dimensions in the 
nano range of 1 – 100 nm; (3) ISO/TS 27687 – definition: Nano-object: Material confined in one, two, or three dimensions at the nanoscale. This includes nanoparticles (all three dimensions in the nanoscale), nanofibres 
(two dimensions in the nanoscale) and nanoplates (one dimension in the nanoscale). Nanofibres are further divided into nanotubes (hollow nanofibre), nanorods (solid nanofibre) and nanowire (electrically conducting or 
semiconducting nanofiber); (4) EC – definition: Nanomaterial means a natural, incidental or manufactured material containing particles, in an unbound state or as an aggregate or as an agglomerate and where, for 50 % 
or more of the particles in the number size distribution, one or more external dimensions is in the size range 1 nm-100 nm; (5) SCENIHR – definition: Nanomaterial: Any form of a material that is composed of discrete 
functional parts, many of which have one or more dimensions of the order of 100 nm or less. 6) Paik et al. 2008, 7) Zalk et al. 2009, 8) Cornelissen et al. 2011, 9) Höck et al. 2008, 10) Höck et al. 2011, 11) Höck et al. 
201, 12) van Duuren-Stuurman et al. 2012, 13) Ostiguy et al. 2010, 14) Riediker et al., 2012, 15) Kristensen et al. 2010, 16) Jensen et al. in prep 
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Grieger et al. (2012) analysed a number of environmental tools and approaches and compared 
them to 10 criteria, including transparency, precaution and life cycle perspective, which have 
been proposed by a variety of sources as important parameters for the environmental and 
health risk analysis of nanomaterials (Grieger et al. 2012). Denominators for these tools were 
that they had been proposed as alternatives for environmental risk assessment. They found 
that most frameworks were flexible for multiple nanomaterials, suitable for multiple decision 
contexts, included life cycle perspectives and precautionary aspects, were transparent and able 
to include qualitative and quantitative data. Nevertheless, Grieger et al. (2012) also found that 
most frameworks were primarily applicable to occupational settings, with a few minor 
environmental considerations, and that most of them had not been thoroughly tested on a wide 
range of nanomaterials (Grieger et al. 2012) (see Table 10). 
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Table 10. Evaluation of selected frameworks proposed by large organizations/ regulatory bodies for environmental risk analysis of NMs (From Grieger et al. 2012) 
 Criteria 
Framework 
1.  
Variety 
of NM 
2. 
Multiple decision 
contexts 
3.  
Uncert. 
Analysis 
4.  
Life cycle 
perspect. 
5.  
Iterative or 
adaptive 
6.  
Timely decision 
making 
7.  
Transparent 
 
8. 
Stakeholders 
 
9.  
Precaution 
 
10.  
Qual./ 
quan. data 
IRGC Risk Governance 
Framework** X X X x x -* x X x X 
CEA*,**  X X X X A A x X x X 
Nano Risk 
Framework**  X X X X X -* X x X X 
Nano LCRA***  X X X X x - x -* x X 
MCDA*  X X X A A A X A A X 
CENARIOS**,***  X X - x X A x N/R x x 
Precautionary 
Matrix **,*** X - - X A A x N/R x X 
XL Insurance Database 
Protocol* 
X 
 X - x A A x N/R A X 
Note: literature documenting theory and applications range from peer-reviewed journal articles (*) to organizational reports (**) and other non-peer reviewed material (***) (e.g., presentation slides, webpage, book chapter). 
X = criterion is obvious and embedded in the framework and demonstrated through application; x = criterion is included to some extent or to a lesser degree or not fully demonstrated in application; A = criterion is not directly 
included in the framework but can be easily adapted or included and which has been demonstrated through application; - = criterion is absent from the framework; N/R = criterion was not relevant to the framework; * = 
Considered or mentioned to be important but not included or integrated in framework specifically. 
Table 11. Nano risk assessment (RA) and risk management (RM) frameworks and their characteristics. (Adapted from Hristozov et al. 2012) 
Framework  Scope  RA/RM  Iterative 
structure  
Policy 
model 
 Refers to conventional 
 RA and RM paradigm? 
REACH 
oriented?  
                  Data requirements 
ED & DuPont (2007) HHRAa/ 
ERAb 
RM Yes Trans- 
parent 
Yes No Phys-chem properties; (eco-)toxicity; biological/ 
environmental fate and behaviour; hazard data; exposure  
IRGC (2006) HHRA/ 
ERA 
RM Yes Trans- 
parent 
Yes No Phys-chem properties; (eco-)toxicity biological/ 
environmental fate and behaviour; exposure  
Liao et al. (2008)  HHRA RA No N/A Yes No Toxicity; biological fate and behaviour; exposure  
Oberdorster 
et al. (2005) 
HHRA RM No Decisi- 
onist 
Yes No Phys-chem properties; toxicity/ecotoxicity; exposure 
SCENHIR (2007)  HHRA/ 
ERA 
RA No N/A Yes No Phys-chem properties; (eco-)toxicity; exposure  
Tyshenko & Krewski 
(2008)  
HHRA/ 
ERA 
RM 
 
Yes 
 
Trans- 
parent 
Yes 
 
No 
 
Phys-chem properties; toxicity/ecotoxicity effects; exposure 
data 
aHuman health risk assessment; bEcological risk assessment. 
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Hristozov et al. (2012) reviewed available data and nano risk assessment approaches from a 
regulatory perspective in regard to their added value, in light of present limitations and 
uncertainties, and found that most of them were designed to serve preliminary risk screening 
and/or research prioritisation, but they did not support regulatory decision-making and were 
not REACH-oriented (see Table 11). In a more recent publication, Hristozov et al. (2016) 
reviewed forty-eight frameworks and tools to facilitate risk assessment of NMs and grouped 
into 7 different types: Control banding, risk screening, occupational and consumer exposure, 
environmental fate and exposure, hazard assessment, physicochemical characterization, and 
decision support tools. Evaluating the identified frameworks and tools up against sixteen 
criteria e.g.: Nano-specific requirements, lifecycle thinking, pre-assessment phase, exposure-
driven approach, iterative and adaptive structure, transparency of objectives and 
communication with all involved stakeholders, document applications, allowing for/giving 
directions on grouping and read-across of NMs, tools, easy to use, quantitative information, 
uncertainty analysis, assessment tier, transparency in application. Hristozov et al. (2016) 
found that none of the frameworks and tools fulfilled all the criteria and called for the 
development of a new tool that integrates data and current models to support risk assessment 
and management of NMs.  
Finally, Arvidsson et al. (2016) investigated existing screening risk assessment methods 
for nanomaterials and found a total of 20: ANSES, CB Nanotool 2.0, early warning signs, 
Genaidy’s method, Groso’s method, Guidance, Hierarchical Rank Aggregation, LICARA 
nanoSCAN, Nano-Evaluris, NanoHAZ, NANoREG, NanoRiskCat, NanoSafer, Occupational 
Hazard Band for Nano, Precautionary Matrix, Relative Risk Analysis, Risk Trigger Scores, 
Stoffenmanager Nano, TEARR and the WCD model. In their review, Arvidsson et al. (2016).  
Many of these were included in the reviews by Hansen et al. (2011), Grieger et al. 
(2012), Brouwer et al. (2012), Hristozov et al. (2012, 2016) and Liguori et al. (2016) but 
many had not been reviewed earlier. Despite identifying 20 methods the number could easily 
have been much higher as Arvidsson et al. (2016) did not include several of the tools 
reviewed in other papers, such as in IRGC (2005, 2007, 2009), SCENIHR (2007) and 
Tervonen et al. (2009), or some of the more recent approaches proposed, such as Alternatives 
Assessment (Hjorth et al. 2017b) and GreenScreen Nano (Sass et al. 2016). Nevertheless, 
Arvidsson et al. (2016) found that most methods focused on occupational human health risks, 
while fewer focused on environmental risks.  
Overall, many of the methods were found to share features in regard to e.g. scoring and 
ranking of risk on ordinal scales, but the scoring and ranking procedure varied in complexity 
and the exact scales differed. Some methods are relatively simple and require few hazard 
input parameters, while others are more complex, and require many input parameters, some of 
which are difficult to determine (Arvidsson et al. 2016).  
 
6.2 Opportunities and Weaknesses of Existing Tools and Frameworks 
Generally, it is clear that there is an urgent need for adaptive, transparent, easily 
comprehensible, communicational and yet robust scientific methods, approaches and 
frameworks to evaluate the potential of exposure, and hazard and risk related to the 
production and application of nanomaterials (Hansen et al. 2011, Grieger et al. 2012, 
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Hristozov et al. 2012, 2016, Fleury et al. 2013, Ligouri et al. 2016 and Mackevica and Hansen 
2016, Romero-Franco et al. 2017).  
When comparing the opportunities and weaknesses of existing tools and frameworks it 
is important to note that such a comparative analysis can never do full justice to all tools and 
frameworks. The methods, approaches and frameworks presented herein are all helpful in the 
primary evaluation of the potential hazards, exposures and risks related to the production and 
application of nanomaterials, although they might not all be equally helpful in meeting the 
goals of regulators and risk assessors in a given situation (Hansen et al. 2011, Hristozov et al. 
2016, Ligouri et al. 2016, Romero-Franco et al. 2017). 
Many of the tools, such as Genaidy et al. (2009), the Nanorisk framework (ED & 
DuPont 2007) and LICARA NanoSCAN (van Harmelen et al. 2016) are developed in order to 
help developers, SMEs and producers of nanomaterials complete crude risk estimations and 
risk-benefit estimations. In that sense, their scope is much broader than just limited to risk 
assessment (see figure 20). The hope is that this will make developers and producers focus on 
minimising exposure, or that it will facilitate the implementation of various more or less 
stringent control measures to protect workers in the primary production and handling of 
nanomaterials. In that sense, they may enable and support the implementation of effective risk 
handling procedures that can be applied despite a lack of full scientific knowledge (Hansen et 
al. 2011, Brouwer 2012, Ligouri et al. 2016). However, only some of the methods and 
frameworks, e.g. the Swiss Precautionary Matrix and the MCM risk-based classification 
system, involve professional end-users, consumers and the environment, which might be 
helpful in some situations and unnecessary in others. 
Although varying considerably in focus and scope, most of the approaches and 
frameworks provide guidance on how to make a crude assessment of the hazards and 
exposure associated with a nanomaterial and its use(s). In regard to the hazard of 
nanomaterials, all but the framework proposed by Genaidy et al. (2009) set up a series of 
criteria or hazard end-points that have to be considered.  
It is, however, not always clear why a given criterion was included or excluded from the 
analysis. Furthermore, some of the criteria are based on mass, which many of the authors of 
the proposed frameworks themselves state is not sufficient to deal with nanomaterials. Among 
others, the Swiss Precautionary Matrix, the MCM risk-based classification system and the CB 
Nanotool assign numbers or ranges to the extent of various reported effects, which makes the 
frameworks easy and transparent to use in the sense that these numbers are assigned to 
various effects by default, and the scoring process can be validated by others.  
However, how the numbers or ranges have been assigned to the various effects is less 
transparent. In this sense, these tools are able to cope with less extensive input data 
information in regard to hazard identification and hazard characterisation.  
Regarding nanomaterial exposure, most approaches and frameworks use an estimate of 
the likelihood of exposure or a more-or-less precise relative scale. These are useful for 
identifying activities with potential risks of exposure, as shown through the completely 
qualitative model proposed by Genaidy et al. (2009).  
One weakness of these tools, however, is that they do not provide a strong basis for 
estimating an actual exposure level. It would be helpful to identify whether, for instance, a 
high likelihood of exposure would also give cause to “high exposure.” The CB Nanotool 
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provides the ability to assess the exposure level based on the amount of material handled, and 
the frequency of the activity. The system developed by BSI and the Swiss Precautionary 
Matrix use either a simple assessment or actual exposure measurements, the latter of which 
require the use of a series of fairly complex measurement methods to estimate the fraction of 
the nanomaterial airborne in the workplace. The development of a quantitative model would 
make it possible to complete exposure assessments before nanomaterials are used on a large 
scale. New methods are under development and hopefully they will help to solve some of 
these problems, but there is a long way before we have models comparable to those we now 
have for assessing atmospheric and environmental exposure to chemicals. In this regard, these 
tools combined are able to cope with less extensive input data information in regard to 
exposure assessment. Overall, they seem less prone in the final risk evaluation to the 
vulnerability of exposure assessment.  
Combining the hazard and exposure assessments, all of the tools and frameworks derive 
an overall score which is again linked to a classification (e.g. A, B, Cor “high”, “medium”, 
“low”), and so the results of the process make it easy to summarise and communicate risks. 
They, however, carry the risk of masking the process, any evidence and the line of 
argumentation used to derive the overall score and subsequent classification. A number of 
frameworks translate the overall score into a set of recommendations for generally prescribed 
management measures. Such an approach, for example, is explored in the Swiss 
Precautionary Matrix and the CB Nanotool. In order for these recommendations to be generic 
they have to be very broadly defined, which perhaps implies making them too general and 
non-specific in relation to providing input into real decision support. Overall, these tools seem 
to be less prone in the final risk evaluation to the vulnerability of one or more of the preceding 
steps regarding hazard identification, hazard characterisation and exposure assessment. 
Except for NanoRiskCat, which was developed to be applicable despite a lack of information, 
most of the tools available today have fairly high input data requirements, and some of the 
scientific information needed in order to apply them is inconclusive at the moment or even 
non-existent. Lack of information and data is part of the reality today, even for nanomaterials 
that are applied in high quantities. NanoRiskCat seems to be the only safety evaluation tool 
that has been designed to support regulatory decision-making and which is REACH- and 
CLP-oriented (Hansen et al. 2011, 2014, Hristozov et al. 2012, Romero-Franco et al. 2017).  
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Table 14. Human health and environmental hazard potentials and HH- and EE-sentences for the nanomaterials 
most frequently claimed to be used in products in The Nanodatabase.  
NM Human health Environment 
Unknown  
HH 20. Based on the identity of the nanomaterial not being 
disclosed or available, which hampers any human hazard 
evaluation 
 
EE 13. Based on the identity of the 
nanomaterial not being disclosed or 
available, which hampers any 
environmental hazard evaluation 
Ag  
HH 7b and 8b. Based on in vivo and in vitro evidence of a 
combination of two or more of the following, i.e., one of the 
following genotox/ mutagenicity, respiratory effect, cardio-
vascular effect, acute neurotoxic effect, reproductive damage, 
carcinogenicity, organ accumulation 
 
EE 2. Based on nanospecific LC50 or EC50 
< 10 mg/l 
 
Ti  
HH 21. Based on no information or data being available in 
the scientific literature 
 
EE 14. Based on no information or data 
being available in the scientific literature 
TiO2  
HH 8b. Based on in vitro evidence of a combination of two 
or more of the following, i.e., one of the following 
genotox/mutagenicity, respiratory effect, cardio-vascular 
effect, acute neurotoxic effect, reproductive damage, 
carcinogenicity, organ accumulation 
 
EE 2. Based on nanospecific LC50 or EC50 
< 10 mg/l 
 
C  
HH 7a. Based on in vivo evidence of an effect when testing 
the nanomaterial, i.e., one of the following 
genotox/mutagenicity, respiratory effect, cardio-vascular 
effect, acute neurotoxic effect, reproductive damage, 
carcinogenicity, organ accumulation 
 
EE 14. Based on no information or data 
being available in the scientific literature 
CNTs  
HH 1. Based on evidence of HARN 
 
 
EE 3. Based on possible or confirmative 
evidence of nanospecific L50 or EC50 < 
100 mg/l and T1/2 > 40 days 
P  
HH 21. Based on no information or data being available in 
the scientific literature 
 
EE 14. Based on no information or data 
being available in the scientific literature 
Bamboo 
charcoal 
 
HH 21. Based on no information or data being available in 
the scientific literature 
 
EE 14. Based on no information or data 
being available in the scientific literature 
SiO2  
HH 7b. Based on in vivo evidence of a combination of two or 
more of the following, i.e., one of the following 
genotox/mutagenicity, respiratory effect, cardio-vascular 
effect, acute neurotoxic effect, reproductive damage, 
carcinogenicity, organ accumulation 
 
EE 2. Based on nanospecific LC50 or EC50 
< 10 mg/l 
 
Au   
HH 13. Based on in vivo evidence indicating at least one 
hazard from testing of the nanomaterial 
 
EE 3. Based on possible or confirmative 
evidence of nanospecific L50 or EC50 < 
100 mg/l and T1/2 > 40 d 
Graphene   
HH 7a. Based on in vivo evidence of an effect when testing 
the nanomaterial, i.e., one of the following 
genotox/mutagenicity, respiratory effect, cardio-vascular 
effect, acute neurotoxic effect, reproductive damage, 
carcinogenicity, organ accumulation 
 
EE 14. Based on no information or data 
being available in the scientific literature 
ZnO  
HH 8b. Based on in vitro evidence of a combination of two 
or more of the following, i.e., one of the following 
genotox/mutagenicity, respiratory effect, cardio-vascular 
effect, acute neurotoxic effect, reproductive damage, 
carcinogenicity, organ accumulation 
 
EE 1. Based on bulk CLP classification of 
Acute 1 or Chronic 1 or Chronic 2 
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8. REACT NOW  
The limitations of existing legislation in regard to definitions, risk assessment and test 
methods raise questions about the overall meaningfulness of the so-called “incremental 
approach” adopted by the European Commission, as it seems to have turned into an ever-
increasing number of small adaptations to existing legislation, thereby placing an additional 
burden on already stretched agencies (Hansen 2010, 2013, Vogelezang-Stoute 2014). In view 
of the pace of development in the field of nanomaterials and their applications, it seems that a 
complete reworking of existing regulatory frameworks is needed, in order for the incremental 
approach to be successful. However, a complete reworking of existing regulations is very 
rare, as noted by Davies (2006), who, more than a decade ago, argued that only the 
establishment of a separate, specific regulation on nanomaterials could be tailored to the 
unique properties of nanotechnology. More recently, representatives of the European 
Commission have also noted that NMs are difficult to regulate, due to lack of information, 
their complexity and a regulatory framework custom-made for chemicals rather than for 
manufactured materials (Laursen, 2014 cited in OECD 2016a).  
Based on the analysis in Chapters 2-7, I see the implementation of a new regulatory 
framework for NMs as the only way in which to ensure the safe use of NMs for humans and 
for the environment, but so far, no one has been able to put forward a flexible and holistic 
option that is able to provide timely decision support before the risks of nanomaterials have 
materialised themselves. That is why I propose the adoption of a framework called 
Registration, Evaluation, Authorisation, Categorisation and Tools to Evaluate Nanomaterials 
– Opportunities and Weaknesses (REACT NOW), key elements of which are presented 
below, while the workflow process is presented in Figure 27 (Hansen 2017). 
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Under REACT NOW, NMs should be defined according to the proposal made by 
SCENIHR (2010) and not according to the European Commission’s Recommendation 
2011/696/EU (Hansen 2017). According to SCENIHR, a material is considered to be a 
nanomaterial when > 0.15% of the particle number size distribution is < 100 nm, or for dry 
materials when the volume-specific surface area is > 60 m2/cm3 (SCENIHR 2010). This is in 
contrast to the current situation, for example in the BPR and the proposals made by CIEL, 
ClientEarth and BUND (2012), Germany (Schwirn et al. 2014) and Sweden (KEMI 2013), as 
these adheres to the EC definition of a NM. The reason why SCENIHR’s definition is 
preferred here is that there is a serious risk that some NMs will not be captured by the EC 
definition if a 50% threshold is applied as noted by the Committee on the Environment, 
Public Health and Food Safety (2014). Furthermore, the very high 50% threshold leaves too 
much room to manipulate the size distribution. Finally, the EC definition is simply too far 
away from what manufacturers, developers, scientists and society would normally have 
perceived as nanomaterials prior to 2011 (Hansen 2017). 
 
8.2 Registration of nanomaterials in REACT NOW 
8.2.1 Substance identification and naming of NMs  
It is clear that from the EC’s attempts to regulate NMs under REACH, their correct and 
unambiguous identification is essential, and so a distinction between the bulk and nanoforms 
of a given material need to be specified in REACT NOW (Hansen 2013, 2017). As suggested 
by member state, NGO and ECHA experts during the RIP-oN1 discussion, it is furthermore 
clear that nanomaterials cannot be identified solely by chemical composition. Additional main 
identifiers should be included when identifying and naming nanomaterials (European 
Commission Joint Research Centre 2011, Hansen 2013, 2017). In contrast to the German 
dossier-in-dossier proposal (Schröder 2012, UBA, BfR and BAuA 2013, Schwirn et al. 2014), 
particle size is seen as an “identifier” along with shape, specific surface area and surface 
treatments, as these are believed to identify a nanomaterial uniquely, influence the properties 
of the specific NM and govern the risk profile of NMs. In order to distinguish between two 
nanomaterials, supplementary information is required on:  
a) The primary particle size distribution 
b) Chemical composition of the functionalisation and/or coating(s), if any are 
followed by the suffixes “functionalised” and/or “coated”  
c) Degree of purity of the core 
d) The crystal form(s) of the core, if different forms exist 
e) Number of walls and/or layers, if any 
f) Chemical composition of the primary nanoparticle core 
g) Shape, including the prefix “nano,” e.g. nanotubes, nanorods, nanospheres). 
It follows that NMs have to be named in REACT NOW with: a) the primary particle size 
distribution followed by b) the chemical composition of the functionalisation and/or 
coating(s) followed by <c) degree of purity of the core followed by d) the crystal form(s) of 
the core, if different forms exist followed by e) number of walls and/or layers, if any followed 
by f) chemical composition of the primary nanoparticle core followed by g) shape, including 
the prefix “nano”. If one or more of the elements in the generic naming convention described 
above are not applicable, these should be left out of the name, for instance “25-28 nm ZnO-
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coated 95% rutile TiO2 nanospheres.” Similarly, for a functionalised and coated 
nanosubstance for which the primary size distribution varies and for which the shape is 
spherical, using this naming convention would result in the name “hydroxyl-functionalised 
AlZr-coated >92.5 % rutile TiO2 nanospheres.”  
 
8.2.2 Pre-market obligation to register in REACT NOW 
Manufacturers and importers of NMs that fall under SCENIHR’s definition of a NM are 
required to register, prior to their NMs being commercialised in Europe and independent of 
production volumes (Hansen 2013), as there is evidence from Germany that fewer than 10 
kg/year are utilised in activities related to production, use and processing involving 
nanomaterials (BAuA 2008, CIEL, ClientEarth and BUND 2012). Registration, furthermore, 
is to be independent of the concentrations of a nanomaterial by weight, e.g. 0.1% w/w in the 
final product, as their usually low concentration could potentially exclude some nanomaterials 
from REACT NOW (Franco et al. 2007, Hansen and Baun 2012b). For NMs already on the 
market, manufacturers and importers should be required to register and fulfil the REACT 
NOW requirements within a certain time period e.g. six months (Hansen 2017). In REACT 
NOW, primary particle size distribution, shape (including aspect ratio), specific surface area 
and surface treatment are considered identifiers and not characterisers, as in the German 
proposal (UBA, BfR and BAuA 2013). In practice, this means that any variation in the size, 
shape, surface area and surface of a treated NM that is commercialised in the EU has to be 
registered separately and put into a separate registration dossier. Although it has been argued 
that this would lead to “the extreme splitting of similar materials into various substances on 
their own and that tonnage bands which trigger a registration obligation would not be reached 
as a consequence” (UBA, BfR and BAuA 2013), not all conceivable combinations of 
different substances are commercially relevant, and so making registration a prerequisite, 
independent of production volumes, means that registration obligations will be obligatory 
even for NMs produced in low volumes. Given the urgency of generating data on 
nanomaterials, registration fees must be reduced to encourage registration, as suggested by 
Hansen (2013).  
 
8.2.3 Information requirements in REACT NOW 
The information requirements in REACT NOW are related specifically to documenting the 
identity of the registered NM, its functional use, the specific reason for which authorisation is 
sought and, finally, to fill out a NanoRiskCat evaluation (see Table 15) (Hansen 2017). The 
latter includes requirements to provide: 1) accurate physicochemical characterisation, using 
multiple techniques and taking pros and cons into account, 2) a detailed description of the test 
material/sample and sample preparation and 3) considerations of the most 
appropriate/relevant metric following the presentation of several metrics (Hankin et al. 2011, 
Christensen et al. 2012). Additionally, the registrant has to provide a description of the 
analytical methods that allow the identification and quantification of the NM in the uses 
specified in the registration. If the data submitted by the registrant are not satisfactory, they 
are not allowed to market, import or use NM(s) for a certain time period e.g. 2 years, after 
which they may re-register the NM and its uses.  
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Table 15: Overview of information requirements in REACT NOW (From Hansen 2017). 
Column 1: standard information required Column 2: specific rules for adaptation 
from column 1 
1. Registration and NM identity   
1.1 Primary size distribution  
1.2 Analytical methods used and their applicability in regard to 
primary size distribution 
 
1.3 Chemical composition of the primary nanoparticle core  
1.4 Analytical methods used and their applicability in regard to 
chemical composition 
 
1.5 Degree of purity of the core  
1.6 Analytical methods used and their applicability in regard to 
determining the degree of purity of the core 
 
1.7 Crystal form(s) of the core  
1.8 Analytical methods used and their applicability in regard to 
determining crystal form(s) 
 
1.9 Shape, including the prefix “nano,” e.g. nanotubes, 
nanorods, nanospheres, and number of walls and/or layers, if 
any 
 
1.10 Analytical methods used and their applicability in regard 
to shape  
 
1.11 Surface chemistry  
1.12 Analytical methods used and their applicability in regard 
to surface chemistry 
 
2. Uses of NMs  
2.1 Relevant uses of NM   
2.2 Location of the NM for each use  
2.3 Mass concentration for each use  
3. Functional need and necessity  
3.1 Function of the NM for each specific use  
3.2 Necessity of the NM for each specific use  
4. Effectiveness  
4.1 Minimum mass concentration at which use is effective on 
each occasion 
4.1.1 Justification for the selected concentrations for each use 
has to be provided and based on data and information in the 
form of laboratory studies, field test data, etc. 
 
4.2 Analytical methods used and their applicability in regard to 
measuring effectiveness for each use 
 
4.3 Method of application, if known, to influence effectiveness 
4.3.1 Specification of NM concentration-effectiveness 
relationship  
 
4.4 Known limitations on effectiveness, e.g. specific 
environmental or other conditions or the presence of other 
substances for each use 
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Table 15 continued: Overview of information requirements in REACT NOW (From Hansen 2017). 
5. Human health  
5.1 HARN 5.1 The study does not need to be conducted 
if there is scientific evidence proving HARN 
5.2 Bulk CLP 5.2 The study does not need to be conducted 
if:  
- NM is a HARN 
5.3 Acutely toxicity 5.3 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
5.4 Genotoxicity and mutagenicity 5.4 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
- NM is acutely toxic 
- There is scientific evidence proving that the  
- NM is genotoxic and mutagenic 
5.5 Carcinogenicity 5.5 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
- NM is acutely toxic 
- There is scientific evidence proving that the 
NM is carcinogenic 
5.6 Respiratory toxicity  
 
5.6 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
- NM is acutely toxic 
- There is scientific evidence proving that the 
NM causes respiratory toxicity 
5.7 Cardiovascular toxicity 5.7 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
- NM is acutely toxic 
- There is scientific evidence proving that the 
NM causes cardiovascular toxicity 
5.8 Neurotoxicity 5.8 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
- NM is acutely toxic 
- There is scientific evidence proving that the 
NM causes neurotoxicity 
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Table 15 continued: Overview of information requirements in REACT NOW (From Hansen 2017). 
5.9 Reproductive effects in humans and/or laboratory animals 5.9 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
- NM is acutely toxic 
- There is scientific evidence proving 
reproductive effects in humans and/or 
laboratory animals 
5.10 Organ-specific accumulation 5.10 The study does not need to be conducted 
if:  
- NM is a HARN 
- NM has a bulk CLP classification 
- NM is acutely toxic 
- There is scientific evidence proving 
accumulates in specific organs 
 
6. Environment 
 
6.1 Bulk CLP  
6.2 Aquatic toxicity 
6.2.1 Short-term toxicity testing on invertebrates  
6.2.2 Growth inhibition study aquatic plants (algae preferred) 
6.2 The study does not need to be conducted 
if:  
- NM has a bulk CLP classification 
6.3 Freshwater tests for degradation 6.3 The study does not need to be conducted 
if:  
- NM has a bulk CLP classification 
- NM has a LC50 < 100 mg/L 
6.4 Bioaccumulation 6.4 The study does not need to be conducted 
if:  
- NM has a bulk CLP classification 
- NM has a LC50 < 100 mg/L 
- NM has a T1/2 < 40 day 
6.5 Scientific review in regard to: dispersive or long-range 
transport, ecosystem effects and novelty 
6.5 The study does not need to be conducted 
if:  
- NM has a bulk CLP classification 
- NM has a LC50 < 100 mg/L 
- NM has a T1/2 < 40 day 
- NM has a BMF > 0.1 
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In order to take into account that the test methods currently used were originally developed 
for soluble chemicals and might not be applicable to nanomaterials (Hansen et al. 2017a, b), a 
range of measures should be taken to ensure that the tests performed meet the information 
requirements are indeed tailor-made to investigate the (eco)toxicological effects of NMs.  
Most importantly, nanomaterial dispersion stability should be measured using multiple 
characterization methods and the pros and cons of these methods should be clearly described. 
The dissolved fraction should furthermore be characterized over time and for various test 
concentrations, covering the setup for the aquatic toxicity test conducted (Hansen et al. 
2017a). When it comes to algal growth inhibition tests, the impact of shading must be 
accounted for and, for bioaccumulation tests, trophic transfer has to be considered as both 
exterior bound and/or accumulated nanomaterials in prey organisms will be available for 
predator organisms with nanomaterials (Hansen et al. 2017a). These aspects regarding 
dispersion, dissolution, shading and bioaccumulation have been highlighted in the draft 
updates of the guidance that ECHA provides and hence, these can be used by the registrant in 
regard to living up to the REACT NOW requirements. However, a number of aspects have 
been pointed out by Hansen et al. (2017a) that should furthermore be taken into account. For 
nanomaterials, which dissolve substantially and are composed of elements known to be 
hazardous to the aquatic environment, a short-term 3h pulse exposure may be applied instead 
of the commonly used 48 h exposure. In regard to algae at least two endpoints should be 
determined: one being algal growth rate inhibition or carbon-assimilation and another being 
subtler effects to the individual algal cells, such as membrane damage and oxidative stress 
(Sørensen 2016).  
In cases were NPs dissolve over time in media, one acute toxicity test should be 
conducted using a freshly prepared suspension of NPs in test medium, and one test should be 
conducted using an aged suspension where NPs are added to the media 1-3 days prior to 
testing, depending on the shelf life of the media (Sørensen and Baun 2015). This aging step 
may increase or decrease toxicity and the lowest EC50 value obtained should be used in 
REACT NOW. 
Similarly, two tests are required on crustaceans for each endpoint as toxicity has been 
observed to be feeding dependent and the reporting on food abundance in all tests is required. 
One of the tests has to be with low food availability that follows the OECD TGs (for instance 
OECD guideline 211) and one with three times the amount applied in the low food abundance 
scenario (Mackevica et al. 2015). Finally, uptake and depuration of ENPs in test organisms 
has to be determined for each commercialized functionalization of the nanomaterials (Hansen 
et al. 2017a). 
 
8.2.4 Is there a reasonable functional use and a technological need?  
The third and fourth aspects to be addressed in REACT NOW are similar to the requirements 
that currently exist in EU food legislation (EP and the Council 2008a, Commission 2011) and 
relate to whether there is a reasonable functional use of the NM in the product and if the 
application of the NM and nanoproduct is useful and necessary (Hansen 2017).  
For many applications of NMs, at least for consumer products, it is often unclear why 
NMs were used for other than commercial purposes (e.g. product branding). As noted by 
Hjorth et al. (2017b), it may be easiest in such cases simply to avoid using a given NM if it 
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serves no necessary function or is completely redundant. Hence, in order to obtain 
authorisation, the registrant has to describe the purpose of using NM(s) and the functional use 
of NM(s) in the applications for which they seek authorisation, as well as provide information 
necessary to verify that the proposed use does not mislead the consumer and that it has 
advantages and benefits for the consumer (EP and the Council 2008a). Functional use being 
defined as the why and how the NM is used (Tickner et al. 2015). Furthermore, verification 
has to be provided that there is a reasonable functional and technological need that cannot be 
achieved by other economically and technologically practicable means, such as in the case of 
EU regulation on food additives.  
 
8.2.5 Is the use for which authorisation is sought usable and effective? 
A fifth aspect to be addressed in REACT NOW is whether the application of the NM is to be 
considered usable and does what the producer claims, as well as whether the NM can be 
expected to be effective in the concentrations used and/or released during use (Hansen 2017). 
Usability is not only limited to the effectiveness, for instance, of biocidal active substances 
and products, but it also covers “the extent to which a product can be used by specified users 
to achieve specified goals with effectiveness” (ISO 1998). However, it is especially relevant 
for NM and biocidal products and biocidal applications, as it has been reported that minimum 
inhibitory concentrations of bacteria are magnitudes higher than the total NM released 
(Mackevica et al. 2016b).  
Inspired by the requirement to document efficacy under the BPR, the effectiveness of 
NMs should be described and specified for each use and method of application, if the latter 
does indeed influence effectiveness (ECHA 2014). This includes specifying the 
concentration-effectiveness relationship of the NM and the possible existence of a threshold 
concentration for the desired effect. Furthermore, justification for the selected concentrations 
for each use has to be provided and based on data and information in the form of laboratory 
studies, field test data, etc. Moreover, the registrant must demonstrate that the NM is effective 
and suitable for its intended use when applied according to its instructions. The use 
concentration should ideally be the minimum effective concentration under real conditions for 
the respective service life, taking into account all relevant parameters that affect efficacy. Any 
known limitations on effectiveness should be specified, including possible factors that may 
reduce efficacy, for instance hot, cold or humid environments, or the presence of other 
substances, in addition to as an explanation as to the reasons for these limitations (ECHA 
2014).  
In order to enhance the quality and image of products based on nanotechnology, and to 
protect consumers’ rights, the agency should set up a system for certifying nanoproducts, 
similar to the one currently implemented since 2004 by the Industrial Development Bureau, 
Ministry of Economic Affairs in Taiwan (Mackevica et al. 2016a). Authorisation should only 
be granted to uses of NMs that are considered good enough for a specified level after tests 
have to be completed by qualified and verified laboratories validating the claims made by 
manufacturers regarding the particle size and chemical constitution of the nanomaterials and 
their advertised efficacy (Hsu 2006). Hence, under the proposed regulatory framework 
REACT NOW, it is mandatory to disclose and report the use of NMs, and it is illegal to 
advertise and market products as “nano” when they do not contain nanomaterials. The 
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purpose of this strict regulation is to avoid confusion and protect the rights of consumers 
while also preventing “bad products from driving out good ones in a market glutted with 
nanoproducts of different quality” (Taiwan Nanotechnology Industry Development 
Association 2007, Industrial Development Bureau 2016).  
 
8.3 Evaluation and safety evaluation in REACT NOW 
A key component of REACT NOW is the safety evaluation used to lay the foundation for 
decisions about when authorisation should be given, and so it is suggested to employ 
NanoRiskCat to evaluate NMs and their uses (Hansen et al. 2014, 2017c, Hansen 2017).  
As mentioned earlier, existing legislation relies heavily on chemical risk assessment, 
but this has repeatedly been found to have a number of limitations when it comes to 
nanomaterials despite a decade of EHS research into adapting chemical risk assessments. For 
instance, Syberg and Hansen (2016) have pointed out that chemical risk assessment has a 
series of limitations, such as the fact that hazard identification, hazard characterisation and 
exposure assessment are highly data- and resource-intensive, and overall, they seem 
inadequate for informing policymakers in a timely manner about the complex health and 
environmental risks of nanomaterials, if not in the short term then most definitely in the long 
term. It has furthermore been argued that chemical risk assessment has a tendency to pack a 
wealth of information into a single number, thereby ignoring any nuances and richness.  
We do not know enough to say that nanomaterials are safe in quantitative terms, but 
there is evidence that some are certainly hazardous, depending on their particle 
characteristics, how they are applied and how humans and the environment are exposed to 
them. There is so much uncertainty about the hazards and exposure of NMs that any kind of 
quantitative risk characterisation and risk assessment does not make sense.  
As under REACH, the burden is on industry and it is up to the registrant to provide 
information in REACT NOW and fill out a NanoRiskCat evaluation for their NM and its 
specific uses. For guidance on how to fill out a NanoRiskCat evaluation, see Hansen et al. 
(2014, 2017c) and The Nanodatabase (2017) for numerous examples of how this can be done. 
In REACT NOW, the registrants are asked to fill out and report the human hazard and 
environmental hazard profiles first and subsequently the exposure profiles of the specific uses 
for which they seek authorisation. The agency is subsequently required to evaluate critically 
their submitted information as well as the NanoRiskCat evaluation completed by the 
registrant. Specifically, the agency has to ensure that the data used to fill out the NanoRiskCat 
evaluation are specifically relevant to the NM subject to the registration. When evaluating the 
information submitted by the registrant, the agency should rely on the approach developed by 
Hartmann et al. (2016) rather than Klimisch et al. (1997). 
 
8.4 Authorisation and Categorisation  
The generated NanoRiskCat safety evaluation can be divided into four overall 
categories, each of which includes a human health category as well as an environmental 
category (see Table 16).  
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Table 16. Overall NanoRiskCat categories based on the NanoRiskCat evaluations 
Category Outcome of NanoRiskCat Exposure potential evaluation Outcome of the NanoRiskCat hazard potential evaluation 
1 Human 
 
or 
 
    combined with or        
1 Environment    
 
   combined with      or   
2 Human 
 
or 
 
    combined with or        
2 Environment    
 
   combined with      or   
3 Human 
 
or 
 
    combined with or or      
3 Environment    
 
   combined with      or or 
 
4 Human 
 
or 
 
or or combined with          
4 Environment    
 
or  combined with          
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Depending on the outcome of the NanoRiskCat evaluation, manufacturers and importers of 
NMs and producers of NM products might have to seek authorisation to market or use 
specific NMs in specific applications. In REACT NOW, authorisation can only be given for 
specific uses of NMs and nanoproducts that are deemed necessary and obtaining general 
authorisation to use a given NM for several unspecified applications is not possible. The same 
goes for uses of NMs and products that are deemed unnecessary, as suggested by Baun et al. 
(2009).  
For uses of NMs that have a NanoRiskCat evaluation that falls into category 1 in Table 
16, meaning that they have a red professional end-user and/or consumer exposure profile 
combined with a red human health hazard profile, the registrant should be required to 
complete an Alternatives Assessment and the agency shall be required in REACT NOW to 
seek opinion on safe use from the European scientific committee of relevance, i.e. EFSA 
when it comes to food applications, SCCS when it comes to cosmetics and SCENIHR for all 
other applications. Similarly, for uses of NMs that have a red environmental exposure profile 
combined with a red environmental hazard profile, an Alternatives Assessment should be 
completed, and the agency should ask the Scientific Committee of Health and Environmental 
Risks (SCHER) for an opinion about safe use (Hansen 2017).  
It is important to underline that although the use of a given NM or a nanoproduct might 
be assigned an unfortunate combination of red hazard and exposure profiles, it does not imply 
that there is necessarily a risk of using the given product, as the actual concentrations used in 
it might be too low to cause adverse effects when used (Hansen et al. 2014, 2017c). 
As under the Novel Food regulation and the European regulation on cosmetic products, 
scientific committees should give their opinion within six months on the safety of a 
nanomaterial for specified uses upon receiving a request from the agency. In their opinion, 
and in their evaluation of the information submitted by the registrant as well as the 
Alternatives Assessment, aspects such as necessity of applied uses, the use of personal 
protection equipment for professional end-users, the possibility of skin penetration for 
consumer applications and actual NM concentration in the final product could be taken into 
consideration. Furthermore, as in the regulation concerning novel foods and novel food 
ingredients, possible effects on vulnerable groups of the population should be taken into 
consideration, by verifying that the most up-to-date test methods have been used to assess 
safety and highlighting uncertainties and limitations, where relevant.  
It is possible that products that have an all-red colour profile according to the 
NanoRiskCat, e.g. in the use of TiO2 in sunscreens, will be deemed safe to use by the 
scientific committees. In such cases, authorisation should be granted, but only if the specific 
use under consideration is deemed necessary. Here, it is furthermore important to note that 
especially the hazard evaluations in NanoRiskCat should be re-evaluated continuously in light 
of the published scientific literature as well as independent scientific expert evaluations 
(Hansen et al. 2014, 2017c). 
NM uses deemed not to be safe by the scientific committees, e.g. dispersive uses of 
HARN, indoor consumer uses of spray products with NMs associated with respiratory 
toxicity, should not be granted authorisation and should not be given permission to be 
marketed in Europe. The same goes for NMs and their uses that have one or more grey 
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exposure or hazard profiles in the NanoRiskCat evaluation, as this means that the registrant 
has not fulfilled the REACT NOW information requirements (Hansen 2017).  
For all other combinations of exposure and hazard profiles, i.e. NanoRiskCat categories 
2-4, the agency can ask for an opinion from the scientific committees of relevance on a case-
by-case basis. As a general rule, authorisation should only be given for specific professional 
end-user and consumer applications, if they have a green human health hazard profile 
combined with a green professional end-user exposure profile and consumer exposure profile, 
respectively. The same goes for uses that are expected to lead to environmental exposure – 
that they should only be granted authorisation if the NM in question has a green 
environmental hazard profile. Should the agency or the scientific committees have questions 
about the safety of the NM and its specific use, they can request additional information, which 
must be generated within 3 years, during which time conditional authorisation may be granted 
(Hansen 2017).  
For combinations of yellow exposure and hazard profiles, e.g. a yellow consumer 
exposure profile combined with a yellow human hazard potential or a yellow environmental 
exposure profile combined with a yellow environmental hazard profile, conditional 
authorisation is possible for a time-limited period, such as for 3 years, during which time the 
agency should ask the registrant to generate additional information (Hansen 2017).  
Overall, this means that a NM and a nanoproduct can be granted authorisation for 
specific professional end-user applications but not be granted authorisation when it comes to 
consumer uses. Similarly, a product would be granted authorisation under the condition that 
there is no environmental exposure throughout the life cycle of the product and this has been 
and can be documented (Hansen 2017).  
  
8.5 Alternatives Assessment  
REACH requires an Alternatives Assessment for substances of very high concern for which 
registrants seek authorisation (ECHA 2011). Broadly speaking, the use of Alternatives 
Assessments may help guide decisions when one potentially more toxic material or substance 
may be substituted by a less toxic alternative (Baun et al. 2009). According to Geiser et al. 
(2015), a “chemical Alternatives Assessment is a process for identifying, comparing and 
selecting safer alternatives to chemicals of concern (including those in materials, processes, or 
technologies) on the basis of their hazards, performance, and economic viability”. The 
blueprint for a Alternatives Assessment can be structured around three overall steps: 1) scope, 
2) assessment and 3) selection and implementation, according to Geiser et al. (2015), whereas 
Jacobs et al. (2016) work with six standard AA components: 1) hazard assessment, 2) 
exposure characterisation, 3) life cycle impact considerations, 4) technical feasibility, 5) 
economic feasibility assessment and 6) decision-making (i.e. how trade-offs among 
alternatives are evaluated and resolved) (Geiser et al. 2015, Jacobs et al. 2016, Malloy et al. 
2016).  
In REACT NOW, an Alternatives Assessment is required for uses of NMs that have 1) 
a red professional end-user and/or a consumer exposure profile combined with a red human 
health hazard profile and/or 2) a red environmental exposure profile combined with a red 
environmental hazard profile (Hansen 2017). This means that registrants have to identify 
candidate alternatives that will achieve the same purpose or function served by the chemical 
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of concern for a given application, evaluate and compare alternatives and the NM of concern 
based on a range of human and environmental health endpoints at critical life cycle points 
(e.g. manufacturing, use, disposal), and evaluate and compare technical and economic 
feasibility characteristics (OECD 2013, NRC 2014, Jacobs et al. 2016, Hjorth et al. 2017b).
More than a dozen Alternatives Assessment frameworks have been published over the last 
decade by academic institutions and by non-governmental and governmental organisations, 
and in REACT NOW, the registrants have to follow the National Academy of Sciences’ 
framework for Alternatives Assessment (NRC 2014) (see Figure 28), in which the focus 
should be on e.g. functional substitution, and not just on NM substitution (Tickner et al. 2015, 
Hjorth et al. 2017b). In a study by Hjorth et al. (2017b), the overall applicability of 
Alternatives Assessment for nanomaterials was tested when it comes to manufacturing 
processes and products, and it was concluded that Alternatives Assessment is appropriate for 
nanomaterials, though some adaptations are required (Hjorth et al. 2017b). Specifically, it was 
recommended 1) that the hazard comparison should be based primarily on results of actual 
toxicity tests (including high-throughput testing) rather than on hazard extrapolations from 
inherent physicochemical properties, 2) that the intrinsic exposure potential is considered as 
part of the comparative assessment process because there are distinct physicochemical 
properties as well as use characteristics that will distinguish which alternative (nano or bulk 
chemical) is fundamentally safer and, finally, 3) that the normal hazard assessment module 
might fail to differentiate between different alternatives incorporating nanomaterials, because 
it may not account adequately for the differences in toxicity among similar materials with 
slightly different properties (Hjorth et al. 2017b). In their Alternatives Assessment, registrants 
will have to document how they consider these and related aspects.  
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Figure 28: US NRC Alternatives Assessment framework (From Hjorth et al. 2017b)
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establishment of a publically available and searchable NM and NM product database (Hansen 
2010, Hansen and Baun 2012b). The NM database should include information provided as 
part of the registration and could be structured similar to the Nanowerk Nanomaterial 
Database (Nanowerk 2016), though it should also include the NanoRiskCat human health and 
environmental hazard profile of the NM and the HH and EE sentences. In regard to the NM 
product database, the agency could find inspiration in how The Nanodatabase is structured 
and run.  
Technical expertise is required in a lot of places in REACT NOW, especially when it 
comes to fulfilling information requirements. In order to assist registrants and especially 
SMEs in regard to gathering and/or generating the data and information they need in order to 
fulfil the information requirements technical assistance should be provided as part of REACT 
NOW (Hansen 2013, 2017). Given the nature of such a task, this requirement could fall under 
the jurisdiction of an entity such as the European Commission Joint Research Centre. 
Specifically, this entity would be responsible for providing confidential technical assistance 
on aspects related to the registration of NMs, such as whether a given NM falls under the 
SCENIHR definition used in REACT NOW, how to describe functional use, how to 
document technical needs and, finally, how to complete tests dismissing or validating the 
claims made by manufacturers regarding the particle size, advertised efficacy and chemical 
constitution of the nanomaterials in their products (Hansen 2010, 2013, 2017, Mackevica et 
al. 2016a). The current Nano Mark System, implemented by the Industrial Development 
Bureau, Ministry of Economic Affairs in Taiwan in 2004 for certifying nanoproducts, could 
be used as an inspiration for certification activities for which such an entity would be 
responsible under REACT NOW, whereas the Massachusetts Toxics Use Reduction Institute 
(TURI) could be a model for how to provide research, education, technical guidance and 
support to small and medium-sized companies (Hansen and Rejeski 2008, Mackevica et al. 
2016a). 
 
8.9 Opportunities and weaknesses of REACT NOW 
Although REACT NOW provides a number of opportunities there are weaknesses that are 
important to be aware of. Very often, these are not clear-cut opportunities or weaknesses, but 
rather issues of a dual nature in the sense that they can be perceived as opportunities or 
strengths from one perspective or under one set of circumstances and as weaknesses from 
another perspective or under another set of circumstances.  
One of first notable strengths of REACT NOW is that its scope covers production and 
all applications of NMs and that it is not limited to the manufacturing and import of NMs or 
in articles. This creates the opportunity to have one single regulatory framework for all uses 
on NMs and thus to ensure consistency across different pieces of EU legislation.  
SCENIHR’s definition of NMs is preferred in REACT NOW as there is a serious risk 
that some nanomaterials and uses of nanomaterials will not be captured by the EC definition 
if a 50% threshold is applied as noted by the Committee on the Environment, Public Health 
and Food Safety (2014). The SCENIHR definition, however, has several of the same 
limitations as the EC definition when it comes to operationalization, e.g. lack of validated 
standard methods to determine size and size distribution. These limitations can still not be 
avoided in REACT NOW – however technical and non-technical support is provided in 
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REACT NOW in order to assist especially SMEs in determining whether their materials are a 
nanomaterial or not. Similarly, having no volume registration threshold ensures that REACT 
NOW err on the side of caution as more materials that will be defined as nanomaterials, in 
comparison to the EC definition, and would subsequently have to go through the registration 
and safety evaluation process. 
Another prominent strength of REACT NOW is the unambiguous identification and 
naming of NMs and the fact that any variation in size, shape, surface area and surface of a 
treated NM that is commercialised in the EU has to be registered separately and put into a 
separate registration dossier. This will eliminate current confusion about whether 
nanomaterials should be considered different from their bulk counterpart, and the possibility 
of tonnage bands, which trigger a registration obligation, would not be reached. This provides 
regulatory clarity.  
The fact that any variation in the size, shape, surface area and surface of a treated NM 
that is commercialised in the EU has to be registered separately in REACT NOW could lead 
to what has been called “the extreme splitting of similar materials into various substances on 
their own” (UBA, BfR and BAuA 2013). Whether this is a weakness of REACT NOW what 
will eventually materialize itself is not quite clear as not all conceivable combinations of 
different nanomaterials and surface treatments are or should be commercially relevant in the 
first place. REACT NOW requirements to provide justification of necessity, functional need 
and effectiveness should also ensure that not all conceivable combinations of different 
nanomaterials will be registered.  
It is unclear at the moment, how the current information and testing requirements are to 
be applied to risk assess nanomaterials in many pieces of EU legislation e.g. REACH and the 
BPR. It is furthermore unclear how the information and data submitted by the registrant will 
eventually be evaluated and used by regulators. In REACT NOW, the information 
requirements are related specifically to documenting the identity of the registered NM, its 
functional use, the specific reason for which authorisation is sought and, finally, to filling out 
a NanoRiskCat evaluation. This reduces uncertainty about why the information requirements 
have to be fulfilled, which tests have to be completed and how the information and data 
provided by the registrant will eventually be evaluated and used. The information 
requirements are furthermore tiered in such a manner that no more information has to be 
generated once the human health and/or environmental hazard potential have been 
established.  
It is moreover, clear how the NanoRiskCat safety evaluation provides the foundation for 
evaluating when and under which conditions authorization can or is to be given or not given. 
Logical and easy to comprehend labelling	requirements	and	guidance	are	provided. 
When it comes to the evaluation aspect of REACT NOW, a clear tool for completing 
the safety evaluation of NM and its specific uses is provided in the form of NanoRiskCat, 
which again has been applied on more than 2,000 products. As mentioned in 7.3, 
NanoRiskCat has both some opportunities and some weaknesses that may transcend into 
REACT NOW. For instance, the exposure assessment in NanoRiskCat is arguably quite crude 
and does not consider the concentration of nanomaterials in the product nor how much of the 
materials, users are actually exposed to. Many of the nanomaterials subjected to the 
NanoRiskCat evaluation in The Nanodatabase have received a red human health and/or 
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environmental hazard profile, which could indicate that the approach suggested in 
NanoRiskCat is overly precautionary, which again would influence the authorisation process 
in REACT NOW. Here it is, first of all, important to note that the reasons for why the 
different nanomaterials receive a red colour code vary, and hence that there is not one single 
determinant that makes all materials go “red.” (Hansen et al. 2014, 2017c). Secondly, the fact 
that a	 given	 nanomaterial	 has	 gotten a red human health and/or environmental hazard profile 
does not necessarily mean that the use of the nanomaterial will eventually be restricted. It 
simply means that the registrant has to complete an Alternatives Assessment and that the 
information provided by the registrant is to be subject to an expert evaluation by the Scientific 
Committees. Thirdly, even if REACT NOW is precautionary, there is evidence that 
precautionary environmental health regulation does not hamper innovation (EEA 2013, 
Hansen and Tickner 2013, Hansen and Gee 2014). 
In REACT NOW, details are provided on how to complete the information 
requirements using tests that are tailored to investigate the ecotoxicological effects of NMs, 
however such detailed guidance still might have to be further developed in regard to human 
health. For nanomaterials that are not HARN, CLP classified or acute toxic, NanoRiskCat 
furthermore requires a holistic assessment of carcinogenic, respiratory, cardiovascular, 
reproductive effects, etc. in humans and/or laboratory animals. But limited guidance is 
provided in regard to how to complete this holistic assessment in Hansen et al. (2014, 2017c).  
Having to explain the functional uses and providing justification for the technological 
need that cannot be achieved by other economically and technologically practicable means is 
not something that producers, importers and downstream-users are used to in regard to the 
regulation of chemicals and technological development (Hansen and Gee 2014). It is, 
however, a well-established practice in EU food legislation though guidance on how to 
provide this justification is limited in the technical guidance provided by EFSA, and there 
seems to be a need to further develop such guidance.  
Registrants of active substances have a lot of experience with evaluation and providing 
documentation of the effectiveness under the BPR, which again will go a long way in regard 
to addressing the REACT NOW requirements to establish whether the application of the NM 
is to be considered usable, fulfils what the producer claims, and whether the NM can be 
expected to be effective in the concentrations used and/or released during use. 
As said, Alternatives Assessment plays a prominent role in the authorization process of 
REACT NOW, however also Alternatives Assessment still has some elements that need to be 
developed further when it comes to nanomaterials. For instance, which intrinsic hazard 
properties to take into consideration and how to combine hazard evaluation with intrinsic 
exposure consideration (Hjorth et al. 2017b). Guidance of how to complete Alternatives 
Assessments for various uses of nanomaterials should be prepared  
Authorisation should only be granted to uses of NMs that are considered to fulfil a 
specified level, after tests have been completed by qualified and verified laboratories 
validating the claims made by manufacturers regarding the particle size, structure, shape and 
chemical constitution of the nanomaterials and their advertised efficacy. However, what this 
“specified level” is supposed to be and how it can be determined will have to be a future 
challenge for the risk assessment research.  
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9. Conclusion and recommendations 
This doctoral thesis summarises the research that I have been involved in since 2009 with 
regard to the regulation and risk assessment of nanomaterials, specifically in relation to: 1) 
mapping current uses of nanomaterials in Europe, 2) understanding the limitations of existing 
legislation and 3) addressing the restraints of risk assessment and alternatives when it comes 
to nanomaterials. The outcome of this research has led me to conclude that the fact that 
nanomaterials are covered by the scope of existing legislation will not be enough to ensure the 
protection of human health and the environment and that we need a new regulatory 
framework tailored for NMs and their applications.  
The research regarding current uses of NMs clearly shows not only that the diversity of 
applications is immense, but also that we lack information and lack of access to information 
about key pieces of data such as production volumes, the identity of the NMs in various 
consumer products and concentrations used. It is furthermore clear that release from 
consumer products is to be expected and that environmental exposure will occur, although we 
do not understand the properties that govern the environmental fate and behaviour of NMs. 
Overall, this hampers our ability to complete any kind of meaningful risk assessment when it 
comes to NMs.	 
Despite recent revisions, carried out in order to take the specific properties of 
nanomaterials into account, many pieces of existing regulatory frameworks hold a vast 
amount of weaknesses such as, for instance, unclear definitions of key terminology when it 
comes to nanomaterials, threshold values and information requirements not tailored to the 
nanoscale, lack of metrological and characterisation tools and (eco)toxicological methods and 
data, as well as lack of occupational and environmental exposure limits.  
Initiatives that looked promising in the past included developing working definitions of 
nanomaterials, collecting existing data and product information, addressing data gaps in the 
field of (eco)toxicology, establishing best practices in regard to worker, health and safety 
protection and initiating public discussion about nanotechnology (Hansen 2010). However, 
the prospects of these initiatives have faded over the course of the past half-decade, as we 
seem to have become distracted along the way – attributable in part to bureaucratic inertia and 
in part to influential views that research jeopardises innovation and that regulation is bad for 
business (Hansen et al. 2008b, Hansen et al. 2013b). For instance, we have several NM 
definitions that have been hard to operationalise, and we still do not have an overview of what 
is produced, what is used, how much it is used and why it is used in the EU. Additionally, we 
still lack a fundamental understanding of how nanomaterials interact with living systems and 
how to assess the relevant end-points for nanomaterial toxicity, and we still have a paucity of 
usable data on the environmental hazards of nanomaterials. Moreover, we still lack test 
methods that would enable the safety assessment of numerous novel nanomaterials, and the 
public is not better informed or more engaged in the discussion about the benefits and risks of 
nanomaterials, and how they should be regulated than they were a decade ago.  
Many of the initiatives that have been taken are focused on collecting data but without 
making it mandatory for manufacturers and importers to provide this information and without 
making it clear how these data will eventually lead to the completion of risk assessments and 
how the limitations of risk assessment are to be overcome. It is furthermore unclear how the 
results of a risk assessment will lead to transparent risk management measures and how these 
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will be implemented and evaluated (Hansen 2010).   
Overall, it seems that governments and decision-makers in the EU are currently relying 
too heavily on nanomaterials falling under the scope of various pieces of existing legislation, 
e.g. REACH, which again are crumbled by our inability to: 1) develop an operational NM 
definition, 2) accept that NM properties are fundamentally different compared to bulk 
materials and should be considered identifiers and not characterisers and 3) complete a 
meaningful chemical risk assessment of nanomaterials (Hansen 2010, Syberg and Hansen 
2016). Additionally, as noted by representatives of the European Commission at a 2014 
OECD Expert Meeting on Categorisation of Manufactured Nanomaterials, the lack of specific 
risk management tools for assessing NMs means that case-by-case assessment is needed. 
Case-by-case assessment, on the other hand, is becoming increasingly difficult, due to the 
sheer quantity of current nanomaterials and new ones constantly being created. NMs are 
furthermore also difficult to regulate, due to a lack of information, their complexity and a 
regulatory framework tailored to chemicals rather than manufactured materials (Laursen, 
2014 cited in OECD 2016a).  
One of the key limitations identified relates to our lack of ability to complete 
meaningful risk assessments of NMs at this point in time. Several alternatives have been 
proposed, and based on an analysis of 50 of these as well as several reviews, I conclude that 
although there are several tools available that can be applied throughout the life cycle of a 
NM, each of them has a distinct weakness, especially in regard to regulatory relevance. 
Overall, these tools seem to be less prone in the final risk evaluation to the vulnerability of 
one or more of the preceding steps regarding hazard identification, hazard characterisation 
and exposure assessment. Only NanoRiskCat, developed by Hansen et al. (2014), was found 
to entail key elements that have subsequently been used in this thesis to develop a regulatory 
framework tailored to NMs. NanoRiskCat seems to be the only safety evaluation tool that has 
been designed to support regulatory decision-making and which is REACH- and CLP-
oriented – and it has already been applied on products including NMs.  
Given the cross-cutting nature of nanotechnology and nanomaterials, as well as the 
current pace of development, the challenges and limitations identified in the analysis of the 
revisions that have been implemented for existing legislation when it comes to NMs and an 
analysis of the proposed revisions, I conclude that it would be more effective to implement a 
new, authoritative and prescriptive regulatory framework tailored specifically to 
nanomaterials.  
I therefore propose the adoption of a framework called Registration, Evaluation, 
Authorisation, Categorisation and Tools to Evaluate Nanomaterials – Opportunities and 
Weaknesses (REACT NOW). Key elements of REAT NOW are presented in this thesis 
including when nanomaterials have to be registered, information requirements, how 
authorities are to evaluate submitted information, when authorisation to produce and use NMs 
should be granted/denied based on an overall assessment of the functional use, the necessity 
of NM use for which authorisation is sought, the effectiveness of the NM use and, finally, a 
NanoRiskCat evaluation and an Alternatives Assessment.  
It may seem premature to implement a proposal like REACT NOW that is 
fundamentally different, taking into consideration that it ends up with semi-qualitative 
conclusions and no quantitative estimations about risks. I would, however, argue that we have 
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many of the pieces needed in order to set up a whole new legislation framework for NMs. 
REACT NOW puts them together and provides a flexible and holistic framework that is able 
to provide timely decision support before the risks of nanomaterials have materialised. In 
addition, REACT NOW is inspired by existing amended regulations as well as proposed new 
legislative revisions by EU member states and NGOs, and it further introduces key missing 
elements developed over the past seven years at DTU Environment e.g. NanoRiskCat for 
NMs and Alternatives Assessment.  
We do not have all the answers to the scientific questions currently in circulation and 
which are relevant to raise, but we do know enough to start asking producers and importers to 
provide EHS information about the nanoform that they produce and/or use in their products. 
With REACT NOW we can provide them with some guidance on how to submit this 
information and which methods to use, how they should go about explaining the opportunities 
and weaknesses of their methods, and how they have used a multifaceted approach. We also 
know how to evaluate the applicability of the submitted information, and we have clear ideas 
about how the information itself and its quality can be assessed and evaluated and 
subsequently can provide the basis of an authorisation procedure.  
That is why I urge regulators to initiate REACT NOW, before it is too late. We are 
entering a phase in the development of nanotechnology where the early hype about the 
benefits of this mind-blowing technology is over. Initially, concerns raised about the adverse 
impact of nanomaterials have been very loud, but they are slowly quietening down and we 
can now expect 15-20 years of univocal EHS research that will not provide definitive answers 
(see Lawless et al. 1977, EEA 2001, 2013).  
That is why it is urgent now to react and to implement REACT NOW, to ensure public 
health and to protect the environment from the potential risks of nanomaterials.  
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